MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

Found 2176 cases where Vaccine is BCG or DT or HEPAB or MMR or OPV or TYP and Symptom is Immune system disorder or Immunodeficiency or Immunoglobulins decreased or Lymphadenopathy

Case Details (Sorted by Age)

This is page 1 out of 3

Result pages: 1 2 3   next


VAERS ID:27782 (history)  Vaccinated:1990-09-13
Age:0.7  Onset:1990-09-15, Days after vaccination: 2
Gender:Male  Submitted:1990-09-17, Days after onset: 2
Location:Maryland  Entered:1991-02-06, Days after submission: 142
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: on apnea monitor
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: 15SEP90; WBC 13.1; 15SEP90 T.C. normal
CDC 'Split Type': MD90116
Vaccination
Manufacturer
Lot
Dose
Route
Site
DT: DT ADSORBED (NO BRAND NAME)LEDERLE LABORATORIES2389002IMRL
Administered by: Public     Purchased by: Public
Symptoms: Angioneurotic oedema, Asthma, Convulsion, Deafness, Lymphadenopathy, Pyrexia, Stupor
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Asthma/bronchospasm (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Convulsions (narrow), Oropharyngeal allergic conditions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Eosinophilic pneumonia (broad), Hearing impairment (narrow), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (narrow)
Write-up: Fever 105.0, adenopathy (neck), angioneurotic edema, asthma, marked alteration in LOC, 2 convuls, short term hearing loss.

VAERS ID:28195 (history)  Vaccinated:1989-10-11
Age:0.2  Onset:1989-10-11, Days after vaccination: 0
Gender:Male  Submitted:0000-00-00
Location:South Carolina  Entered:1991-02-11
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': 900170101
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES256959   
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES238940 PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Injection site reaction, Lymphadenopathy, Screaming
SMQs:, Hostility/aggression (broad)
Write-up: CDC reports: 2 mo infant developed adenopathy at inject site area & screaming episode for more than 4 hrs following DTP/OPV immunization. Hospitalized 1 day. Child to receive DT only in future.

VAERS ID:28667 (history)  Vaccinated:1989-09-19
Age:0.4  Onset:1989-09-20, Days after vaccination: 1
Gender:Male  Submitted:0000-00-00
Location:Kansas  Entered:1991-02-12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: NA
Diagnostic Lab Data: NA
CDC 'Split Type': CO3305
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES9G01042  A
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Injection site reaction, Lymphadenopathy
SMQs:
Write-up: Local rxn w/local adenopathy;

VAERS ID:31607 (history)  Vaccinated:1991-03-14
Age:0.8  Onset:1991-03-22, Days after vaccination: 8
Gender:Male  Submitted:0000-00-00
Location:Unknown  Entered:1991-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: HibTITER
Current Illness:
Preexisting Conditions: no relevant hx.
Diagnostic Lab Data: Lymphocyte count - 80%.
CDC 'Split Type': WAES91040025
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 0  
Administered by: Unknown     Purchased by: Unknown
Symptoms: Anorexia, Lymphadenopathy, Lymphocytosis, Pharyngitis
SMQs:, Agranulocytosis (broad), Oropharyngeal infections (narrow)
Write-up: pt. recvd. vax & later developed diffuse lymphadenopathy w/ palpable nodes in inguinal,occipital,& cervical areas.

VAERS ID:33527 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:0000-00-00
Location:Texas  Entered:1991-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: No relevant hx
Diagnostic Lab Data: No relevant data
CDC 'Split Type': WAES90101379
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Lymphadenopathy, Tooth abscess
SMQs:, Osteonecrosis (broad)
Write-up: Pt exp mumps p/vax w/MMR;

VAERS ID:31677 (history)  Vaccinated:1991-04-15
Age:0.0  Onset:1991-04-27, Days after vaccination: 12
Gender:Female  Submitted:1991-06-19, Days after onset: 53
Location:California  Entered:1991-06-24, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': CA9153
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0695S0SC 
Administered by: Public     Purchased by: Public
Symptoms: Arthralgia, Lymphadenopathy, Paraesthesia, Rash, Urticaria, Vasodilatation
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Hypersensitivity (narrow), Arthritis (broad)
Write-up: Following vax pt felt hot, no temp measured; rash other than @ inject site, generalized adenopathy, hives, pain in joints, tenderness in joints, paresthesis continues as of 20MAY91;

VAERS ID:32499 (history)  Vaccinated:1990-08-20
Age:0.3  Onset:1991-01-14, Days after vaccination: 147
Gender:Male  Submitted:1991-04-22, Days after onset: 97
Location:Pennsylvania  Entered:1991-07-12, Days after submission: 81
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Pt exp fever x 24hrs p/2nd dose of OPV @ 3.5mo;
Other Medications:
Current Illness: Fever x 24hrs p/2nd dose
Preexisting Conditions: NONE
Diagnostic Lab Data: Culture bopsy reveals polio type 2;
CDC 'Split Type': PA91225
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER 1  
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES2719541  
Administered by: Private     Purchased by: Private
Symptoms: Globulins decreased, Immune system disorder, Myocarditis, Paralysis flaccid, Poliomyelitis
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Cardiomyopathy (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)
Write-up: Pt vaxed w/ 1st & 2nd dose;of DTP/OPV on 29JUN90 &20AUG90 respectively & exp viral myocarditis 14JAN91 admitted to Hosp; Culture biopsy reveals polio type 2, now has flaccid paralysis & graft versus host disease; Dx w/hypogammaglobulinemia;

VAERS ID:35689 (history)  Vaccinated:1991-08-05
Age:0.2  Onset:1991-08-07, Days after vaccination: 2
Gender:Male  Submitted:1991-10-02, Days after onset: 56
Location:Virginia  Entered:1991-10-21, Days after submission: 19
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': VA91083
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3049240IMLL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM580HC0IMRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3049540PO 
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Injection site oedema, Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: PC from MD, pt temp 101; pt would cry but no sound would come out of mouth; some local adenopathy @ inject site of DTP;

VAERS ID:36352 (history)  Vaccinated:1991-01-02
Age:0.4  Onset:1991-01-03, Days after vaccination: 1
Gender:Male  Submitted:1991-01-10, Days after onset: 7
Location:Arkansas  Entered:1991-11-14, Days after submission: 308
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': AR912
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2939500IMRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0617F0PO 
Administered by: Public     Purchased by: Public
Symptoms: Cough, Crying, Injection site reaction, Lymphadenopathy, Pyrexia, Rash, Screaming, Vomiting
SMQs:, Anaphylactic reaction (narrow), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Hypersensitivity (narrow)
Write-up: Low grade fever (99.8F), local rxn, rash other than @ inject site, adenophy generalized, abnormal crying $g4 hrs, vomiting; c/o coughing x 10 days;

VAERS ID:40527 (history)  Vaccinated:1991-12-16
Age:0.3  Onset:1991-12-16, Days after vaccination: 0
Gender:Male  Submitted:1992-01-06, Days after onset: 21
Location:Washington  Entered:1992-03-23, Days after submission: 77
Life Threatening? No
Died? Yes
   Date died: 1991-12-16
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: NA
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': WA92673
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3069241IMRL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM680HE1IMLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3089571PO 
Administered by: Private     Purchased by: Public
Symptoms: Atelectasis, Haemorrhage, Hepatocellular damage, Lymphadenopathy, Petechiae, Pulmonary oedema, Spleen disorder, Sudden infant death syndrome
SMQs:, Cardiac failure (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Neonatal disorders (narrow)
Write-up: SIDS found dead in crib;

VAERS ID:40604 (history)  Vaccinated:1988-08-29
Age:0.2  Onset:1988-08-29, Days after vaccination: 0
Gender:Male  Submitted:1992-03-19, Days after onset: 1298
Location:Virginia  Entered:1992-03-27, Days after submission: 8
Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: dx immune system def called histiocytosis-x-hands christian shuller disease;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2149500 L
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES2056080PO 
Administered by: Public     Purchased by: Other
Symptoms: Agitation, Bone disorder, Crying, Immune system disorder, Lymphadenopathy, Neoplasm, Pain, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Tumours of unspecified malignancy (narrow)
Write-up: High pitched crying, fever, large lymphnodes appearance x 5 days, not able to eat because of crying so much; lasted a period of days; pt taken to MD & told nothing was wrong, sx still occured & worsened; irritable behavior, jump in sleep;

VAERS ID:41988 (history)  Vaccinated:1992-03-05
Age:0.2  Onset:1992-03-17, Days after vaccination: 12
Gender:Male  Submitted:1992-03-25, Days after onset: 8
Location:Ohio  Entered:1992-05-15, Days after submission: 50
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': OH92026
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3169750IMRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3069560PO 
Administered by: Public     Purchased by: Public
Symptoms: Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: temp up & down from date of vax until 17MAR92 when mom found swollen gland neck & temp of 101;

VAERS ID:42047 (history)  Vaccinated:1992-04-30
Age:0.2  Onset:1992-05-01, Days after vaccination: 1
Gender:Unknown  Submitted:0000-00-00
Location:Michigan  Entered:1992-05-19
Life Threatening? No
Died? Yes
   Date died: 1992-05-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: pt had a UTI 1st wk of life;
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)MICHIGAN DEPT PUB HLTHTR1217A0IMRL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM190HK0IMLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0643L0PO 
Administered by: Private     Purchased by: Public
Symptoms: Apnoea, Atelectasis, Bronchitis, Cardiac arrest, Cyanosis, Lymphadenopathy, Petechiae, Sudden infant death syndrome
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Cardiomyopathy (broad), Neonatal disorders (narrow), Hypotonic-hyporesponsive episode (broad)
Write-up: @ 5AM on 1MAY92 pt was fed & put to sleep, 45 min later pt was foun blue & not breathing; despite CPR & ALLS rescue techniques pt died;

VAERS ID:37454 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:0000-00-00
Location:New York  Entered:1992-06-09
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: No relevant data;
CDC 'Split Type': WAES91070269
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: Pt recvd MMR vax & 3 wks later pt exp fever, adenopathy, & rash; no further details were provided;

VAERS ID:44481 (history)  Vaccinated:1992-05-22
Age:0.2  Onset:1992-05-26, Days after vaccination: 4
Gender:Male  Submitted:1992-06-03, Days after onset: 8
Location:Tennessee  Entered:1992-08-24, Days after submission: 82
Life Threatening? No
Died? Yes
   Date died: 1992-05-26
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': TN9280
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3189070 LL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM210HK0 RL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0653B0PO 
Administered by: Public     Purchased by: Public
Symptoms: Asphyxia, Hypoxia, Lung disorder, Lymphadenopathy, Petechiae, Pulmonary oedema, Respiratory disorder
SMQs:, Cardiac failure (narrow), Asthma/bronchospasm (broad), Haemorrhage terms (excl laboratory terms) (narrow), Acute central respiratory depression (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Eosinophilic pneumonia (broad)
Write-up: autopsy results not back sudden infant death synd;

VAERS ID:47818 (history)  Vaccinated:1992-09-24
Age:0.2  Onset:1992-09-28, Days after vaccination: 4
Gender:Male  Submitted:1992-12-02, Days after onset: 65
Location:Oklahoma  Entered:1992-12-07, Days after submission: 5
Life Threatening? No
Died? Yes
   Date died: 1992-09-28
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: small for gestational age
Diagnostic Lab Data: autopsy ruled out other causes of death;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3269140IMLL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM150JA0IMLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES 0  
Administered by: Private     Purchased by: Private
Symptoms: Enteritis, Hepatocellular damage, Laryngeal oedema, Lymphadenopathy, Petechiae, Respiratory disorder, Spleen disorder, Sudden infant death syndrome
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Anaphylactic reaction (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Pseudomembranous colitis (broad), Acute central respiratory depression (broad), Gastrointestinal nonspecific inflammation (narrow), Neonatal disorders (narrow), Hypersensitivity (narrow), Noninfectious diarrhoea (broad)
Write-up: died SIDS 4 days p/vax;

VAERS ID:49953 (history)  Vaccinated:1992-06-05
Age:0.5  Onset:1992-06-15, Days after vaccination: 10
Gender:Male  Submitted:1993-01-05, Days after onset: 204
Location:North Carolina  Entered:1993-02-17, Days after submission: 43
Life Threatening? No
Died? Yes
   Date died: 1992-06-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type': NC93006
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3149571IMRL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM18HH1IMLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0653F1PO 
Administered by: Public     Purchased by: Public
Symptoms: Haemorrhage, Lymphadenopathy, Stupor, Sudden infant death syndrome
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Neonatal disorders (narrow)
Write-up: pt expired (SIDS) on 15JUN92; pt did not awaken from afternoon nap; pt was not ill;

VAERS ID:51431 (history)  Vaccinated:1990-12-05
Age:  Onset:0000-00-00
Gender:Male  Submitted:1993-03-19
Location:Unknown  Entered:1993-04-01, Days after submission: 13
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: ~~ ~~In patient
Other Medications: Anthrax;
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: pos cervical & ax lymp adenopathy; pos Bx-nonsnuclear infilt
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
ANTH: ANTHRAX (NO BRAND NAME)UNKNOWN MANUFACTURER    
CHOL: CHOLERA (NO BRAND NAME)UNKNOWN MANUFACTURER    
MEN: MENINGOCOCCAL (NO BRAND NAME)UNKNOWN MANUFACTURER    
TYP: TYPHOID VI POLYSACCHARIDE (NO BRAND NAME)UNKNOWN MANUFACTURER    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Arthralgia, Asthenia, Laboratory test abnormal, Lymphadenopathy, Rash
SMQs:, Anaphylactic reaction (broad), Guillain-Barre syndrome (broad), Hypersensitivity (narrow), Arthritis (broad)
Write-up: rash hands, joint pains, fatigue, lymph node swelling;

VAERS ID:51577 (history)  Vaccinated:1993-02-09
Age:0.6  Onset:1993-02-11, Days after vaccination: 2
Gender:Female  Submitted:1993-03-10, Days after onset: 27
Location:Oklahoma  Entered:1993-04-05, Days after submission: 25
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: xray of knot in lt neck, blood work w/ inc WBC (small amt);
CDC 'Split Type': OK9312
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES2A411261IMLL
HIBV: HIB (HIBTITER)LEDERLE PRAXSIS150JA1IMRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3329731PO 
Administered by: Public     Purchased by: Public
Symptoms: Diarrhoea, Injection site hypersensitivity, Injection site mass, Leukocytosis, Lymphadenopathy
SMQs:, Neuroleptic malignant syndrome (broad), Pseudomembranous colitis (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypersensitivity (narrow), Noninfectious diarrhoea (narrow)
Write-up: severe diarrhea 2 days p/vax w/no fever; no fussiness; knot in lt parotid gland that involved lt side of face & neck; prev shots had no knots @ site of inject but this time both inject sites were red & hard x 3 days;

VAERS ID:52338 (history)  Vaccinated:1993-03-10
Age:0.2  Onset:1993-03-16, Days after vaccination: 6
Gender:Male  Submitted:1993-04-19, Days after onset: 33
Location:Colorado  Entered:1993-05-03, Days after submission: 14
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': CO93030
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES2A411270IMRL
HEP: HEP B (FOREIGN)MERCK & CO. INC.0891T1IMLL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM585JD0IMLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0668M0PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Apnoea, Lung disorder, Lymphadenopathy, Pericarditis, Petechiae, Pneumonia, Pulmonary haemorrhage, Pulmonary oedema
SMQs:, Cardiac failure (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Acute central respiratory depression (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Eosinophilic pneumonia (broad), Chronic kidney disease (broad)
Write-up: poss SIDS, bronchopneumonio, mild, respiratory, edema & endocarditis;

VAERS ID:54411 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:0000-00-00
Location:Illinois  Entered:1993-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: No relevant data;
CDC 'Split Type': WAES92100255
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: Pt recvd vax & exp low grade fevers, skin rashes, swollen glands; No further details were provided;

VAERS ID:56343 (history)  Vaccinated:1993-09-14
Age:0.4  Onset:1993-09-14, Days after vaccination: 0
Gender:Female  Submitted:1993-09-22, Days after onset: 8
Location:California  Entered:1993-09-28, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: complement specific immune complex 21 H;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES3429721 RL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM110KA0 LA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0690A1PO 
Administered by: Private     Purchased by: Private
Symptoms: Immune system disorder, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: pt recvd vax 14SEP93 & parents called that evening pt broke out w/rash all over; advised to bring pt to ER; In ER Atarax was given;

VAERS ID:56871 (history)  Vaccinated:1993-10-05
Age:0.2  Onset:1993-10-15, Days after vaccination: 10
Gender:Male  Submitted:1993-10-18, Days after onset: 3
Location:North Dakota  Entered:1993-11-01, Days after submission: 14
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': ND93017
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES3J410633IMRL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM175HN3IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1690V0SCRA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES679M12PO 
Administered by: Public     Purchased by: Public
Symptoms: Lymphadenopathy, Pyrexia, Scrotal oedema, Vasodilatation
SMQs:, Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: t102, swollen glands on neck, red swollen scrotum, glands in genital area also swollen;

VAERS ID:60401 (history)  Vaccinated:1993-06-25
Age:0.2  Onset:1993-06-28, Days after vaccination: 3
Gender:Male  Submitted:1994-02-02, Days after onset: 219
Location:Michigan  Entered:1994-03-10, Days after submission: 36
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Pt exp vax @ 2 mos w/OPV #1;
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)MICHIGAN DEPT PUB HLTHTR1219B0IML
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM190JF0IML
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3409200PO 
Administered by: Public     Purchased by: Other
Symptoms: Anorexia, Crying, Drug ineffective, Immune system disorder, Infection, Leukopenia, Otitis media, Poliomyelitis
SMQs:, Haematopoietic leukopenia (narrow), Lack of efficacy/effect (narrow), Systemic lupus erythematosus (broad), Depression (excl suicide and self injury) (broad)
Write-up: Pt recvd vax & refused to drink formula also devel a fever, was fussy & t102.5; cont to scream a high pitched cry; viral meningitis; JUL93 devel ear infect; stool specimen & the spinal column fluid contained both type 1 & type 2 polio;

VAERS ID:61813 (history)  Vaccinated:1994-03-09
Age:0.6  Onset:1994-03-09, Days after vaccination: 0
Gender:Male  Submitted:1994-03-10, Days after onset: 1
Location:Illinois  Entered:1994-04-18, Days after submission: 38
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': IL94029
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES3F511242IMRL
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.1414W2IMRL
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM005KP2IMRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3689822PO 
Administered by: Public     Purchased by: Public
Symptoms: Crying, Injection site mass, Injection site oedema, Injection site pain, Lymphadenopathy, Pyrexia, Screaming, Vasodilatation
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Depression (excl suicide and self injury) (broad)
Write-up: onset of 1st sx t102.4; local react site lt leg; pain swelling, inc warmth induration of lump w/o abscess; adenopathy local (inject site area); screaming episode high pitch lasting 3 hrs;

VAERS ID:62980 (history)  Vaccinated:1990-09-26
Age:0.3  Onset:1990-10-11, Days after vaccination: 15
Gender:Male  Submitted:1993-11-15, Days after onset: 1131
Location:Virginia  Entered:1994-05-18, Days after submission: 183
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NA
Preexisting Conditions: NONE diagnosed @ time;
Diagnostic Lab Data: polio disability;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER    
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURER 1  
Administered by: Private     Purchased by: Other
Symptoms: Arthritis, Drug ineffective, Immune system disorder, Immunoglobulins decreased, Infection, Muscle atrophy, Poliomyelitis, Pyrexia
SMQs:, Lack of efficacy/effect (narrow), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Arthritis (narrow)
Write-up: recpvered w/polio disability; pt developed fever, rash, then lost use of legs; devel arthritis of both knees; polio dx''d, then found Bruton''s agammaglobulinemia; undergoing PT; walks, but rt leg has muscle atrophy;

VAERS ID:65536 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:0000-00-00
Location:California  Entered:1994-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: No relevant data;
CDC 'Split Type': WAES93060269
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: pt recvd vax & devel submandibular gland swelling; No further details were provided;

VAERS ID:63380 (history)  Vaccinated:1994-03-31
Age:0.3  Onset:1994-04-08, Days after vaccination: 8
Gender:Male  Submitted:1994-05-24, Days after onset: 46
Location:California  Entered:1994-06-13, Days after submission: 20
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: Blood tests, bone marrow, coombs test; Hemoglobin 2.8; Hematacrit 8.1;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES3589181  
HEP: HEP B (ENGERIX-B)SMITHKLINE BEECHAM1268B21  
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3649781  
Administered by: Private     Purchased by: Private
Symptoms: Anaemia, Diarrhoea, Haemolysis, Haemolytic anaemia, Hypochromic anaemia, Immune system disorder, Pallor, Somnolence
SMQs:, Haemolytic disorders (narrow), Haematopoietic erythropenia (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Pseudomembranous colitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypotonic-hyporesponsive episode (broad), Noninfectious diarrhoea (narrow)
Write-up: 8-10APR excessive sleepiness, diarrhea, pale; 11-15APR pt recvd blood transfusions for profound anemia-hemoglobin 2.8, hematacrit 8.1; 15-19APR blood transfusions dx-autoimmun hemalytic anemia;

VAERS ID:64754 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061055
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w autism & encephalopathy;

VAERS ID:64755 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061056
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64756 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061057
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64757 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061058
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64758 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061059
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64759 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061060
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64760 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061061
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64761 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061062
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax & was dx w/ autism & encephalopathy;

VAERS ID:64762 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1994-07-13
Location:California  Entered:1994-07-15, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES94061063
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Autism, Drug ineffective, Immune system disorder
SMQs:, Lack of efficacy/effect (narrow)
Write-up: pt recvd vax; pt had fever & szs; Pt dx w/ autism & encephalopathy;

VAERS ID:65907 (history)  Vaccinated:1994-04-09
Age:0.5  Onset:1994-06-25, Days after vaccination: 77
Gender:Male  Submitted:1994-08-04, Days after onset: 40
Location:Utah  Entered:1994-08-15, Days after submission: 11
Life Threatening? Yes
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: bare lymphocyte synd; polio type II virus isolated from stool;
CDC 'Split Type': UT941818
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES3669482 LL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES699F22PO 
Administered by: Private     Purchased by: Private
Symptoms: Drug ineffective, Immune system disorder, Infection, Influenza, Meningitis, Pneumonia, Poliomyelitis, White blood cell disorder
SMQs:, Haematopoietic leukopenia (broad), Lack of efficacy/effect (narrow), Noninfectious meningitis (narrow), Eosinophilic pneumonia (broad)
Write-up: fever & cold-like sx began 25JUN94 pt was given Septra sx did not improve; MD visit 5JUl94 & dx w/pneumonia, ear infections & flu; mom reported child''s lt arm limp 8JUL94; on 9JUL94 visted hosp ER; spinal tap revealed meningitis;

VAERS ID:72057 (history)  Vaccinated:1995-03-03
Age:0.8  Onset:1995-03-05, Days after vaccination: 2
Gender:Female  Submitted:1995-03-06, Days after onset: 1
Location:Illinois  Entered:1995-03-13, Days after submission: 7
Life Threatening? No
Died? Yes
   Date died: 1995-03-05
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: autopsy is pending;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES4H510571 LL
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.1006A1 RL
HIBV: HIB (HIBTITER)LEDERLE LABORATORIES4M511181 LL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3849391PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Haemorrhage, Laryngeal oedema, Lymphadenopathy, Petechiae, Pulmonary oedema, Vasodilatation
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow)
Write-up: no react-no local react, no fever, no fussiness, no drowsiness, no loss of appetite) Sudden death;

VAERS ID:73323 (history)  Vaccinated:1993-12-21
Age:0.2  Onset:1993-12-25, Days after vaccination: 4
Gender:Male  Submitted:1995-04-13, Days after onset: 473
Location:Illinois  Entered:1995-04-18, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: skin biopsy-dx non malignant mastocytosis;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES3B510200 RL
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0851W0 L
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM130JC0 L
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES3609520PO 
Administered by: Public     Purchased by: Private
Symptoms: Immune system disorder, Injection site hypersensitivity, Laboratory test abnormal, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow)
Write-up: urticaria covering body began 4 days p/vax @ inj site; eventual dx of mastocytosis;

VAERS ID:74100 (history)  Vaccinated:1995-04-25
Age:0.2  Onset:1995-04-25, Days after vaccination: 0
Gender:Male  Submitted:1995-04-25, Days after onset: 0
Location:Texas  Entered:1995-05-15, Days after submission: 20
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NA
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type': TX95078
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES4A611030 RL
HEP: HEP B (ENGERIX-B)SMITHKLINE BEECHAM1646B21 LL
HIBV: HIB (ACTHIB)CONNAUGHT LABORATORIES4A611030 RL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0707B0PO 
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Crying, Cyanosis, Lymphadenopathy, Pallor, Rhinitis, Vasodilatation
SMQs:, Anaphylactic reaction (broad), Anticholinergic syndrome (broad), Dementia (broad), Acute central respiratory depression (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad)
Write-up: mom stated pt awoke w/high pitch scream & color was bad advised to take pt to ER;pt had drainage @ back of throat; glands were swollen, color flushed, pale, blue corner of mouth & temple

VAERS ID:74954 (history)  Vaccinated:1995-05-17
Age:0.6  Onset:1995-05-18, Days after vaccination: 1
Gender:Male  Submitted:0000-00-00
Location:New York  Entered:1995-06-16
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: none
Other Medications:
Current Illness: none
Preexisting Conditions: premature
Diagnostic Lab Data:
CDC 'Split Type': BAS022
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER    
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME)UNKNOWN MANUFACTURER    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Agitation, Anorexia, Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad)
Write-up: pt recv vax; swollen glands; fever 103; irritable, loss of appetite

VAERS ID:75158 (history)  Vaccinated:1995-06-05
Age:0.3  Onset:1995-06-05, Days after vaccination: 0
Gender:Male  Submitted:1995-06-07, Days after onset: 2
Location:Illinois  Entered:1995-06-19, Days after submission: 12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: heart murmur premature infant
Diagnostic Lab Data: NONE
CDC 'Split Type': IL950067
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0734A0SC 
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Face oedema, Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Hypersensitivity (narrow)
Write-up: 7PM pt began to feel hot, irritable; 730 mom gave APAP, t101.2 @ that time; 830PM temp elevated 103; gave 20 mins tepid bath; temp elevated 103.4; eye swollen, red rash; MD stated rxn to MMR; glands & eyes swollen

VAERS ID:77540 (history)  Vaccinated:1995-09-12
Age:0.2  Onset:1995-09-12, Days after vaccination: 0
Gender:Male  Submitted:1995-09-12, Days after onset: 0
Location:Pennsylvania  Entered:1995-09-19, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: pt sibling exp crying 10hrs, swollen leg, local rxn @ 2mos w/DTP/HIB 1st dose
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES4280330IMLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0723L0PO 
Administered by: Private     Purchased by: Private
Symptoms: Immune system disorder, Screaming
SMQs:, Hostility/aggression (broad)
Write-up: unconsolable crying for 5 hrs p/vax; pt recovered; uneventfully

VAERS ID:77914 (history)  Vaccinated:1994-11-14
Age:0.2  Onset:1995-01-17, Days after vaccination: 64
Gender:Female  Submitted:0000-00-00
Location:California  Entered:1995-10-05
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER    
HIBV: HIB (NO BRAND NAME)UNKNOWN MANUFACTURER    
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURER    
Administered by: Private     Purchased by: Private
Symptoms: Convulsion, Drug ineffective, Hypocalcaemia, Immune system disorder, Infection, Paralysis flaccid, Poliomyelitis, Weight decreased
SMQs:, Rhabdomyolysis/myopathy (broad), Lack of efficacy/effect (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Generalised convulsive seizures following immunisation (narrow), Chronic kidney disease (broad), Tumour lysis syndrome (broad)
Write-up: pt recvd vax & devel rash-dx''d seborrhea given Pred;next couple days limbs stopped moving, became floppy, wgt loss, high BP, hospitalized w/low CA x 1 1/2mo;to another hosp told had advanced stage polio;dx''d genetic immune disorder;

VAERS ID:78203 (history)  Vaccinated:1995-10-03
Age:0.2  Onset:1995-10-05, Days after vaccination: 2
Gender:Male  Submitted:1995-10-09, Days after onset: 4
Location:California  Entered:1995-10-18, Days after submission: 9
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: observed
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES4280370 LA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES720M20PO 
Administered by: Private     Purchased by: Private
Symptoms: Lymphadenopathy, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: diffuse over lying erythema & Pecan size (2-3cm) reactive lymphadenitis in lt inguinal area above inj site on lt thigh;no inj site inflammation nor abscess

VAERS ID:82824 (history)  Vaccinated:1995-08-10
Age:0.3  Onset:1995-08-10, Days after vaccination: 0
Gender:Female  Submitted:1995-08-18, Days after onset: 8
Location:Virginia  Entered:1996-01-11, Days after submission: 146
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: unk
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': 895262005L
Vaccination
Manufacturer
Lot
Dose
Route
Site
DT: DT ADSORBED (NO BRAND NAME)LEDERLE LABORATORIES 1IM 
HIBV: HIB (HIBTITER)LEDERLE PRAXSIS 1IM 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Private     Purchased by: Private
Symptoms: Lymphadenopathy
SMQs:
Write-up: pt recvd vax & devel lymphadenopathy on rt side of neck;

VAERS ID:86703 (history)  Vaccinated:1995-04-07
Age:  Onset:1995-04-09, Days after vaccination: 2
Gender:Female  Submitted:0000-00-00
Location:New Jersey  Entered:1996-06-05
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data
CDC 'Split Type': WAES95040725
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Arthralgia, Injection site pain, Lymphadenopathy, Oedema peripheral, Pharyngitis, Pyrexia
SMQs:, Cardiac failure (broad), Agranulocytosis (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Arthritis (broad)
Write-up: pt recv vax 7APR95 & 8APR95 or 9APR95 pt exp pain around site & swelling;lymph node in the lt axilla swelled;14APR95 t103 & soreness & enlargement of the node cont;MD gave cephalexin for tx;15 or 16APR95 pt exp joint pain, sore throat;

VAERS ID:87052 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:0000-00-00
Location:Wisconsin  Entered:1996-06-05
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: no relevant data;
CDC 'Split Type': WAES96021108
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: pt recv vax & pt devel swollen glands 48hrs p/vax given;no further details were provided;

VAERS ID:92303 (history)  Vaccinated:1996-11-14
Age:0.3  Onset:1996-11-14, Days after vaccination: 0
Gender:Male  Submitted:1996-11-21, Days after onset: 7
Location:California  Entered:1996-11-26, Days after submission: 5
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: cardiac echo
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES4391931 RL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0750A1PO 
Administered by: Private     Purchased by: Private
Symptoms: Agitation, Coronary artery disease, Dehydration, Lymphadenopathy, Mucous membrane disorder, Pyrexia, Vasculitis, Vomiting
SMQs:, Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Other ischaemic heart disease (narrow), Vasculitis (narrow)
Write-up: pt devel fever, irritability, vomiting win 2hr of vax;pt became dehydrated, devel mucositis & was found to have kawasakis disease (mucocataneous lymph node synd) w/coronary artery deilation dx 6 day p/vax;

VAERS ID:94642 (history)  Vaccinated:1996-01-31
Age:0.0  Onset:1996-02-01, Days after vaccination: 1
Gender:Male  Submitted:1996-04-04, Days after onset: 63
Location:Texas  Entered:1997-01-21, Days after submission: 292
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: NA
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: MAR96 blood cult-negative;WBC inc;spinal tap-nl, x-ray (arm) nl;US-nl;liver function-nl immunoglobulin-nl;
CDC 'Split Type': 1925
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (TICE)ORGANON-TEKNIKA 0SCLA
Administered by: Private     Purchased by: Other
Symptoms: Injection site abscess, Injection site mass, Injection site oedema, Leukocytosis, Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: arm became swollen;early abscess formation occurred;ax lymph node was swollen to 2x2cm & supraclavicular node was 1x1cm;t103 & adm to hosp;few days later fever persisted;dx lymphadenopathy/fever;affected area indurated;elevated WBC;

VAERS ID:100026 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:0000-00-00
Location:Florida  Entered:1997-06-02
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: No relevant data;
CDC 'Split Type': WAES96110052
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Drug ineffective, Infection, Lymphadenopathy, Rash
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Hypersensitivity (narrow)
Write-up: pt recv vax & devel a rash & inflammation of lymph nodes;pt was dx w/rubella by MD;

VAERS ID:100082 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:0000-00-00
Location:New York  Entered:1997-06-02
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: No relevant data;
CDC 'Split Type': WAES97020797
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: pt recv vax & 7 days p/vax pt devel sx indicative of measles, including gen rash, swollen glands, fever of 102-103;

VAERS ID:99842 (history)  Vaccinated:1996-02-29
Age:0.1  Onset:1996-03-06, Days after vaccination: 6
Gender:Female  Submitted:1997-07-01, Days after onset: 481
Location:Arizona  Entered:1997-07-09, Days after submission: 8
Life Threatening? No
Died? Yes
   Date died: 1996-03-06
   Days after onset: 0
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: Autopsy report: interstitual pneumonia, mesenteric lymphadenopathy, passive congestion of viscera, benign ovarian cysts, & acute encephalomyelitis;COD pneumonia;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES426115  RL
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0094B  LL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES7334E PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Agitation, Apnoea, Cyst, Encephalitis, Infection, Lymphadenopathy, Pneumonia, Vasodilatation
SMQs:, Anticholinergic syndrome (broad), Dementia (broad), Acute central respiratory depression (narrow), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Eosinophilic pneumonia (broad)
Write-up: 6 days p/vax pt died suddenly @ home;father was holding pt & fell asleep when awoke pt not breathing- had be fussier than usual;Autopsy report: interstitual pneumonia, mesenteric lymphadenopathy, passive congestion of viscera;COD pneumonia

VAERS ID:102768 (history)  Vaccinated:1997-01-30
Age:0.4  Onset:1997-02-04, Days after vaccination: 5
Gender:Female  Submitted:1997-09-15, Days after onset: 222
Location:Ohio  Entered:1997-09-29, Days after submission: 14
Life Threatening? No
Died? Yes
   Date died: 1997-02-07
   Days after onset: 3
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Ceftriaxone, tremethoprim;sulfamethoxazole, acetaminophen
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: 4FEB positive leukocyte esterase;6FEB hemoglobin 2.3;WBC 65;coombs test positive;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES4386211 LL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES4398711PO 
Administered by: Private     Purchased by: Private
Symptoms: Anorexia, Apnoea, Cardiac arrest, Coagulopathy, Haemolytic anaemia, Immune system disorder, Renal failure acute, Urinary tract infection
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Haemolytic disorders (narrow), Anaphylactic reaction (broad), Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Cardiomyopathy (broad), Tumour lysis syndrome (broad)
Write-up: 4FEB97 fussy, dec oral intake, fever, nasal congestion;impression: UTI. Plan: ceftriaxone & Bactrim 3/4 teas 12hr x 1wk;6FEB97 lethargy, irritability;hosp hemolytic anemia;7FEB97 acute renal failure, disseminated intravascular coagulation

VAERS ID:102826 (history)  Vaccinated:1997-05-26
Age:0.3  Onset:1997-06-09, Days after vaccination: 14
Gender:Male  Submitted:1997-06-24, Days after onset: 15
Location:Texas  Entered:1997-09-30, Days after submission: 98
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: Keflex for peri rectal abscess @ that time;
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: spinal tap being done that revealed 48 WBC, 2RBC, 100% lymphocytes;spinal fluid glucose was 44;protein 55;sodium 139, potassium 4.5, chloride 102, co2 21 creatinine 0.2;WBC 12,300 w/48segs & 52 lymph
CDC 'Split Type': TX97117
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPHIB: DTP + HIB (TETRAMUNE)LEDERLE LABORATORIES4432641 LL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0760L1PO 
Administered by: Private     Purchased by: Private
Symptoms: Cough, Hypokinesia, Infection, Lymphadenopathy, Paralysis, Poliomyelitis, Pyrexia, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hypotonic-hyporesponsive episode (broad)
Write-up: pt recv vax & devel fever 10 days;v x2, fussy,sl cough, neck & ax nodes;dx viral synd;fever x 2 1/2 days;pt reported not to use or be moving lt leg;dec activity lt leg;referred to orthopedist;lt leg paresis;dx viral infect;

VAERS ID:107095 (history)  Vaccinated:1991-12-30
Age:0.5  Onset:0000-00-00
Gender:Male  Submitted:1997-11-04
Location:New Jersey  Entered:1998-01-21, Days after submission: 78
Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: unk
Current Illness: none
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': 897324004L
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES  IM 
HIBV: HIB (HIBTITER)LEDERLE PRAXSIS  IM 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0645F2PO 
Administered by: Private     Purchased by: Other
Symptoms: Anorexia, Hyperkinesia, Immune system disorder, Infection, Mental retardation severity unspecified, Thinking abnormal
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Akathisia (broad), Psychosis and psychotic disorders (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad)
Write-up: pt recv vax & mom report child is having problems w/child mentally & physically;dx of attention deficit hyperactivity disorder made a number of times;mom attributes problems to stealth virus infect & believes orimune to be the source of inf

VAERS ID:109835 (history)  Vaccinated:1998-04-01
Age:0.7  Onset:1998-04-09, Days after vaccination: 8
Gender:Female  Submitted:1998-04-10, Days after onset: 1
Location:Arizona  Entered:1998-04-20, Days after submission: 10
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NA
Other Medications: APAP & motrin
Current Illness:
Preexisting Conditions: hx amoxicillin allergy-rash in past
Diagnostic Lab Data: NA
CDC 'Split Type': AZ9833
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (TRIPEDIA)CONNAUGHT LABORATORIES0915783 LA
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM195RF3  
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.10009E0SC 
VARCEL: VARICELLA (VARIVAX)MERCK & CO. INC.1326E0SC 
Administered by: Public     Purchased by: Public
Symptoms: Face oedema, Lymphadenopathy, Rash maculo-papular
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow)
Write-up: maculopapular rash cheeks $g small amount trunk & chest & legs;mild upper eyelid edema;cervical node rt;

VAERS ID:111617 (history)  Vaccinated:1997-07-10
Age:  Onset:1997-07-30, Days after vaccination: 20
Gender:Female  Submitted:1998-05-29, Days after onset: 303
Location:Florida  Entered:1998-06-02, Days after submission: 4
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: No relevant data;
Other Medications: unk
Current Illness:
Preexisting Conditions: unk
Diagnostic Lab Data:
CDC 'Split Type': WAES97080126
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: pt was exposed to a child who recv vax 10JUL97 & 30JUL97 pt felt that through household contact may have measles;devel swollen glands;

VAERS ID:111709 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:1998-05-29
Location:Florida  Entered:1998-06-02, Days after submission: 4
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: No relevant data;
Other Medications:
Current Illness:
Preexisting Conditions: unk
Diagnostic Lab Data:
CDC 'Split Type': WAES97111470
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
VARCEL: VARICELLA (VARIVAX)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: pt recv vax & 3wk p/vax pt exp swollen lymph nodes all over the body;

VAERS ID:114751 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:1998-09-30
Location:Kentucky  Entered:1998-10-06, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: unk
Other Medications: Synthroid, Zantac, Propulsid, Vit B12;
Current Illness: NONE
Preexisting Conditions: allergies, HTN, gastric,bypass,negative varicella titer also
Diagnostic Lab Data: WNL titer MMR 6wk from administration;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0738E SCLA
Administered by: Public     Purchased by: Other
Symptoms: Diarrhoea, Headache, Injection site pain, Lymphadenopathy, Nausea, Pyrexia
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow)
Write-up: T99 to 101;soreness in area shot given (2wk lasting);swollen glands under jaw line;nausea, h/a, diarrhea;titer negative to MMR prior to vaccine;

VAERS ID:115465 (history)  Vaccinated:1998-05-05
Age:0.0  Onset:0000-00-00
Gender:Male  Submitted:1998-07-24
Location:Ohio  Entered:1998-10-30, Days after submission: 98
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: hepatitis vaccine
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: cult of removed lymph nodes-revealed acid fast bacilli
CDC 'Split Type': BOO4798
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (TICE)ORGANON-TEKNIKA451C0230 RA
Administered by: Public     Purchased by: Other
Symptoms: Infection, Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: pt recv vax & devel T104 maximum & inflamed rt axillary lymph nodes;approx the beginning of JUL pt lymph nodes had to be removed;cult of rt axillary lymph nodes revealed acid fact bacilli;sl swollen lymph & low temp;

VAERS ID:116376 (history)  Vaccinated:1998-09-15
Age:  Onset:1998-10-12, Days after vaccination: 27
Gender:Unknown  Submitted:1998-10-13, Days after onset: 1
Location:Minnesota  Entered:1998-11-13, Days after submission: 31
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0769E   
Administered by: Unknown     Purchased by: Unknown
Symptoms: Ear pain, Face oedema, Infection, Lymphadenopathy, Pyrexia
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: pt recv vax 15SEP98 & on 12OCT98 pt came down w/a fever & earache;13OCT98 reported to MD w/rt sided neck swelling in addition to the above complaints;MD dx vaccine induce mumps since there is no known exposure;

VAERS ID:118486 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:1998-09-25
Location:Arizona  Entered:1999-02-01, Days after submission: 129
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: UNK
Other Medications: UNK
Current Illness: UNK
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': U199800554
Vaccination
Manufacturer
Lot
Dose
Route
Site
TYP: TYPHOID VI POLYSACCHARIDE (TYPHIM VI)CONNAUGHT LABORATORIESPO323   
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: Pt recv vax on unknown day; post vax pt exp swollen lymph nodes of the inguinal region

VAERS ID:120511 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:1999-03-03
Location:Tennessee  Entered:1999-03-23, Days after submission: 20
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: pt sibling also had a severe immune deficiency & devel vax assoc paralytic polio
Other Medications: unk
Current Illness: unk
Preexisting Conditions: severe immune deficiency
Diagnostic Lab Data: unk
CDC 'Split Type': 899072060A
Vaccination
Manufacturer
Lot
Dose
Route
Site
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Other     Purchased by: Other
Symptoms: Immune system disorder, Infection, Paralysis flaccid
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)
Write-up: MD reported pt recv vax & devel vaccine-associated paralytic poliomyelitis;it was later determined that pt had severe immune deficiency;the child died 8 or 9 years ago d/t the immunodeficiency;MD stated event poss reported to CDC;

VAERS ID:120512 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:1999-03-03
Location:Tennessee  Entered:1999-03-23, Days after submission: 20
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: pt sibling had severe immune deficienty & devel vax assoc paralytic polio
Other Medications: unk
Current Illness: unk
Preexisting Conditions: severe immune deficiency
Diagnostic Lab Data: unk
CDC 'Split Type': 899077002L
Vaccination
Manufacturer
Lot
Dose
Route
Site
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES  PO 
Administered by: Other     Purchased by: Other
Symptoms: Immune system disorder, Infection, Paralysis flaccid
SMQs:, Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)
Write-up: pt recv vax & devel vaccine-associated paralytic poliomyelitis;it was later determined that the pt had severe immun deficiency;the child died 4 or 5 year ago d/t the immunodeficiency;MD stated this event may have been reported to CDC;

VAERS ID:121673 (history)  Vaccinated:1999-04-14
Age:  Onset:1999-04-15, Days after vaccination: 1
Gender:Unknown  Submitted:0000-00-00
Location:Alabama  Entered:1999-04-28
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (TRIPEDIA)CONNAUGHT LABORATORIES6916CB0IMLA
MMR: MEASLES + MUMPS + RUBELLA (MMR I)MERCK & CO. INC.1916H1IMRA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0801F3PO 
Administered by: Private     Purchased by: Private
Symptoms: Injection site hypersensitivity, Injection site mass, Lymphadenopathy
SMQs:, Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (narrow)
Write-up: Pt recv vax on 4/14/99; on 4/15/99 pt exp LA area of erythema &induration, tender lt axillary node

VAERS ID:127748 (history)  Vaccinated:1999-08-20
Age:0.5  Onset:1999-08-20, Days after vaccination: 0
Gender:Female  Submitted:1999-08-23, Days after onset: 3
Location:Michigan  Entered:1999-08-30, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: nitoral, triamenic;APAP
Current Illness: congestion, maculopapular rash on belly & upper thigh
Preexisting Conditions: has had condidiasis in the past 7 tx w/Niztral;
Diagnostic Lab Data: ordered CBC w/diff;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (ACEL-IMUNE)LEDERLE LABORATORIES4623162 RL
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0079J2 LL
HIBV: HIB (HIBTITER)LEDERLE PRAXSIS450253A2 RL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES4632812PO 
Administered by: Private     Purchased by: Public
Symptoms: Lymphadenopathy, Pyrexia, Rash, Rhinitis
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: immed p/vax mom states lump appeared behind ear;parents state that it could have been there a/vax;rash appeared that noc on head & back, now on belly & axillae;congestion, clear mucous, had fever 102 @ home;afeb today;

VAERS ID:129211 (history)  Vaccinated:1999-09-14
Age:0.2  Onset:1999-09-21, Days after vaccination: 7
Gender:Male  Submitted:1999-10-05, Days after onset: 14
Location:Arkansas  Entered:1999-10-12, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: strep screen negative;
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME)UNKNOWN MANUFACTURER   RA
Administered by: Public     Purchased by: Unknown
Symptoms: Arthralgia, Lymphadenopathy, Pharyngitis, Pyrexia, Rhinitis
SMQs:, Agranulocytosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Arthritis (broad)
Write-up: arthralgias, low grade fever, adenopathy, rhinitis, pharyngitis;

VAERS ID:155191 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2000-05-24
Location:Ohio  Entered:2000-06-21, Days after submission: 28
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: Diagnostic lab-rubella IgG antibodies-negative; Diagnostic lab-MMR-BIA <15
CDC 'Split Type': WAES99080250
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
Administered by: Other     Purchased by: Other
Symptoms: Immunoglobulins decreased
SMQs:
Write-up: Information has been received from a veterinarian concerning a "couple of older" female pts who were vaccinated with MMR and 2 months, post vax, the pts'' lab results revealed a lack of seroconversion. Follow-up information from a veterinarian reported that the first antibody titer was done 52 days, post vax, and the EIA <15. Only the rubella titer was done and the IgG checked. Additional information has been requested.

VAERS ID:157182 (history)  Vaccinated:2000-05-18
Age:  Onset:2000-06-04, Days after vaccination: 17
Gender:Male  Submitted:2000-06-13, Days after onset: 9
Location:Texas  Entered:2000-07-18, Days after submission: 35
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: CBC - results consistent with viral infection
CDC 'Split Type': TX0074
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (INFANRIX)SMITHKLINE BEECHAM914A2 IMLA
IPV: POLIO VIRUS, INACT. (POLIOVAX)CONNAUGHT LTD.P12312 LA
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1976H0SCRA
VARCEL: VARICELLA (VARIVAX)MERCK & CO. INC.1727J0SCRA
Administered by: Public     Purchased by: Public
Symptoms: Face oedema, Lymphadenopathy, Oedema, Pyrexia, Viral infection
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Hypersensitivity (narrow)
Write-up: Great grandmother noted "Slight fever" June 4 &5. On June 6 there was slight swelling under his ears, more swelling there on June 7. The morning of June 9, his neck was swollen, even facial, under eye area was swollen area was like a hard knot. She took child to MD. Dx Mumps.

VAERS ID:166517 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2000-02-22
Location:Unknown  Entered:2001-03-05, Days after submission: 377
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: UNK
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': HQ1106317FEB2000
Vaccination
Manufacturer
Lot
Dose
Route
Site
TYP: TYPHOID VI POLYSACCHARIDE (ACETONE INACTIVATED DRIED)PFIZER/WYETH  SC 
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: A pt reported that she received a vaccine 12/99 and subsequently developed lymphadenopathy in her groin. The pt is being seen by the physician; the lymphadenopathy persists.

VAERS ID:169162 (history)  Vaccinated:2001-04-13
Age:  Onset:2001-04-20, Days after vaccination: 7
Gender:Female  Submitted:2001-04-25, Days after onset: 5
Location:California  Entered:2001-04-27, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0987K SCLA
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Myalgia, Pyrexia
SMQs:, Rhabdomyolysis/myopathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Eosinophilic pneumonia (broad)
Write-up: This patient had swollen cervical and occipital lymph glands, fever, and myalgias.

VAERS ID:169396 (history)  Vaccinated:1992-08-25
Age:0.1  Onset:1992-08-25, Days after vaccination: 0
Gender:Male  Submitted:2001-04-20, Days after onset: 3160
Location:Virginia  Entered:2001-05-04, Days after submission: 14
Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: Not immune to Mumps, Measles or Rubella although vaccinated.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (ACEL-IMUNE)LEDERLE LABORATORIES331912 IMRL
HIBV: HIB (HIBTITER)LEDERLE LABORATORIESM130SB IMRA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0659E PO 
Administered by: Private     Purchased by: Private
Symptoms: Abdominal pain, Antisocial behaviour, Autism, Diarrhoea, Drug ineffective, Dyskinesia, Immune system disorder, Injection site erythema, Injection site swelling, Intestinal perforation, Nervous system disorder, Neurodevelopmental disorder, Pyrexia, Screaming, Speech disorder, Staring, Vomiting
SMQs:, Acute pancreatitis (broad), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Pseudomembranous colitis (broad), Dyskinesia (narrow), Gastrointestinal perforation (narrow), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (narrow), Ischaemic colitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Noninfectious diarrhoea (narrow)
Write-up: It is reported by the pt''s mother stating that she noticed mild neurological change during the course of his immunization schedule from 1992 to 1997. After each course of vaccines he reacted with swollen shot sight fever screaming and 10 to 15 days later high fever hives malice. In 1994, he was placed in special pre-ed at 3-, 1/2 yrs for speech and motor skill delays. She noticed a decline in health speech motor skills after every immunization visit. It wasn''t until his big 5 year old prekindergarten mega dose DPT, Pollomeyelitis, and MMR that she connected his decline with vaccinations. After the last round of vaccines he was never the same. The day of the vaccination on 05/28/1997 within six hours red hot swollen shot site: Given both in left and right arm, glassed look, fever, arms to sore to lift six days of fever, malice, glass look lethargic. The mother reported these symptoms to his pediatrician and talked about her concerns but he was vaccinated anyway. She states that,"he vomited every time I washed his hair, he heard noises that pained him severely, he had to be wrapped in sleeping bags to control him at school, he suffered from severe abdominal pain, his hands could not hold onto a swing, he banged himself into the wall, he conforted himself by total absorption in lining up his plastic animals, he slept restlessly, he was insistent on routine and structure, his health declined:strep infection fever severe diarrhea and constipation, he varied from extreme hyper activity to extreme muscle fatigue, no social skills, delayed toilet training not able to sit down to have bowel movement, biting growling violent angry."

VAERS ID:169399 (history)  Vaccinated:1990-06-11
Age:0.4  Onset:1990-06-11, Days after vaccination: 0
Gender:Male  Submitted:2001-04-18, Days after onset: 3964
Location:Ohio  Entered:2001-05-04, Days after submission: 16
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: DTP (unknown mfr);;;1;In Sibling
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER 2IM 
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURER 1PO 
Administered by: Private     Purchased by: Private
Symptoms: Apraxia, Asthenia, Crying, Drooling, Ear disorder, Encephalopathy, Erythema, Gastrointestinal disorder, Hypotonia, Immune system disorder, Infection, Nervous system disorder, Pyrexia, Staring
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Chronic kidney disease (broad), Hypersensitivity (broad)
Write-up: Red, crying, temperature, irritable. Given Tylenol, same day, sick with ear infections for weeks after. Given antibiotics. Was drooling 6-8 weeks later, lost eye contact 4 months later and weakness 4 months later. Auto-immune disorder; encephalopathy, apraxia hypotonic. The 60 day follow-up report states neurological immune disorder gastrointestinal. This child was developing normally and was insulted by vaccines over a period of time not a single vaccine caused this much regression on his systems. Missing vaccine information not available. Dx autoimmune encephalopathy, high functioning autistic. Tx aricet solu- Medrol and IVIG. Poor social skills. Limited eye contact. low mptor strength. Encorpresis. Also notes generalized weakness and droopy eyes before 8 months of age. Onset unrecalled.

VAERS ID:170873 (history)  Vaccinated:2000-11-01
Age:  Onset:2000-11-06, Days after vaccination: 5
Gender:Female  Submitted:2001-05-30, Days after onset: 204
Location:Unknown  Entered:2001-06-01, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data:
CDC 'Split Type': WAES00111211
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Abnormal behaviour, Asthenia, Hyperhidrosis, Infection, Lymphadenopathy, Pyrexia, Screaming, Sleep disorder
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Hostility/aggression (broad)
Write-up: Asthenia/Fatigue, behavioral disturbance, lymphauenopathy; Perspiration, fever - Information has been received from a pharmacist concerning her daughter who on 01 Nov 2000 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation. Five days post-vaccination, the patient became very lethergic and unusually waking up at night screaming. It was also noted that the patient developed a fever and sweats. Ten days post vaccination, the patient developed swollen lymph glands in the groin area. The reporter was concerned about her daughter receiving a booster dose because she felt that her daughter had adverse reactions from the MMR vaccine. Additional information has been requested.

VAERS ID:170954 (history)  Vaccinated:1994-12-01
Age:  Onset:1994-12-15, Days after vaccination: 14
Gender:Female  Submitted:2001-05-30, Days after onset: 2357
Location:Georga  Entered:2001-06-01, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES#01033343
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Arthralgia, Lymphadenopathy, Polyarthritis, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arthritis (narrow)
Write-up: fever, arthralgia,lymphadenopathy - Information has been received from a physician concerning her sister (nurse practitioner) who in early december 1994, was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation. After two to three weeks, the patient developed a low grade fever, lymphadenopathy and arthralgia. The physician reported that she feels the vaccine virus may have been transmitted to her (waes# 01033343) (also reported as transmission of rubella from this vaccinated individual). No further detail were provide. On follow-up the physician reported that her sister developed lymphadenopathy, polyarthritis and low grade fever after vaccination. No further details were provided.

VAERS ID:174766 (history)  Vaccinated:1975-02-04
Age:  Onset:0000-00-00
Gender:Male  Submitted:0000-00-00
Location:Florida  Entered:2001-08-28
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: UNK
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': HQ8156805JUL2000
Vaccination
Manufacturer
Lot
Dose
Route
Site
ADEN: ADENOVIRUS (TYPE 7, NO BRAND NAME)PFIZER/WYETH  PO 
FLU3: INFLUENZA (SEASONAL) (NO BRAND NAME)UNKNOWN MANUFACTURER    
OPV: POLIO VIRUS, ORAL (ORIMUNE)PFIZER/WYETH 0PO 
Administered by: Military     Purchased by: Military
Symptoms: Epistaxis, Hepatitis C virus, Lymphadenopathy, Pharyngitis
SMQs:, Agranulocytosis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Oropharyngeal infections (narrow)
Write-up: A male pt reported that he received a dose of Adenovirus Vaccine Live Oral Type 4, Adenovirus Vaccine Live Oral Type 7, Poliomyelitis virus and Influenza Bivalent vaccines on 2/4/75 when he was in the military. The pt noted that his medical records indicate that a "couple of days" after vaccination, he developed "nose bleeding and neck adenopathy". He also reported that he has been dx''d with chronic Hepatitis C. The reporter indicated that "his neck is swollen to this day". Additional information received on 7/11/00 included the pt''s medical records which indicated that the pt had recurrent nose bleeds from his right nostril, his throat was inflammed and had neck adenopathy.

VAERS ID:179191 (history)  Vaccinated:2001-11-09
Age:  Onset:2001-12-11, Days after vaccination: 32
Gender:Female  Submitted:2001-12-10, Days after onset: 1
Location:California  Entered:2001-12-18, Days after submission: 8
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: negative titer for rubella 10/30/01
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1093L SC 
Administered by: Private     Purchased by: Public
Symptoms: Cough, Dizziness, Dysphonia, Lymphadenopathy, Malaise, Pulmonary congestion
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Vestibular disorders (broad)
Write-up: 11/30/01 malaise , lightheaded, 12/1/01 no change, 12/2/01 stated slight cough, 12/4-12/6/01 hoarseness, chest congestion started 12/4 & cough productive (yellow-green) no F/U lump on neck since 12/6 R knee twisted in bed 12/6 better now. apparently better today. Treated for URI and released.

VAERS ID:183430 (history)  Vaccinated:2001-09-01
Age:  Onset:0000-00-00
Gender:Male  Submitted:2002-04-08
Location:Unknown  Entered:2002-04-15, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: IgM and IgG-elevated; "drainage and culture" of the gland
CDC 'Split Type': WAES0203USA02894
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SC 
Administered by: Other     Purchased by: Other
Symptoms: Bacterial infection, Immunoglobulins increased, Lymphadenopathy
SMQs:, Hypersensitivity (broad)
Write-up: Information has been received on 3/26/02 from an RN concerning a male child who in 9/01 was vaccinated with a dose of MMRII. It was reported that "later", the pt had a positive IgM and had a swollen gland. The pt was reportedly taken to the hospital, was dx''d with mumps and had "drainage and culture" of the gland. The reporter did not think this was a vaccine failure and was concerned how long an IgM and IgG remained elevated, post vax. Follow-up information received on 4/1/02, reported that the child was admitted to the hospital for a staphylococcal infection, "that had nothing to do with the MMRII vaccination and that he child did not have the mumps". Additional information has been requested.

VAERS ID:198801 (history)  Vaccinated:1995-04-25
Age:0.3  Onset:2003-04-27, Days after vaccination: 2924
Gender:Male  Submitted:2003-02-25, Days after onset: 60
Location:Connecticut  Entered:2003-03-05, Days after submission: 8
Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER 1 RL
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURER 1  
Administered by: Private     Purchased by: Other
Symptoms: Chromosome abnormality, Convulsion, Drug toxicity, Immune system disorder, Neuropathy
SMQs:, Peripheral neuropathy (narrow), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Congenital, familial and genetic disorders (narrow), Convulsions (narrow), Drug abuse and dependence (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow)
Write-up: My son had a seizure less than 48 hours after his 4 month DPT vaccine. He was hospitalized and continues to have seizures to this day. The medical record states Kleinelter''s syndrome and neurodegenerative disorder. My son still has seizures on a daily basis. He is developmentally delayed. His immune system is damaged. He has heavy metal toxicity due to these vaccines CDPT- from the thimersol. He does not live a normal childhood and hasn''t since the age of 4 months and lost his identical twin due to these vaccines.

VAERS ID:204348 (history)  Vaccinated:1982-06-27
Age:0.5  Onset:1982-06-28, Days after vaccination: 1
Gender:Male  Submitted:2003-05-30, Days after onset: 7641
Location:Unknown  Entered:2003-06-04, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type': WAES0208USA02006
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Pyrexia, White blood cell count increased
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Information has been received from a consumer concerning her 6 month old son with no past medical history and no known allergies who on 6/27/82 was vaccinated with a dose of MMR (second generation). There was no concomitant medication. On 6/28/82, the next day, the patient''s gland on the right side of his neck swelled up. The patient also had a fever and his white blood cells were elevated. The swelling lasted several months. The patient sought unspecified medical attention. Additional information has been requested.

VAERS ID:204425 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2003-05-30
Location:Massachusetts  Entered:2003-06-04, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data:
CDC 'Split Type': WAES0211USA02036
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Myalgia
SMQs:, Rhabdomyolysis/myopathy (broad), Eosinophilic pneumonia (broad)
Write-up: Information has been received from a nurse practitioner concerning a female who was vaccinated with MMR II. Subsequently the pt developed enlarged lymph nodes and myalgia without fever. After a few days the pt recovered. The pt sought unspecified medical attention. Additional info has been requested.

VAERS ID:204857 (history)  Vaccinated:1993-05-01
Age:  Onset:1993-05-01, Days after vaccination: 0
Gender:Female  Submitted:2003-06-10, Days after onset: 3692
Location:Unknown  Entered:2003-06-13, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Medical history: Immune system disorder: Pregnancy.
Diagnostic Lab Data: Immune to measles 1991, 1992, 1997; susceptible to rubella May 1993; immune to rubella 1991
CDC 'Split Type': WAES0306USA00323
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 1  
Administered by: Other     Purchased by: Other
Symptoms: Drug ineffective, Immune system disorder, Systemic lupus erythematosus
SMQs:, Lack of efficacy/effect (narrow), Systemic lupus erythematosus (narrow)
Write-up: It was reported in a published article that a female patient in 1983 was vaccinated with a first dose of MMR (second generation) because of a measles outbreak in college. She tested immune to measles in 1991, 1992, and 1997. During her first pregnancy in 1991, she tested immune to rubella and had a healthy, normal son. At the birth of her second son, in May 1993, she was found to be rubella susceptible and was given a second dose of MMR (second generation) in the postpartum period. The patient now had markers for lupus. Upon internal review, lupus was considered to be an important medical event (OMIC). It was unknown if medical attention was sought. It was reported in a published article, title as stated above, that this patient had developed measles, rubella and mumps despite being vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation). Because of a diagnosis of "some immune problem", the patient received injections of gamma globulin for awhile. It was reported that the patient received the hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown) series in 1998-1999. Upon internal review, lupus was considered to be an important medical event. The reporter indicated that the patient''s son had autism (WAES #0306USA00452). It was unknow if medical attention was sought.

VAERS ID:216828 (history)  Vaccinated:2003-09-17
Age:  Onset:0000-00-00
Gender:Female  Submitted:2004-02-24
Location:California  Entered:2004-02-25, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (VIRIVAC)MERCK & CO. INC.0633N1IM 
Administered by: Private     Purchased by: Private
Symptoms: Lymphadenopathy, Rash pruritic
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: Pruritic rash on trunk and proximal arms; anterior cervical lymphadenopathy; throat irritation with oropharyngeal erythema.

VAERS ID:220048 (history)  Vaccinated:2004-04-22
Age:  Onset:2004-04-28, Days after vaccination: 6
Gender:Male  Submitted:2004-04-30, Days after onset: 2
Location:California  Entered:2004-05-07, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Exposure to Mumps case
Preexisting Conditions: NONE
Diagnostic Lab Data: Pending- Sed egg R 1gg
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0392N0POLA
Administered by: Public     Purchased by: Unknown
Symptoms: Lymphadenopathy
SMQs:
Write-up: Pt was exposed to mumps case 4/10 by hugging. 4/10 came for immunization 4/22, no prc h/o immunization. Developed right peri-auricular lymphadenopathy x2

VAERS ID:227804 (history)  Vaccinated:2004-09-13
Age:  Onset:2004-09-16, Days after vaccination: 3
Gender:Female  Submitted:2004-10-08, Days after onset: 22
Location:Unknown  Entered:2004-10-15, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Received Dtap in right thigh.
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Axillary temp= 98 on 09/17/04
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (PEDVAXHIB)MERCK & CO. INC.0093P IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0809N SC 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Erythema, Feeling hot, Immune system disorder, Injection site mass, Injection site pain
SMQs:, Anaphylactic reaction (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (broad)
Write-up: Pt received HIB and MMR immunizations in left thigh on 9/13/04. On 9/16/04 mom called clinic complaining that area was sore and had a lump which felt like a golf ball. The area also was warm to the touch. Mom and daughter came to clinic on 09/17/04 for follow up. Temp was 98 Lump was 4-5cm on left lateral thigh w/no discharge, slight erythema. Looked more like immune response than frank infection. The pt had full sensation down leg. Mom advised to use children''s ibuprofen and RTC or ER if pt becomes febrile, stops eating, has N/V, or lump changes shape, color, or has discharge. As of 10/8/04, no further follow up has been needed.

VAERS ID:235207 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:0000-00-00
Location:Georga  Entered:2005-03-21
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: the patient has a history of transient thrombocytopenia which occurred as a neonate. He also has a sibling with a history of febrile seizures. He did not have any illness at the time of vaccination.
Diagnostic Lab Data:
CDC 'Split Type': 200403779
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (DAPTACEL)SANOFI PASTEURC1699AA3IMRL
IPV: POLIO VIRUS, INACT. (IPOL)SANOFI PASTEURX10402IMRL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0312P SCLL
PNC: PNEUMO (PREVNAR)PFIZER/WYETHA57559E IMLL
Administered by: Private     Purchased by: Unknown
Symptoms: Lymphadenopathy
SMQs:
Write-up: From initial infomation received on 11/22/2004

VAERS ID:258113 (history)  Vaccinated:2005-09-30
Age:  Onset:2005-09-30, Days after vaccination: 0
Gender:Female  Submitted:2006-05-19, Days after onset: 231
Location:Unknown  Entered:2006-05-22, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Pregnancy NOS (LMP=unknown)
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0502USA04365
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.   UN
Administered by: Other     Purchased by: Other
Symptoms: Dizziness, Lymphadenopathy, Unintended pregnancy
SMQs:, Anticholinergic syndrome (broad), Vestibular disorders (broad), Normal pregnancy conditions and outcomes (narrow)
Write-up: Information has been received from a consumer concerning her daughter, who lives in another country, who on 30-SEP-2005 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (manufacturer unknown). The reporter indicated that her daughter was vaccinated against "measles and rubella". She became pregnant and feels that 01-OCT-2005 was the conception date. The vaccines were given " a day or two before conception" to her daughter by the "nurse on the street" and she did not know any specifics on dosage or how they were delivered. Her daughter had since developed swollen lymph nodes and was always dizzy. There was no product quality complaint involved. Additional information has been requested.

VAERS ID:258394 (history)  Vaccinated:2006-05-02
Age:  Onset:2006-05-12, Days after vaccination: 10
Gender:Male  Submitted:2006-05-15, Days after onset: 3
Location:Iowa  Entered:2006-06-14, Days after submission: 30
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': IA06011
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0729R0SC 
Administered by: Public     Purchased by: Public
Symptoms: Fatigue, Lymphadenopathy, Oral intake reduced, Pharyngolaryngeal pain, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: MMR shot Tues. 5/2. Wed. t/10 thru Mon May 15, pt had fever, mild sore throat, swollen glands on side of neck, fatigue, decreased appetite. In addition to above symptoms on Mon. May 15, he complained of headache. Tues. May 16, starting to feel better. Back to school on Wed. May 17. Treated with Tylenol and Motrin, alternating q 4-6 hrs for 2 1/2 days.

VAERS ID:262215 (history)  Vaccinated:2006-08-25
Age:  Onset:2006-08-25, Days after vaccination: 0
Gender:Female  Submitted:2006-08-28, Days after onset: 3
Location:Unknown  Entered:2006-08-28
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions:
Diagnostic Lab Data: Also c/o swollen glands, temp 99.3 (0) noted "dots on feet", offered appt today at student health.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME)UNKNOWN MANUFACTURER    
TD: TD ADSORBED (NO BRAND NAME)UNKNOWN MANUFACTURER    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Feeling hot, Injection site erythema, Injection site swelling, Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow)
Write-up: Warmth, swelling and redness at left arm below site of Td injection, size 2" x 4". Plans to visit provider who administered vaccine for follow up tomorrow 8/29/06 AM.

VAERS ID:268663 (history)  Vaccinated:2006-10-06
Age:  Onset:2006-11-17, Days after vaccination: 42
Gender:Female  Submitted:2006-11-30, Days after onset: 13
Location:Maryland  Entered:2006-12-11, Days after submission: 11
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Glucosin, Diovan, Lipitor, Folic acid, Calc, Baby ASA
Current Illness: NONE
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0292R0SCLA
Administered by: Private     Purchased by: Private
Symptoms: Arthralgia, Joint stiffness, Lymphadenopathy, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Arthritis (broad)
Write-up: Received MMR 10/06/06 on 11/17/06 developed swollen lymph nodes in neck, 11/20 rash on trunk, 11/22 joint pain, stiffness, 11/26 fine and asymptomatic.

VAERS ID:283703 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:2007-05-30
Location:Unknown  Entered:2007-06-04, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0702USA01838
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Mumps
SMQs:, Oropharyngeal infections (narrow)
Write-up: Information has been received from a physician concerning his son, who was vaccinated "many years ago" with MMR II. Subsequently the patient experienced mumps and swelling of the neck glands. No further information is available.

VAERS ID:315275 (history)  Vaccinated:2008-05-09
Age:  Onset:2008-05-10, Days after vaccination: 1
Gender:Female  Submitted:2008-06-06, Days after onset: 27
Location:Georga  Entered:2008-06-06
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: zoloft 100mg protonix40mgsingulair 10mgnasonex 50mcg,depakote er 500mg, glucophage 850 mg
Current Illness: none
Preexisting Conditions: Depression, prolonged, asthma, seizure disorder, polycystic ovaries/stein-leventhal syndrome, over weight status,allergic arthritis, GERD esophageal reflux
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0871U SCLA
Administered by: Public     Purchased by: Private
Symptoms: Feeling hot, Lymphadenopathy, Malaise, Pyrexia, Rash, Tenderness
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: Patient got sick the night of MMR administration. States just did not feel well, nonspecific. She had a fever, did not take temperature, states felt warm. She then developed a rash with swollen lymph nodes, some tenderness. No fever or chills or other problems. This is documented by physician on 05-21-08.

VAERS ID:321222 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:0000-00-00
Location:Puerto Rico  Entered:2008-08-04
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No
Current Illness: Celiac disease and autism
Preexisting Conditions: Allergies to milk, specific to casein and immunology problems.
Diagnostic Lab Data: He have autism and celiac disease and his autism not is specific.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
HEP: HEP B (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
IPV: POLIO VIRUS, INACT. (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Private     Purchased by: Private
Symptoms: Immune system disorder, Intestinal functional disorder, Sensory disturbance, Walking disability
SMQs:, Peripheral neuropathy (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Gastrointestinal nonspecific inflammation (narrow)
Write-up: After the vaccine my son began to walk in a feet''s tip and he began to present serious sensory problems. He have after the vaccine serious and grave problems in his intestine and immunology like a candida albicans. he have special diets now.

VAERS ID:382611 (history)  Vaccinated:2009-05-11
Age:  Onset:2009-05-22, Days after vaccination: 11
Gender:Female  Submitted:0000-00-00
Location:Unknown  Entered:2010-03-10
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': BERNA20090194
Vaccination
Manufacturer
Lot
Dose
Route
Site
TYP: TYPHOID LIVE ORAL TY21A (VIVOTIF)BERNA BIOTECH, LTD  PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Lymph node pain, Lymphadenopathy
SMQs:
Write-up: The patient started VIVOTIF oral vaccination (batch no: unknown) on 11.May.2009 for her trip on 25.May.2009 and administered all capsules at the scheduled times. On 22.May.2009 she developed swollen and painful lymph nodes under her arm. The symptoms were persistent at time of reporting. At the time of reporting they are still swollen, bilateral, however pain was relieving. Follow-up request was sent to the reporter on 23.Jun.2009 regarding batch no. and filling the VAERS form.

VAERS ID:388390 (history)  Vaccinated:2002-06-06
Age:  Onset:2002-06-17, Days after vaccination: 11
Gender:Male  Submitted:2010-05-14, Days after onset: 2888
Location:Unknown  Entered:2010-05-18, Days after submission: 4
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Neuroblastoma
Preexisting Conditions:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0907USA00667
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Autoimmune disorder, Condition aggravated, Fall, Immune system disorder, Infection, Neuroblastoma, Opsoclonus myoclonus
SMQs:, Accidents and injuries (narrow), Ocular motility disorders (narrow), Neonatal disorders (broad), Malignant tumours (narrow)
Write-up: Information has been received from a case in litigation via a case report concerning a male child patient who on approximately 06-JUN-2002 was vaccinated with a dose of MMR II (Lot number not reported). Subsequently, the patient experienced OMS. On 17-JUN-2002 approximately 11 days after the vaccination, the patient fell and cut his upper lip, according to the record. Twenty days after vaccination, his mother took him to the doctor because he had been falling frequently for the previous five days. A physician reported that the MMR vaccination triggered an autoimmune response in a child whose immune system was already under assault by a neuroblastoma and various infections. No further information is available.

VAERS ID:388755 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2010-05-14
Location:Unknown  Entered:2010-05-18, Days after submission: 4
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: body temp, 103 F
CDC 'Split Type': WAES1002USA03492
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Body temperature increased, Lymphadenopathy, Pyrexia, Rash papular
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with MMR II. Subsequently the patient experienced a fever as high as 103 F, a papular rash and submandibular lymphadenopathy two weeks after vaccination. The patient sought unspecified medical attention. Subsequently, on an unspecified date the patient recovered from these events. Additional information has been requested.

VAERS ID:412600 (history)  Vaccinated:2010-04-26
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2010-11-02
Location:Unknown  Entered:2010-11-23, Days after submission: 21
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0878222A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS 0UNUN
Administered by: Other     Purchased by: Other
Symptoms: Fatigue, Lymphadenopathy, Vaccine positive rechallenge
SMQs:
Write-up: This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of swollen gland in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). Concurrent medications at the time of the 2nd dose of TWINRIX included Antibiotics. On 26 April 2010 and 20 August 2010 the subject received 1st dose and 2nd dose of TWINRIX (details unknown). In April 2010 and August 2010, within 1 or 2 days of each vaccination with TWINRIX, the subject experienced swollen glands and exhaustion. The events occurred after each dose of TWINRIX. The healthcare professional was inquiring as to whether the subject should receive the 3rd dose of TWINRIX. At the time of reporting the outcome of the events was unspecified.

VAERS ID:424403 (history)  Vaccinated:2010-10-06
Age:  Onset:2010-10-18, Days after vaccination: 12
Gender:Female  Submitted:2011-05-26, Days after onset: 220
Location:Unknown  Entered:2011-06-01, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: None
Diagnostic Lab Data: Body temp, 10/19/10, 104 F
CDC 'Split Type': WAES1010USA03523
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 0UNUN
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenitis, Lymphadenopathy, Pyrexia, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)
Write-up: Information has been received from a physical therapist concerning her daughter with no pertinent medical history and no drug reactions/allergies who on 06-OCT-2010 was vaccinated with the first dose of MMR II. There was no concomitant medication. On 18-OCT-2010 the patient developed swollen glands on the left side of her neck. The patient was examined by her unspecified physician on that date and was diagnosed with cervical lymphadenopathy or lymphadenitis. She was prescribed AUGMENTIN. On 19-OCT-2010, the patient developed vomiting and a fever of 104F. She was admitted on that date to an unspecified hospital and was treated intravenously with multiple unspecified antibiotics. The patient was discharged from the hospital on 25-OCT-2010. She was currently taking an oral antibiotic at home. The patient was afebrile but the lymphadenopathy was unchanged. At the time of reporting, the patient was recovering from these adverse events. Cervical lymphadenopathy or lymphadenitis, vomiting and a fever of 104F were considered to be other important medical events by the reporter. Additional information has been requested.

VAERS ID:426752 (history)  Vaccinated:2011-06-23
Age:  Onset:2011-06-25, Days after vaccination: 2
Gender:Female  Submitted:0000-00-00
Location:Maine  Entered:2011-07-06
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions: None
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0154Z UNLA
Administered by: Private     Purchased by: Unknown
Symptoms: Lymphadenopathy, Pain, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Body aches, pain, low-grade fever, swollen glands.

VAERS ID:486018 (history)  Vaccinated:2013-01-30
Age:  Onset:2013-02-02, Days after vaccination: 3
Gender:Female  Submitted:2013-03-01, Days after onset: 27
Location:Unknown  Entered:2013-03-01
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1302USA013420
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.H012569 SCUN
Administered by: Other     Purchased by: Other
Symptoms: Decreased appetite, Feeling hot, Headache, Lymphadenopathy
SMQs:
Write-up: This spontaneous report as received from a pharmacist refers to a female patient of unknown age who on 30-JAN-2013 was vaccinated with a 0.5 ml dose of M-M-R II subcutaneously (anatomical location was not provided) lot number reported as H0125569. On 02-FEB2013, the patient experienced a headache, her body was warm all over and she had not appetite. The patient visited to physician and was diagnosed with lymphadenopathy. The patient was treated with unspecified steroids. The outcome of lymphadenopathy was unknown. The relatedness for lymphadenopathy was unknown for M-M-R II. Additional information is not expected. This is one of several reports received from the same source.

VAERS ID:487963 (history)  Vaccinated:2013-03-05
Age:  Onset:2013-03-14, Days after vaccination: 9
Gender:Male  Submitted:2013-03-25, Days after onset: 11
Location:California  Entered:2013-03-28, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Not reported
Diagnostic Lab Data:
CDC 'Split Type': 201304190
Vaccination
Manufacturer
Lot
Dose
Route
Site
ANTH: ANTHRAX (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
SMALL: SMALLPOX (ACAM2000)SANOFI PASTEUR  IDUN
TYP: TYPHOID VI POLYSACCHARIDE (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Military     Purchased by: Military
Symptoms: Bronchitis, Lymphadenopathy, Nasal congestion, Productive cough, Rhinorrhoea, Troponin increased
SMQs:, Myocardial infarction (narrow)
Write-up: This study case was received from the investigator on 19 March 2013. A male subject (date of birth not reported) had received the following vaccinations on 05 March 2013: ACAM2000 (lot number, route and site not reported), Typhoid (Manufacturer Unknown, lot number, route and site not reported), and Anthrax (Other Manufacturer, lot number, route and site not reported). Nine days later, on 14 March 2013, the subject was found to have an elevated Troponin level. Rapid results for blood draw were negative. The troponin lab values were drawn on 13 March 2013 with an elevated value of 0.12 ng/ml (<0.10). The subject had no cardiac symptoms. The subject also experienced bronchitis which included the symptoms of producing cough, nasal congestion and nasal draining which started on 06 March 2013 and swollen glands which started on 08 March 2013 and stopped on 09 March 2013. Treatment included MUCINEX 600mg twice daily (BID). The subject''s troponin will be retested and an ECG will be done when the subject is well enough to come in. The subject''s smallpox injection site looked normal. The subject''s outcome was not recovered. According to the Investigator, the event of elevated troponin was considered an important event and possibly related. Documents held by sender: None.

VAERS ID:514020 (history)  Vaccinated:2013-01-01
Age:  Onset:2013-01-01, Days after vaccination: 0
Gender:Male  Submitted:2013-10-14, Days after onset: 285
Location:Arkansas  Entered:2013-11-20, Days after submission: 37
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: There were no other vaccinations administered on the same date. At the time of reporting, there were no concomitant medications or relevant medical history.
Diagnostic Lab Data: UNK
CDC 'Split Type': A1031531A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS 0UNUN
Administered by: Public     Purchased by: Public
Symptoms: Erythema, Lymphadenopathy, Skin warm, Tenderness
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (broad)
Write-up: This case was reported by a healthcare professional and described the occurrence of swollen lymph nodes in neck and axillary region in a male subject aged between 20 and 29 years old who was vaccinated with TWINIX. In January 2013 the subject received 1st dose of TWINRIX (1 "dose", unknown route, unknown deltoid). In January 2013, within hours after vaccination with TWINRIX (described as "later that night"), the subject experienced swollen lymph nodes in neck and axillary region, erythema neck area, neck tenderness and warm to touch. The events of erythema neck area, neck tenderness and warm to touch described the lymph nodes in the neck and arm pit areas. Per the reporter, the arm pit was “the arm where the injection was administered.” The healthcare professional stated that the subject “returned to the office so they can see it” and “no medication was given.” At the time of reporting the outcome of the events were unspecified.

VAERS ID:517026 (history)  Vaccinated:0000-00-00
Age:  Onset:2013-11-01
Gender:Female  Submitted:2013-12-18, Days after onset: 47
Location:Unknown  Entered:2013-12-18
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1312USA006064
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  SCUN
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy, Mumps, Smear buccal, Viral test
SMQs:, Oropharyngeal infections (narrow)
Write-up: This spontaneous report, as received from a company representative, refers to a female patient of less than twenty years old (not further specified). Her medical history was unknown. On an unspecified date, the patient was allegedly vaccinated with M-M-R II. She then (about a month ago, in November 2013) developed mumps and symptoms of extremely swollen glands in the lymph node area under the ears. The patient sought medical attention because of the adverse events, by going to the health department. A buccal test and blood test for mumps were performed on an unknown date. The results of the tests were unknown. The outcome of mumps and symptoms of extremely swollen glands in the lymph node area under the ears was unknown. A causality assessment was not provided. This report is linked with report 1312USA006048, 1312USA006053 and 1312USA008378, received from the same reporter, regarding the additional patients, who also allegedly underwent vaccination with M-M-R II, and then developed mumps. It was stated that all patients in the linked reports were in close contact to one another by being related or working together. Additional information has been requested.

VAERS ID:517430 (history)  Vaccinated:0000-00-00
Age:  Onset:2013-12-08
Gender:Female  Submitted:2013-12-23, Days after onset: 15
Location:Unknown  Entered:2013-12-23
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1312USA006053
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Fatigue, Lymphadenopathy, Malaise, Mumps, Mumps antibody test, Oropharyngeal pain, Smear buccal
SMQs:, Oropharyngeal infections (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow)
Write-up: This spontaneous report as received from a company representative refers to a female patient over 40 years of age. On an unknown date the patient was "allergedly" vaccinated with M-M-R II (subcutaneous injection). Dosing information and lot number were not provided. On 08-DEC-2013 the patient developed mumps, sore throat, fatigue, "extreme" malaise and swollen glands. The patient sought medical attention because of the adverse events, by going to the health department. A buccal test and blood test for mumps were performed on an unknown date. The results of the tests were unknown. The patient had not recovered from the events. A causality assessment was not provided. This report is linked with report 1312USA006048, 1312USA006064 and 1312USA008378, received from the same reporter, regarding five additional patients, who also allegedly underwent vaccination with M-M-R II, and then developed mumps. It was stated that all patients in the linked reports were in close contact to one another by being related or working together. Additional information has been requested.

VAERS ID:529829 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2014-04-30
Location:Unknown  Entered:2014-04-30
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: DiGeorge''s syndrome
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0989131A
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
IPV: POLIO VIRUS, INACT. (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Croup infectious, Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: This case was reported in a literature article and described the occurrence of croup in a subject of unspecified age and gender born between 1974 and 2008 who was vaccinated with DTaP (manufacturer unspecified), MMR vaccine (non-gsk) and IPV (non-gsk). This case refers to a subject. Concurrent medical conditions included DiGeorge''s syndrome and had a chromosome 22q11.2 microdeletion detected by fluorescence in situ hybridization assay. No further information on the subject''s medical, family history or concurrent medication is available. On an unspecified date, the subject received an unspecified dose of DTaP (small content) (administration site and route unknown, batch number not provided), an unspecified dose of MMR vaccine (Non-GSK) (unknown) and an unspecified dose of IPV (Non-GSK) (unknown). 39 days after vaccination with DTaP (small content), MMR vaccine (Non-GSK) and IPV (Non-GSK), the subject experienced croup, fever and lymphadenopathy. This case was assessed as medically serious by GSK. At the time of reporting, the outcome of the events was unspecified. The author''s conclusion stated that their data expanded the findings of smaller studies indicating that live vaccination of patients with DGS with mild-to-moderate immuno-suppression was well-tolerated. Prospective studies are needed to confirm their findings and offer guidance for live vaccination. Because this study included few patients with DGS with severe immunosuppression, further retrospective investigation of this population is warranted. This case is one of the 18 cases reported in the same literature article.

VAERS ID:531292 (history)  Vaccinated:2014-05-08
Age:  Onset:0000-00-00
Gender:Female  Submitted:2014-05-19
Location:Unknown  Entered:2014-05-19
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1405USA008789
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 0SYRUN
Administered by: Other     Purchased by: Other
Symptoms: Lymphadenopathy
SMQs:
Write-up: This spontaneous report as received from a nurse refers to an adult female patient of unknown age, who worked in a nursing home. On approximately 08-MAY-2014 (also reported as last week), the patient was vaccinated with her first dose of M-M-R II injection, dose (unknown) and route of administration (unknown). No concomitant medications were reported. In approximately MAY 2014 (also reported as on an unspecified date), the patient developed cervical lymphadenopathy. Patient sought medical attention (unknown type). Action taken with respect to M-M-R II was not applicable. No product quality complaint was involved. The outcome of cervical lymphadenopathy was not resolved. Causality was not reported. No further information provided. Additional information has been requested.

VAERS ID:535782 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2014-07-03
Location:Unknown  Entered:2014-07-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medicaitons
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1407USA000434
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Laboratory test, Lymphadenopathy, Pyrexia, Vaccination complication
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: This spontaneous report as received from the patient''s mother, concerning her child of unknown age and gender. On an unknown date the patient was vaccinated with a dose of M-M-R II (lot #, dose and route not reported). Concomitant therapy was not reported. The reporter stated that on an unknown date her child had serous side effects after receiving M-M-R II. The patient had a different set of symptoms, high fever and lymph node problems, the child underwent many tests (data not reported) and an unspecified health care professional determined that it was a reaction to the M-M-R II. The outcome of reaction to the M-M-R II, high fever and lymph nodes problems was unknown. This is one of several reports received from the same reporter: MARRS: 1407USA000508 and 1407USA000509. Additional information is not expected.

VAERS ID:158893 (history)  Vaccinated:2000-07-05
Age:0.8  Onset:2000-07-28, Days after vaccination: 23
Gender:Female  Submitted:2000-08-10, Days after onset: 13
Location:Foreign  Entered:2000-08-16, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Tick bite at the end of 5/00
Diagnostic Lab Data: NMR exam-leuco-encephalitis, metabolic analysis-pending; ECG on 7/31/00-slow electrogenesis compatible with diffuse pain; 8/2/00, still electrogenesis with asymmetry at the expense of left derivations; 8/11/00-marked improvement; LP-increas
CDC 'Split Type': U2000005970
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (TRIPEDIA)CONNAUGHT LABORATORIES 2IM 
HIBV: HIB (ACTHIB)CONNAUGHT LABORATORIES 2IM 
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURER  PO 
Administered by: 0     Purchased by: 0
Symptoms: Anorexia, Apathy, CSF test abnormal, Convulsion, Electrocardiogram abnormal, Encephalitis, Hemiparesis, Hypotonia, Inflammation, Lymphadenopathy, Pain, Platelet count increased, Pyrexia, Rash macular, Respiratory acidosis, Skull malformation
SMQs:, Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Congenital, familial and genetic disorders (narrow), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (narrow)
Write-up: "It was reported that a 9 month old baby girl was vaccinated for the 3rd time with a DTP and Haemophilus influenza type B vaccine (combined vaccination of ActHib and Triamer) on 7/5/00. She received at the same moment an Oral Polio Vaccine. The pt had no fever short after vaccination (preventively she had received acetylsalicylic acid). On 7/28/00, the pt presented with fever (around 38-38.5C) and was hospitalized for left lateralized convulsions. The pt had neither antecedents nor pathology. A NMR exam reveals an under cortical diffuse leuco-encephalitis of unknown origin. The pt is slightly recuperating but is still suffering of hypotonia and is not taking food. Further information is awaited. F/U on 8/11/00: The pt presented with right side hemiparesis on 7/28/00 which was treated with anticonvulsives of diazepam and phenobarbital. F/U on 3/2/01: The pt was hospitalized from 7/28/00 to 8/11/00 because of prolonged convulsion episode. A respiratory acidosis had also been signaled before admission but no more dx''d afterwards. On 7/29/00, the pt again had convulsions (left laterized) and was feverish (however, no source of infection could explain the fever. Amoxicillin was given). The pt stayed hypotonic and apathic, refusing to eat. 48 hours after her admission, she presented an atypia maculous eruption on the left part of the body. When discharged on 8/11/00, the rash was gone, she was sitting alone, moved all 4 limbs with a right hand side minor weakness, a facial asymmetry and a tendency to lean the head towards the left. Phenobarbital (2x10mg) was prescribed at the moment of the discharge. Between 9/20/00 and 9/26/00, the pt was hospitalized again. On 9/20/00, in the AM, the pt had to undergo a marrow punction to explore her thrombocytosis. She started having fever in the PM of up to 40C then a submandibular swelling appeared and the inflammatory syndrome was then much more important than in the AM. The pt was treated with amoicillin IV and had no more fever the next day. Platelets were still elevated. Other

VAERS ID:166111 (history)  Vaccinated:1997-10-01
Age:0.8  Onset:1997-12-18, Days after vaccination: 78
Gender:Female  Submitted:2001-02-20, Days after onset: 1160
Location:Foreign  Entered:2001-02-23, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: She had 2 older brothers who were born in Bangladesh and had received BCG vaccinations without complication.
Diagnostic Lab Data: Histopathology of the lymph node revealed a centrally necrotizing granuloma typical of mycobacterial infection. Ziehl-Nielsen stain was positive for mycobacteria. Culture grew mycobacteria of a BCG strain sensitive to ethambtol, isoniazid a
CDC 'Split Type': U200000866
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (MYCOBAX)AVENTIS PASTEUR  SCRA
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bacterial infection, Granuloma skin, Lymphadenopathy, Skin necrosis
SMQs:, Severe cutaneous adverse reactions (narrow), Hypersensitivity (narrow)
Write-up: Assessed as serious on basis of "Medical Judgement". "A 10 month old girl of Bangladesh parents, after a Mantoux skin test performed on 10/13/97 was negative, was vaccinated on her right deltoid with 0.05 ml, of BCG vaccine (CSL/Connaught) intradermally. The pt was sent back by her local medical doctor 2 months later (12/18/97) due to an enlarged and firm right supraclavicular lymph node which measured 3cm and was almost on the verge of rupturing through the skin. Excision of the lymph node was carried out. The pt was started on a 3 month regimen of isoniazid and Rifampicin. She tolerated the medications well and showed signs of resolution after 1 week. No further follow-up was continued after the family returned to Bangladesh. Upon follow-up review from 2/15/01, it was determined that version zero of this report was incorrectly reported to the wrong product. The correct product for this report was BCG-Mycobax not BCG-Theracys as previously reported.

VAERS ID:169140 (history)  Vaccinated:0000-00-00
Age:0.2  Onset:0000-00-00
Gender:Male  Submitted:2002-05-06
Location:Foreign  Entered:2001-04-27, Days after submission: 374
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: At autopy-M. Bovis var BCG, was recovered from lung tissue and numerous acid-fast bacilli were observed in bone marrow and 1 adrenal gland, confirming the dx of disseminated BCG infection. Immunologic investigations revealed normal number o
CDC 'Split Type': U2001006610
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (TICE)ORGANON-TEKNIKA 0SC 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bacterial infection, Chromosome abnormality, Cough, Hepatomegaly, Irritability, Lymphadenopathy, Oral intake reduced, Pancytopenia, Pyrexia, Respiratory failure, Splenomegaly
SMQs:, Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Agranulocytosis (narrow), Haematopoietic cytopenias affecting more than one type of blood cell (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Congenital, familial and genetic disorders (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Cardiomyopathy (broad), Hypersensitivity (broad), Myelodysplastic syndrome (broad)
Write-up: "Male infant was born in 8/96, following a normal pregnancy. He was well initially. BCG vaccine was administered in the left arm at 3 weeks of age. At 9 weeks of age, he was seen in hospital with a brief history of cough and fever. He was found to have markedly enlarged liver, spleen and was admitted for investigation. CMV was cultured from his urine; treatment was undertaken with ganciclovir and IV immunoglobulin on suspicion that the virus was responsible for his hepatosplenomegaly. While in hospital, that infant developed enlarged left axillary nodes. At the same time, his liver enlargement increased and pancytopenia became severe, necessitating repeated platelet infusions. Excision biopsy of an axillary lymph node showed abundant acid-fast bacilli, later identified as M. bovis, var BCG. He was treated with isoniazid, rifampin, pyrazinamide and clarithromycin on suspicion that he had disseminated BCG infection. However, he failed to improve and died of respiratory failure after 32 days in hospital; 17 days of anti-TB therapy took place during this time. Details of the infant''s disorder and studies of his parents will be published separately. The parents were healthy and unrelated. F/U received 4/16/01; F/U-has been published as Disseminated bacille Calmette-Guerin infection in an infant with a novel deletion in the interferon-gamma receptor gene. From fazed correspondence on 4/29/02-6 weeks after receiving BCG vax, an aboriginal infant presented with suspected sepsis, lymphadenopathy and hepatosplenomegaly. Other mutations in this gene have led to disseminated atypical mycobacterial infections in children as well. The authors believed that the infant''s impaired response to anti-tuberculosis therapy and eventual fatal infection was consistent with the interferon-gamma receptor gene mutation. Standard 0.05ml BCG vaccine was administered in the left deltoid at 2 weeks of age. He presented at 8 weeks of age with a 3 day history of cough, irritability, decreased feeding and a 1 day history of fever. The liver edge

VAERS ID:172993 (history)  Vaccinated:1993-09-02
Age:0.3  Onset:1993-11-01, Days after vaccination: 60
Gender:Male  Submitted:2001-06-28, Days after onset: 2795
Location:Foreign  Entered:2001-07-06, Days after submission: 8
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Febrile seizure; measles
Diagnostic Lab Data: EEG-"very abnormal" on 9/95; On 3/25/96 all nml results on MRI of brain; Visual evoked potentials; ERG; Urea; Electrolytes; Creatinine; Calcium; Magnesium; liver function; Urate; ammonia; Blood and CSF lactate; CBC, etc. Abnormal tests incl
CDC 'Split Type': WAES99031502
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0261W SC 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Abdominal distension, Abdominal pain, Abnormal behaviour, Alpha 1 foetoprotein increased, Clumsiness, Constipation, Coordination abnormal, Diarrhoea, Disturbance in attention, Electroencephalogram abnormal, Febrile convulsion, Gastrointestinal disorder, Immunoglobulins decreased, Infection, Neurodevelopmental disorder, Psychomotor hyperactivity, Sleep disorder, Urine analysis abnormal
SMQs:, Acute pancreatitis (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Convulsions (narrow), Pseudomembranous colitis (broad), Tumour markers (narrow), Akathisia (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Foetal disorders (broad), Generalised convulsive seizures following immunisation (narrow), Noninfectious diarrhoea (narrow)
Write-up: Information has been received from a foreign legal firm concerning a male who on 9/2/93 was vaccinated with MMRII (lot 791750U, 606926/0261W). It is alleged that the pt suffers from epilepsy, ataxia, behavioral problems, severe learning difficulties and gastrointestinal problems. The pt had 2 febrile convulsions associated with measles infection on 8/10/93. He had additional convulsions during 12/93, 4/95 and 8/95. Within 2 months, post vax, he was noted to have become clumsy, bumping into things and falling over. Sudden deterioration in sleep pattern, concentration span and speech development. By 8/94, he developed behavioral difficulties including hyperactivity. On 10/12/95, he was dx''d with epilepsy. This was noted to be in conjunction with developmental problems, slow speech, poor concentration, abnormal social interaction and hyperactivity. In 1/98, he had started suffering from persistent abdominal pain and bloating with stools alternating between solid and loose. Upon internal review epilepsy, convulsions and febrile convulsion associated with measles infection were determined to be "Other Important Medical Events". No further information is available. F/U info from a foreign legal firm indicated that the pt was seen by a consulting pediatrician on 12/4/95 and he noted that there had been a change in the pattern of the pt''s epilepsy and that he was having astatic drop attacks, atonic seizures and probable myoclonic jerks. Current treatment included carbamazepine 200mg bid and sodium valproate 400mg bid. On 3/25/96, the pt was admitted to the hospital for further testing. The neurologist believed the pt''s ataxia was epilepsy related. On 6/21/96, a physician concluded that the pt "has a difficult form of epilepsy which is poorly controlled. He may also have some developmental problems with slow speech and poor concentration, rather abnormal social interaction".

VAERS ID:186324 (history)  Vaccinated:2001-11-28
Age:0.4  Onset:2002-02-22, Days after vaccination: 86
Gender:Male  Submitted:2002-11-22, Days after onset: 273
Location:Foreign  Entered:2002-06-12, Days after submission: 163
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vitamin D
Current Illness:
Preexisting Conditions: Jaundice neonatal; benign neoplasm of eyelid, including canthus; telangiectsia; umbilical hernia NOS
Diagnostic Lab Data: Ultrasound - Multiple cervical adenopathies; Ultrasound - adenopathy; Temperature measurement - fever; WBC count; Band neutrophil count; Neutrophil count; Serum C-reactive protein- High; Temperature measurement - normal; Temperature measure
CDC 'Split Type': WAES0203CAN00001
Vaccination
Manufacturer
Lot
Dose
Route
Site
DT: DT ADSORBED (NO BRAND NAME)UNKNOWN MANUFACTURER 2IM 
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC. 2IM 
HIBV: HIB (NO BRAND NAME)UNKNOWN MANUFACTURER 2IM 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Abscess drainage, Anorexia, Cough, Crying, Jaundice, Lymphadenopathy, Lymphocyte morphology abnormal, Neutropenia, Protein bound iodine increased, Pyrexia, Rash papular, Viral infection, Vomiting
SMQs:, Cholestasis and jaundice of hepatic origin (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypothyroidism (broad), Hyperthyroidism (broad), Depression (excl suicide and self injury) (broad), Malignant lymphomas (broad)
Write-up: Information has been received from an investigator concerning a 21 week old male child with right blepharal nevus with telangiectasia and umbilical hernia and a history of jaundice neonatal who entered a study. On 11/28/2001, the pt was allocated and randomized to either one of three formulations of HRSI vaccine (diphtheria toxoid/haemophilus b conjugate vaccine/hep b vaccine recombinant/pertussis vaccine/poliovirus vaccine/tetanus toxoid) or Pentacel diphtheria toxoid/haemophilus b conjugate vaccine/pertussis vaccine/poliovirus vaccine/tetanus toxiid) and (hep b vaccine recombinant) control vaccines. Pt was randomized to received control vaccines (Pentacel and hep b vaccine recombinant) and was vaccinated on 11/28/2001 with the first dose and on 02/11/2002 with the second dose. Concomitant therapy included vitamin D. After the vaccination, the pt experienced fever with a peak at 39.8 deg C for 5-6 days controlled with Tylenol. He subsequently developed a papular rash on the neck and a viral infection associated with vomiting (x2), dry cough, loss of appetite and increased crying. On 02/22/2002, the pt went to ER because of the sudden apparition of a 2.5cm X 2.5cm cervical mass. The pt had dry cough, vomited twice and his temp was normal at 37 deg C and 37.6 deg C rectal. He had consultations with pediatrics and infectious diseases and was admitted to hospital with a cervical *adenitis* diagnosis. His WBC was 12.4 without any bands and neutrophils, C-reactive protein was increased to 25mg/L. A cervical ultrasound revealed multiple cervical adenopathies. On 02/23/2002, WBC was 10.4 without any bands and neutrophils, lymphocyte count was increased to 6.1 x 10^9/L, monocyte count was increased to 3.4 x 10^9/L and viral throat culture was negative. On 02/24/2002, WBC was increased to 13.8 without any bands and neutrophils, lymphocyte count was increased to 7.7 x 10^9/L, monocyte count was increased to 5.2 x 10^9/L and C-reactive protein was increased to 29mg/L. On 02/25/2002, cervical ultrasound was repeated and adem

VAERS ID:189184 (history)  Vaccinated:2002-08-01
Age:  Onset:2002-08-02, Days after vaccination: 1
Gender:Unknown  Submitted:2002-08-16, Days after onset: 14
Location:Foreign  Entered:2002-08-22, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: UNK
Preexisting Conditions:
Diagnostic Lab Data: 8/2002: Alanine Transaminase, serum-37; Aspartate Transaminase, serum-19; C-Reactive Protein, serum-79; WBC-6,000; Exam-Hepatosplenomegaly; 8/5/02 Temperature-39C
CDC 'Split Type': D0039086A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS 0IM 
Administered by: Other     Purchased by: Other
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Headache, Hepatosplenomegaly, Laboratory test abnormal, Lymphadenopathy, Pain, Pyrexia, White blood cell count decreased
SMQs:, Liver related investigations, signs and symptoms (narrow), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad)
Write-up: On 8/1/02, the pt received the 1st dose of Twinrix adult. Approx. 1 day, post vax, on 8/2/02, the pt experienced fever, headache, limb pain and swollen lymph nodes on the neck. Treatment included cortisone. The events improved at first, but on 8/5/02, the pt had to be hospitalized due to worsening conditions including fever of 39C. Exam showed elevated transaminases, elevated C-reactive protein and hepatosplenomegaly. The most recent information received on 8/7/02, reported the outcome of the event as not resolved. The reporter did not specify the relation of the events to vaccination with Twinrix adult. Additional information has been requested.

VAERS ID:189254 (history)  Vaccinated:1994-07-21
Age:  Onset:1994-07-28, Days after vaccination: 7
Gender:Male  Submitted:2002-11-20, Days after onset: 3037
Location:Foreign  Entered:2002-08-23, Days after submission: 89
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Unk
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': WAES0208USA01694
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1503W   
Administered by: Unknown     Purchased by: Unknown
Symptoms: Abnormal behaviour, Decreased appetite, Diarrhoea, Hearing impaired, Irritability, Listless, Lymphadenopathy, Weight decreased
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Dementia (broad), Pseudomembranous colitis (broad), Psychosis and psychotic disorders (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Hearing impairment (narrow), Noninfectious diarrhoea (narrow)
Write-up: Information has been received from a foreign legal firm concerning a male child who on 21 JUL 1994 was vaccinated with MMR (second generation)(lot # 609505/1503W: batch # 851790U). It is alleged that subsequent to the vaccination the patient experienced behavioral and hearing problems. Upon internal review, the patient''s hearing and behavioral problems were considered to be other important medical events. No further information is available. The follow up states the pt''s legal claim form was received as follow up and reported that around seven days after the vaccination the pt became listless, irritable and developed swollen glands in his neck and groin. His behavior altered between screaming fits and periods of listlessness. Fourteen days later he developed spots and started pulling at his ears. At that time he developed sickness and chronic diarrhea. The diarrhea remained chronic for twelve months after the vaccination and continued intermittently with severe episodes for several years. Four months after the vaccination the pt''s behavior deteriorated and he develpoed angry temper tantrusm. At the same time he had very little appetite and started to lose weight. Five months post vaccination the pt''s mother recalled her son with chronic diarrhea, swollen glands, extremely thin, no appetite and deranged behavior. In September of 1996, the pt was assessed by a speech and language therapist who noted hte pt''s understanding of language and expressive language were at the lower end of hte normal range. In January of 2000, a physician felt that the pt was suffering from depression and started him on amytryptilline, which was stopped a few weeks later by his mother. Another physician felt that there was not engouh evidence to diagnose a depressive illness. At the time that this legal claim was written, the pt displayed routine-based behavior, social withdrawl, preferring his won company. He also continued to be a picky eater. It was noted that the pt was suspected of having measles on 1/27/97. A letter written by a con

VAERS ID:201464 (history)  Vaccinated:2001-09-14
Age:  Onset:2001-09-18, Days after vaccination: 4
Gender:Male  Submitted:2003-04-09, Days after onset: 568
Location:Foreign  Entered:2003-04-15, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Pulmicort; Bricanyl
Current Illness:
Preexisting Conditions: Asthma, foodstuff allergy: pea, chocolate, strawberry, cocoa, fish and additionally one unclear foodstuff.
Diagnostic Lab Data: The clinical analysis on the 9/27/01 showed S-ParvAbG<10 EIU, S-ParvAbm negative, leukocytes was 6.9E9/l, B-Eryt 4.54 E12/L, B-HB 127g/L, B-HKR 0.37, E-MCV 82fl, E-MCH 28pg, E-MCHC 338 g/l, B-Trom 189 E9/l, S-VirLab and S-InfACF was 8 (no u
CDC 'Split Type': E200300188
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (ACTHIB)AVENTIS PASTEUR515002IMGM
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.HL482600IMGM
Administered by: Unknown     Purchased by: Unknown
Symptoms: Depressed level of consciousness, Diarrhoea, Epilepsy, Lymphadenopathy, Pyrexia, Rash papular, Rhinitis, Tremor
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Convulsions (narrow), Pseudomembranous colitis (broad), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Noninfectious diarrhoea (narrow)
Write-up: It was reported that a boy was vaccinated with the 3rd dose of a Hib (Act-Hib, 51500) vaccine and the 1st dose of MMR II (batch HL48260) on 9/14/01. On 9/18/01 the pt presented with an anterior, small papule, red rash. The most of it on the thighs, legs and arms and only little on the face. 8 days after vaccination he got fever, enlarged glands behind the ears and in the neck. On the 9/24/01, he got medication Atarax and Panadol. On 10/26/01, the child was examined by the doctor. The child had slight rhinitis, been sick and has not been eaten well during couple of days. Faeces were clear looser than usual, usually has more constipation. He had the most intensive rash on the thighs, but also on the legs, on lower and upper arms, on front and back of the body. He had slight pimples on clustering and pimply, elevated on the skin, quite pale red. Palms and soles were near. There was no rash history in the family. General condition was OK, no erythema in the pharynx. Tonsils were clean. On 10/9/01, the rash was weakly visible, glands was most unvisible. The child was in a good condition all the time. The mother told that the child got an epileptic seizure while sleeping his afternoon nap on two consecutive days. About some hours after he felt asleep he "snapped" strongly with his mouth and foam-slime become out of his mouth. The child was trembling and couldn''t be waked up. In February 2002 he had a clear convulsions seizure for 10-15 min. He was hospitalized and epilepsy was diagnosed. After that left side limbs have been powerless and speech a little bit mushy for 2 days. Medication for epilepsy has started and seizures were absent until October 2002, when the medication was terminated and the amount of seizures increased again. In October 2002 a video EEG was done at first aid and a lot of outburst was detected during sleep. The medication has decided to change and after that seizure symptoms have been under control. Epileptic symptoms have been partly absence/aura symptoms and symptoms during sleep. Even after the

VAERS ID:213647 (history)  Vaccinated:0000-00-00
Age:0.3  Onset:0000-00-00
Gender:Male  Submitted:2003-12-05
Location:Foreign  Entered:2003-12-09, Days after submission: 4
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data: The haemogram, biochemistry, and urinalysis showed no abnormalities. Chest and bone x-rays were normal. A Mantoux test gave a finding of 16mm. Staining and culturing the adenopathy exudate for mycobacteria gave negative findings. Human immu
CDC 'Split Type': 200303253
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER   LA
Administered by: Unknown     Purchased by: Unknown
Symptoms: Infection, Lymphadenopathy, Pyrexia, Rash papular
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: It was reported through literature a case of adenitis as a complication of BCG vaccine in a baby. A 7 month old boy was referred to our hospital for assessment of an axillry lesion that had been present for 3 and a half months. The picture had begun as a left axillary adenopathy which steadily grew in size, accompanied initially by self-limiting febrile syndrome of short duration. After 6 weeks the adenopathy was large and was starting to fistulize. The epidemiologic history revealed that the pt was an immigrant, where he had been vacinated in accordance with the BCG vaccination calendar at 3 months of age, 15 days before the above-mentioned picture began. He had no known relevant personal or family history and no known contact with tuberculosis. Examination revealed two left axillary adenopathiese measuring 3x3cm and 1.5x1.5cm, hard, with no adhesions. A fistulization crifice was visible on the anterolateral aspect of the thorax, near the larger adenopathy, with slight suppuration. The posterior region of the left arm showed a purple papule at the site of innoculation of the BCG vaccine. The remaining findings were unremarkable. The haemogram, biochemistry and urinalysis showed no abnormalities. Chest and bone x-rays were normal. A Mantoux test gave a finding of 16mm. Staining and culturing the adenopathy exudate for mycobacteria gave negative findings. Human immunodeficiency virus serology was negative. In view of the epidemiologic history and clinical picture the pt was diagnosed with localized BCGitis. Oral isoniazid for 3 months was prescribed. During this period the adenopathies regressed, and at 3 months all that remained was a minimal adenopathy. File to be completed. Follow up on 12/16/03: "According to the author: the incidence of adverse reactions to BCG is low, although it may possibly be underestimated given the benign nature of most of the cases. Regional lymphadenitis is the most frequent complication, with an incidence of between 0.5 and 5%. Suppuration is exceptional; it occurs in only 1% of c

VAERS ID:219548 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2004-04-27
Location:Foreign  Entered:2004-04-28, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: UNK
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC 'Split Type': D0043628A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS    
Administered by: Other     Purchased by: Other
Symptoms: Hepatitis, Immune system disorder, Jaundice
SMQs:, Cholestasis and jaundice of hepatic origin (narrow), Hepatitis, non-infectious (narrow), Acute pancreatitis (broad), Biliary system related investigations, signs and symptoms (narrow), Biliary tract disorders (narrow)
Write-up: This case was reported by a physician and described the occurrence of possible auto-immune hepatitis in a juvenile female subject who was vaccinated with hepatitis A-B vaccine for prophylaxis. The subject''s past medical history has not been reported. In autumn 2003, the subject received the first two doses of hepatitis A-B vaccine. Approximately half a year post vaccination, in spring 2004, the subject developed jaundice and was diagnosed with possible auto-immune hepatitis. The outcome of the events was not reported. According to the reporting physician, the subject''s mother suspected a relationship between auto-immune hepatitis and vaccination with hepatitis A-B vaccine. The reporting physician was not the treating physician. The subject does not live in the same city and the reporting physician did not know the subject''s family doctor. No further information will be available.

VAERS ID:221870 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2004-05-25
Location:Foreign  Entered:2004-05-26, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: UNK
Preexisting Conditions:
Diagnostic Lab Data: UNK
CDC 'Split Type': D0043825A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS    
Administered by: Other     Purchased by: Other
Symptoms: Cardiovascular disorder, Dizziness, Injection site reaction, Lymphadenopathy
SMQs:, Anticholinergic syndrome (broad), Cardiomyopathy (broad), Vestibular disorders (broad)
Write-up: A physician reported the occurrence of a severe injection site reaction in a female subject of unknown age who was vaccinated with hepatitis A-B vaccine for prophylaxis. In the subject''s family, severe injection site reaction were known. On a date not specified the subject received the third dose of hepatitis A-B vaccine. On a date no specified post vaccination the subject developed a severe injection site reaction with enlarged lymph nodes, circulatory disturbance and dizziness. The subject was not able to work for two days. Follow up on 06/07/04 states: "The events resolved on 04/17/04. The reporting physician considered that the event after the third vaccination were probably related to vaccination with hepatitis A-B vaccine."

VAERS ID:244148 (history)  Vaccinated:2004-06-07
Age:0.0  Onset:2004-09-11, Days after vaccination: 96
Gender:Female  Submitted:2005-09-14, Days after onset: 368
Location:Foreign  Entered:2005-09-15, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had no medical history, concurrent conditions, was on no concurrent medications and had no illnesses at the time of vaccination.
Diagnostic Lab Data: Cultures taken showed heavy Strep A.
CDC 'Split Type': 200501355
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (MYCOBAX)AVENTIS PASTEURC1685 IDLA
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bacterial infection, Lymphadenopathy
SMQs:
Write-up: Initial report of a cluster of 4 cases with swelling of lymph nodes was received from a nurse on July 2005. Case 4: A child, age not reported, developed swelling of the lymph nodes, latency not reported, after receiving an intra dermal injection in the left upper deltoid of BCG vaccine, lot number C1685AE. The administration date was not reported. As of July 13 2005, reporters states, no more information other than what was recorded. Follow up information received on Sept 07 2005. This case has been upgraded to serious based on follow up information received. The patients date of birth is June 03 2004 and was vaccinated on June 07 2004 when 4 days old. the patient had no medical history, concurrent conditions, was on no concurrent medications and had no illnesses at the time of vaccination. At the age of 3 months the patient developed a left axillary lump node which burst on Sept 11 2004. Cultures taken showed heavy Strep A. The patient was hospitalized from Sept 12 2004 to Sept 14 2004 and was treated with Cefprozil Q8H. the patient fully recovered, date unknown. The reporter noted that 4 out of 50 children immunized with BCG lot number C1685AE developed swelling of lymph nodes. Same reporter as cases 200501352, 200501353, 20501354. These three patients did not require hospitalization.

VAERS ID:244241 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2005-09-09
Location:Foreign  Entered:2005-09-19, Days after submission: 10
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: SCID
Diagnostic Lab Data:
CDC 'Split Type': 2005132297NL
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Immune system disorder, Infection
SMQs:
Write-up: Clinical events: Disseminated BCG infection (Disseminated Tuberculosis) Narrative: Child was vaccinated with BCG (brand unknown) at 2 days of age for multiple infection in 1993. Patient had a severe immunodeficiency disorder. Patient had concomitant infections and subsequently died. Out come: Fatal

VAERS ID:244242 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2005-09-09
Location:Foreign  Entered:2005-09-19, Days after submission: 10
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: SCID, Bone marrow transplant
Diagnostic Lab Data:
CDC 'Split Type': 2005132292NL
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (MYCOBAX)AVENTIS PASTEURUNK  UN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Immune system disorder, Infection
SMQs:
Write-up: Clinical events: Disseminated BCG infection (Disseminated Tuberculosis) Narrative: child was vaccinated with BCG (brand unknown) at birth for multiple infection in 1993. Patient had a severe immunodeficiency disorder. Patient had concomitant infections and subsequently died after bone marrow transplant. Outcome: fatal.

VAERS ID:244243 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2005-09-09
Location:Foreign  Entered:2005-09-19, Days after submission: 10
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: SCID
Diagnostic Lab Data:
CDC 'Split Type': 2005132291NL
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURERUNK  UN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Immune system disorder, Tuberculosis
SMQs:
Write-up: Clinical events: Disseminated BCG infection (Disseminated Tuberculosis) Narrative: child vaccinated with BCG (brand unknown) at 1 day of age for multiple infection in 1993. Patient had a severe immunodeficiency disorder. Patient had concomitant infections and subsequently dies. Outcome fatal.

VAERS ID:244244 (history)  Vaccinated:0000-00-00
Age:0.1  Onset:0000-00-00
Gender:Unknown  Submitted:2005-09-09
Location:Foreign  Entered:2005-09-19, Days after submission: 10
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: IFN-y receptor deficiency
Diagnostic Lab Data:
CDC 'Split Type': 205132289NL
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURERUNK  UN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Immune system disorder, Tuberculosis
SMQs:
Write-up: Clinical events: Disseminated BCG infection (disseminated tuberculosis). Narrative: child was vaccinated with BCG (brand unknown) at 3 weeks of age for multiple infection in 1993. Patient had an IFN-y receptor deficiency. Patient had concomitant infections and subsequently died. Outcome: fatal.

VAERS ID:244246 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2005-09-09
Location:Foreign  Entered:2005-09-19, Days after submission: 10
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: SCID
Diagnostic Lab Data:
CDC 'Split Type': 2005132270NL
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Immune system disorder, Tuberculosis
SMQs:
Write-up: Clinical events: Disseminated BCG infection (Disseminated Tuberculosis). Narrative: child was vaccinated with BCG (brand unknown) at 3 days of age form multiple infection in 1993. Patient has a sever immunodeficiency disorder, Patient had concomitant infections and subsequently died. Outcome: fatal.

VAERS ID:251284 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2006-02-07
Location:Foreign  Entered:2006-02-07
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': B0409049A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS   UN
Administered by: Other     Purchased by: Other
Symptoms: Hepatitis, Immune system disorder
SMQs:, Hepatitis, non-infectious (narrow)
Write-up: This case was reported by a physician and described the occurrence of an autoimmune hepatitis in a female subject of unspecified age who was vaccinated with hepatitis A inactivated and hepatitis B recombinant vaccine Twinrix, for prophylaxis. On an unspecified date the subject received a dose of Twinrix. At an unknown time following vaccination, the subject developed an autoimmune hepatitis. The physician considered the event was clinically significant (or requiring intervention) (OMIC). AT the time of reporting the outcome of the event was unspecified. Further information has been requested.

VAERS ID:262343 (history)  Vaccinated:0000-00-00
Age:0.3  Onset:0000-00-00
Gender:Female  Submitted:2006-08-23
Location:Foreign  Entered:2006-08-30, Days after submission: 7
Life Threatening? Yes
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Immunophenotypic analysis flow cytometry abnormally low expression of the alfa chain of the IFN gamma receptor, Serum C reactive protein (high), Serum CMV IgM ab (high) level of IgM class anti CMV reactive antibodies, Serum alanine aminotra
CDC 'Split Type': WAES0608POL00005
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  SC 
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC. 0SC 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Alanine aminotransferase increased, Anaemia, Aspartate aminotransferase increased, Granuloma, Haemolysis, Hepatosplenomegaly, Laboratory test abnormal, Liver function test abnormal, Lymphadenopathy, Neutropenia, Pallor, Pyrexia, Renal failure, Sepsis, Thrombocytopenia, Viral infection
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Liver related investigations, signs and symptoms (narrow), Haemolytic disorders (narrow), Agranulocytosis (broad), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Hypotonic-hyporesponsive episode (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad)
Write-up: It was reported in a published article, that a 4 month old girl exhibited enlargement of left axillary lymph nodes during a 1.5 month period (year unknown) as a rare complication of antituberculous vaccination. She was a second child of healthy parents, with no family history of genetic disorders or TB. The first dose of BCG and anti hepatic B virus vaccination (unknown product, unknown manufacturer) the pt received the first day of life, followed by vaccination against diphtheria, tetanus, pertussis, poliomyelitis, and the second dose of anti hepatic B virus vaccination (unknown product) after 6 weeks. On hospital admission the pt was in reasonably good condition but pale, with grossly enlarged adjacent left axillary lymph nodes and hepatosplenomegaly. Lab test showed anemia, thrombocytopenia, elevated transaminase activity, a high C reactive protein level. and high level of IgM class anti cytomegalovirus reactive antibodies, flow cytometry measurements 20% lymphocytes expressed CD 119 (IFN gamma receptor outer subunit R1), chest and bone radiographs negative for infection, Ziehl Neelsen and periodic acid Schiff staining-did not show acid fast bacilli. CMV infection was suspected. The pt was administered a 14 day regimen of ganciclovir., Liver function test and blood count normalized, hepatosplenomegaly decreased. However, the lymph nodes continued to enlarge. Diagnostic excision and bone marrow aspiration were performed to exclude a neoplastic process. A histopathologic image of the excised lymph nodes showed caseating granulomas and tuberculous lymphadenitis was suggested. At that time a diagnosis of disseminated BCG infection as a complication of TB vaccination in a presumed immunocompromised pt was proposed. Flow cytometry measurements showed abnormally low expression of the alpha chain of the interferon IPN gamma receptor on peripheral blood lymphocytes. Only 20% lymphocytes expressed CD 119 (IFN gamma receptor outer subunit R1). Three drug anti tuberculos therapy (rifamipin, Isoniazid and Streptomycin) was

VAERS ID:269852 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2006-12-28
Location:Foreign  Entered:2006-12-29, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES0612TWN00009
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  IMUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Immune system disorder, Thrombocytopenic purpura
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow)
Write-up: Information has been received from the authors of the above entitled published literature article concerning a patient who was vaccinated with MMR II (manufacturer unknown). Subsequently the patient experienced acute immune thrombocytopenic purpura and was hospitalized. Subsequently, the patient recovered from acute immune thrombocytopenic purpura. The reporter felt that acute immune thrombocytopenic purpura was related to therapy with MMR II. No further information is available.

VAERS ID:276711 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:2007-04-17
Location:Foreign  Entered:2007-04-18, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0704USA01702
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 0UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Autism, Immune system disorder, Multiple allergies
SMQs:, Hypersensitivity (narrow)
Write-up: It was reported in a published article, title as stated above that on an unspecified date a male child was vaccinated with a first dose of MMR (manufacturer unknown). Subsequently, on an unspecified date following vaccination, he was diagnosed with severe autism. Unspecified medical attention was sought. It was reported that the patient did not receive a second dose of MMR. No outcome was reported, but the patient''s mother reported, "... if you look at my son he has all these allergies and he reacts to everything and I mean. We have to prepare all his food separately and all the rest of it, and he''s so sensitive, and I always say his immune system is wonky... totally off kilter...". The authors concluded, "so little is still known about the opinions of parents caring for children with autism, illustrators how limited the scope of the research on the autism/MMR controversy has been. This research has highlighted the considerable negative impact that the MMR controversy had had on this group of vulnerable parents. This has implications for health professionals, who need to be particularly aware of the issues these parents face in future MMR decision-making for their affected child and younger siblings. In general, these parents, perhaps more than most, face a particularly difficult decision when trying to decide whether vaccination is in their child''s best interests. Health professionals also need to be sensitive to the fact that some of these parents may feel in part responsible for having sanctioned an intervention that they believe may have contributed to their child''s autism. More generally, there is a need to promote a greater awareness of the important role health visitors can play in parental decision-making and for research examining whether health professionals feel they receive sufficient training in communication skills. Upon internal review, severe autism was determined to be an other important medical event. This is one of several reports received from the same source. No further information is expecte

VAERS ID:276738 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:2007-04-17
Location:Foreign  Entered:2007-04-18, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0704USA01729
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 0UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Autism, Immune system disorder
SMQs:
Write-up: It was reported in a published article, title as stated above that on an unspecified date a male child was vaccinated with a first dose of MMR (manufacturer unknown). Subsequently, on an unspecified date following vaccination, the patient was diagnosed with autism. Unspecified medical attention was sought. It was reported that the patient did not receive a second dose of MMR. No outcome was reported. The patient''s mother was interviewed and noted the following, "... his immune system is shot to pieces... He, he does seem to be one of these children who follows the, the path for antibiotics and then vaccinations and then autism. When he gets a cough or cold he seems to have it much, much longer... But he just gets really ill...it puts him into hospital... I actually asked the consultant before he discharged him last time. I said ''you know, he does seem to be poorly a lot of the time, you known and he does have autism and I think there''s a link between his autism and his immune system'' and the consultant said ''no, that''s absolutely not true, there''s no correlation between autism and the immune, his immune system''. He dismissed it - so I said ''well okay'' but I just felt that I had to say something." The authors concluded, "so little is still known about the opinions of parents caring for children with autism, illustrators how limited the scope of the research on the autism/MMR controversy has been. This research has highlighted the considerable negative impact that the MMR controversy had had on this group of vulnerable parents. This has implications for health professionals, who need to be particularly aware of the issues these parents face in future MMR decision-making for their affected child and younger siblings. In general, these parents, perhaps more than most, face a particularly difficult decision when trying to decide whether vaccination is in their child''s best interests. Health professionals also need to be sensitive to the fact that some of these parents may feel in part responsible for having sanctioned

VAERS ID:295848 (history)  Vaccinated:2007-08-27
Age:0.2  Onset:2007-08-28, Days after vaccination: 1
Gender:Male  Submitted:2007-11-05, Days after onset: 69
Location:Foreign  Entered:2007-11-07, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No concurrent illnesses.
Preexisting Conditions: No known allergies, no pre-existing medical history. He had received the 1st intramuscular dose of Hepatitis B vaccine on 27 June 2007, BCG vaccine on 28 June 2007, and the 2nd dose of Hepatitis B on 30 July 2007. The patient had not experienced any adverse events following prior vaccinations.
Diagnostic Lab Data: Lab test revealed: WBC 17.36*10^9/L on blood routine test; B Ultrasonograph showed obvious abdominal distension.
CDC 'Split Type': 200703591
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (ACTHIB)SANOFI PASTEUR10930IMGM
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURER200606010PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Asthenia, CSF test normal, Cerebral haemorrhage, Convulsion, Demyelination, Foaming at mouth, Gaze palsy, Hyperreflexia, Hypokinesia, Hypotonia, Immunodeficiency, Immunoglobulins decreased, Muscle twitching, Nervous system disorder, Nuchal rigidity, Pupil fixed, Pyrexia, Reye's syndrome, Ultrasound abdomen abnormal, White blood cell count increased
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Haemorrhagic cerebrovascular conditions (narrow), Retroperitoneal fibrosis (broad), Convulsions (narrow), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Noninfectious meningitis (broad), Optic nerve disorders (broad), Demyelination (narrow), Ocular motility disorders (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow)
Write-up: Report received from a healthcare professional on 25 October 2007 via our company representative. A 02-month-old male patient, with no relevant medical history, had received in the morning of 27 August 2007 the 1st dose of Act-Hib, lot reported as "?1093-2" intra-muscularly in the buttock associated with OPV. In the afternoon of 28 August 2007, he experienced fever at 38.5C. After treatment as an outpatient in local healthcare unit, the temperature dropped to normal. On 01 September 2007, the patient presented with eyes fixation, left extremities twitch, right extremities movement decreased and foaming at the mouth. Then the patient was admitted to hospital for further treatment and diagnosis. On 01 September 2007, the physical examination showed: T= 37C, R= 40, P= 120, vomit-milk, extremities muscle power normal, left extremities decreased muscular tone, neck rigidity, knee jerk hyperreflexia, Babinski sign positive. Lab test revealed: WBC 17.36*10^9/L on blood routine test; B Ultrasonograph showed obvious abdominal distension. Preliminary Diagnosis were : 1. central nervous system infection; 2. Intracranial hemorrhage, 3 Convulsion due to brain develop defects, 4 blood poisoning, 5 Reye syndrome. Then the patient received treatment for central nervous system purulent infection on 02 September 2007, but on 03 September 2007, the result of cerebrospinal fluid was normal, and purulent meningitis was excluded. Total immunoglobulin was less than 4g/L, suggesting the possibility of immunodeficiency. On 04 September 2007, he had neck rigidity. Muscle power 3 degree in right lower extremity, left and right upper extremities muscle power was normal. On 05 September 2007, it was noted muscle power 2 degree in the right lower extremity. On 07 September 2007, he presented with muscle power 3 degree in right lower extremity, right knee jerk hyporeflexia. On 08 September 2007, he had muscle power 4 degree in right lower extremity, right knee jerk hyporeflexia. Doctor considered whether there was demyelination following immun

VAERS ID:324112 (history)  Vaccinated:0000-00-00
Age:0.5  Onset:0000-00-00
Gender:Female  Submitted:2008-09-03
Location:Foreign  Entered:2008-09-04, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: She was the 2nd child of healthy 1st degree consanguineous parents. The patient''s sister died at 3 months of age due to sepsis.
Diagnostic Lab Data: Physical examination revealed a wasted female (weight 4 kg, <3rd percentile) with hepatomegaly. There was no palpable spleen or lymphadenopathy. Erythematous patch with satellite lesions were noted on her neck and chest. Laboratory studi
CDC 'Split Type': 200802770
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER 0UNRA
Administered by: Unknown     Purchased by: Unknown
Symptoms: B-lymphocyte count decreased, Blood immunoglobulin A, Blood immunoglobulin A normal, Blood immunoglobulin E, Blood immunoglobulin G decreased, Blood immunoglobulin M, Blood immunoglobulin M normal, Blood product transfusion, Bone marrow transplant, Bone scan abnormal, CD4 lymphocytes abnormal, CD4 lymphocytes decreased, Candidiasis, Chest X-ray abnormal, Computerised tomogram abnormal, Culture positive, Diarrhoea, Diarrhoea infectious, Failure to thrive, Graft versus host disease, Granuloma, HIV antibody negative, Haematocrit normal, Haemoglobin normal, Hepatomegaly, Hepatosplenomegaly, Immunodeficiency, Injection site abscess, Leukocytosis, Lung infiltration, Lymphocyte percentage, Mycobacterial infection, Neutrophil percentage, Neutrophilia, Osteomyelitis, Platelet count increased, Pneumonia, Polymerase chain reaction, Rash erythematous, Skin lesion, Subcutaneous nodule, T-lymphocyte count decreased, Weight decreased, White blood cell count increased, Whole body scan
SMQs:, Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Haematopoietic leukopenia (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Osteonecrosis (broad), Neonatal disorders (broad), Hypersensitivity (narrow), Myelodysplastic syndrome (broad), Noninfectious diarrhoea (narrow)
Write-up: Literature report received on 26 August 2008. A 06-month-old female patient had received her 1st dose of BCG vaccine (MFR UNK, batch number not reported) in the right deltoid muscle on the 1st day of life without any local or systemic reaction. She was referred to hospital on an unspecified date due to chronic diarrhea, failure to thrive and generalized candidiasis. The patient experienced multiple infections, including infectious diarrhea and recurrent pneumonia since the age of 4 weeks. She was the 2nd child of healthy 1st degree consanguineous parents. The patient''s sister died at 3 months of age due to sepsis. Physical examination revealed a wasted female (weight 4 kg, <3rd percentile) with hepatomegaly. There was no palpable spleen or lymphadenopathy. Erythematous patch with satellite lesions were noted on her neck and chest. Laboratory studies on admission revealed hemoglobin 11.8 g/dL, hematocrit 36.6%, WBC 17.830/mm3 (neutrophils 66%, lymphocytes 21%) and platelet count 568000/mm3. Chest X-ray showed perihilar infiltration and absence of thymic shadow. Antibody of human immunodeficiency virus of the patient and her mother were non-reactive. Immunologic studies revealed IgG 44 mg/dL, IgM 26 mg/dL, IgA < 5.7 mg/dL, IgE < 4.5 IU/mL, CD3 7 cells/mm3, CD4 1 cell/mm3, CD8 8 cells/mm3, CD19 2.082 cells/mm3 and CD16/CD56 663 cells/mm3. Lymphocyte proliferation in response to phytohaemagglutinin and purified protein derivative were absent. These findings were compatible with T-B+NK+ severe combined immunodeficiency (SCID). The diagnosis of IL-7Raplha deficiency SCID was confirmed by a mutation analysis. The patient received IV immunoglobulin and prophylactic cotrimoxazole. Bone marrow transplantation (BMT) was attempted at the age of 8 months. She underwent conditioning therapy with fludarabine, busulfan and anti-thymocyte globulin. The purified CD34haploidentical bone marrow from the patient''s father was infused to the patient. Graft versus host disease soon developed and there was no evidence of engraftment. At

VAERS ID:335825 (history)  Vaccinated:0000-00-00
Age:0.4  Onset:0000-00-00
Gender:Male  Submitted:2008-12-19
Location:Foreign  Entered:2008-12-22, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: HIV-positive parents
Diagnostic Lab Data: Nodal aspiration revealed purulent material which stained positive for acid-fast bacilli (AFB) on Zeihl-Neelsen stain.
CDC 'Split Type': 200803988
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (MYCOBAX)SANOFI PASTEUR  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Abscess, Acid fast bacilli infection, Acid fast stain positive, Cachexia, Fluctuance, Hyperaemia, Incisional drainage, Infection, Injection site ulcer, Lymphadenopathy, Oral candidiasis, Purulence, Regressive behaviour, Respiratory tract infection
SMQs:, Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Extravasation events (injections, infusions and implants) (broad)
Write-up: This case is linked with 2008-03989 and 2008-03990 (different patients in the same article). A male patient born to HIV-positive parents had received his dose of BCG vaccine (MFR UNK, batch number, route and site of administration not reported) at 6 weeks of age. He presented at age 5 months with respiratory tract infection, oral candidiasis, generalized wasting and regression of milestones. First-line HAART (highly active antiretroviral therapy) was commenced at age 7 months with ZIDOVUDINE, LAMIVUDINE and NEVIRAPINE. Three weeks later, the patient developed ulceration at the site of his BCG inoculation and an enlarged right axillary lymph node (5 x 4 cm) which increased to 10 x 6 cm and became fluctuant and hyperaemic. Concomitantly, the patient showed marked improvement in his nutritional, neurological and immunological status. Nodal aspiration revealed purulent material which stained positive for acid-fast bacilli (AFB) on Zeihl-Neelsen stain. Ongoing management comprised incision and drainage, daily dressings, oral and topical antibiotics for presumed secondary bacterial infection. The abscess and ulceration slowly resolved over a 6-month period. The outcome was not reported in the article.

VAERS ID:346094 (history)  Vaccinated:2009-04-02
Age:  Onset:2009-04-16, Days after vaccination: 14
Gender:Female  Submitted:2009-05-11, Days after onset: 25
Location:Foreign  Entered:2009-05-11
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: Lymphocyte percentage, Apr2009, 60%; White blood cell count, Apr2009, 20000
CDC 'Split Type': D0061465A
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPAB: HEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS 1UNLA
Administered by: Other     Purchased by: Other
Symptoms: Leukocytosis, Lymphadenopathy, Lymphocyte percentage increased, Lymphocytosis, White blood cell count increased
SMQs:, Neuroleptic malignant syndrome (broad)
Write-up: This case was reported by a physician and described the occurrence of leukocytosis in an adult female subject of unspecified age who was vaccinated with TWINRIX adult (GlaxoSmithKline). The subject was the wife of the reporting physician. Previous vaccination with the first dose of TWINRIX adult (GlaxoSmithKline) was given about 10 years ago. On 02 April 2009 the subject received the second dose of TWINRIX adult (1 ml, unknown). Approximately 14 days post vaccination with TWINRIX adult, on an unknown date in April 2009, within the scope of a preventive medical examination, the subject showed leukocytosis (white blood cell count of 20000), proportional lymphocytosis (lymphocyte percentage 60%) and axillary lymph node swelling both sides. This case was assessed as medically serious by GSK criteria. At the time of reporting the outcome of the events was unspecified. Follow-up information has been requested.

VAERS ID:353027 (history)  Vaccinated:2009-05-21
Age:  Onset:2009-05-22, Days after vaccination: 1
Gender:Unknown  Submitted:2009-07-31, Days after onset: 70
Location:Foreign  Entered:2009-08-03, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': 200903188
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (TRIPEDIA)SANOFI PASTEURC2861A IMUN
OPV: POLIO VIRUS, ORAL (NO BRAND NAME)UNKNOWN MANUFACTURERAOPVB580AD PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Injection site oedema, Lymphadenopathy, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: Initial report received on 23 July 2009 from the foreign Health Authorities (identification number PLURPLOCR20090617002) whose initial reporter was a physician in foreign country. A child received TRIPACEL (lot number C2861A) intramuscularly and Poliovirus vaccine live oral (manufacturer unknown, lot number AOPVB580AD) on 21 May 2009. On 22 May 2009 the patient developed a fever of 39 degrees C, injection site edema, and enlarged axillary lymph nodes of the vaccinated arm. Subsequently the patient was hospitalized. The patient was reported as recovered. List of Documents held by Sender: none.

VAERS ID:353252 (history)  Vaccinated:0000-00-00
Age:0.6  Onset:0000-00-00
Gender:Male  Submitted:2009-08-05
Location:Foreign  Entered:2009-08-06, Days after submission: 1
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: see narrative description.
CDC 'Split Type': 200903283
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Biopsy lymph gland abnormal, Bovine tuberculosis, Death, HIV test negative, Injection site ulcer, Lymphadenopathy, Polymerase chain reaction, Surgery
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Extravasation events (injections, infusions and implants) (broad), Malignant lymphomas (broad)
Write-up: Literature was case received on 30 July 2009. A seven month-old male patient who had received BCG vaccination (manufacturer, batch number, route and site of administration not reported) when three days old, presented with swelling in the left axilla and an ulcer at the site of BCG inoculation of three months duration. Routine investigations were within normal limits and he was HIV negative. Biopsy revealed a matted group of lymph nodes adherent to axillary vessels, which were excised. Pathological findings: Gross examination revealed two gray white tissue masses, larger measuring 5x 3.5x2cm and the smaller measuring 5x2x1 cm. Out surface of the masses were gray white and nodular. No area of necrosis was noted. On light microscopy, the lymph node showed effacement of architecture with proliferation of spindle cells arranged in sheets and fascicles. The cells had indistinct cell borders with eosinophilic granular cytoplasm and round to oval nuclei. These cells were admixed with capillaries, inflammatory cells including small lymphocytes, plasma cells and neutrophils. No multinucleated giant cells, mitotic figures, pleomorphism or necrosis were observed. the ZIEHL NEELSEN stain revealed numerous elongated acid-fast bacilli both within and outside the macrophages. The spindle cells were immunoreactive to CD 68. They were negative for desmin and showed focal positive for S-100 protein. PCR was done on paraffin embedded blocks with two sets of extracts for the IS6110 gene of Mycobacterium tuberculosis complex (includes M. tuberculosis hominis and M. tuberculosis bovis strains). One of the tubes (Phenol-Chloroform extract) was positive by PCR, while the second tube (kit extract) was negative, which was attributed to improper protocol for DNA extraction using the kit. Per the author, proliferation of spindle cells arranged in sheets and fascicles mimicking a spindle cell neoplasm which is one form of pathological pattern for BCG infection associated with immunodeficiency. The immune status of the patient could not be ass

VAERS ID:356759 (history)  Vaccinated:0000-00-00
Age:0.5  Onset:0000-00-00
Gender:Male  Submitted:2009-09-08
Location:Foreign  Entered:2009-09-09, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: He had been born at 1900 g following 32 weeks of gestation as one of twins, no parental consanguinity was present, his twin sister was healthy. Growth percentiles were within the normal range.
Diagnostic Lab Data: Erythrocyte sedimentation rate, 65 mm/h; C-reactive protein, 6.6 mg/dL. Blood and stool culture results were normal. Ultrasonography (USG) indicated three contiguous lymph nodes. Over the course of the disease, fluctuation was palpated and
CDC 'Split Type': 200903795
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Blood culture negative, C-reactive protein increased, Computerised tomogram normal, Culture stool negative, Diarrhoea, Erythema, Flow cytometry, Hypochromic anaemia, Immunoglobulins normal, Leukocytosis, Lymphadenitis, Lymphadenopathy, Lymphocyte count normal, Microbiology test abnormal, Microscopy, Pyrexia, Red blood cell sedimentation rate increased, Ultrasound abdomen normal
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypersensitivity (broad), Noninfectious diarrhoea (narrow)
Write-up: Literature report retrieved on 03 September 2009. A 06-month-old male patient was admitted to hospital for diarrhea and fever. He had a 4 day history of clear watery diarrhea and fever up to 39 C. He had been born at 1900 g following 32 weeks of gestation as one of twins, no parental consanguinity was present, his twin sister was healthy and he had a BCG vaccination (manufacturer, batch number, route and site of administration not reported) at 2 months of age. Growth percentiles were within normal range. A mobile, painless lymphadenopathy with a diameter of 1 cm was palpated in the left axillary region. The evaluation of other body systems was unremarkable. He had a moderate hypochromic microcytic anemia and leukocytosis with neutrophilic predominance. His acute phase reactants were elevated (erythrocyte sedimentation rate, 65 mm/h; C-reactive protein, 6.6 mg/dL). Blood and stool culture results were normal. On the third day of hospitalization the diameter of the left axillary swelling increased with erythema of the overlying skin. Ultrasonography (USG) indicated three contiguous lymph nodes. Over the course of the disease, fluctuation was palpated and a puncture was performed. Microscopy indicated acidoresistant bacilli, hence the diagnosis of BCG lymphadenitis. The patient was then put on follow up without treatment. Two months later the patient was readmitted because the diameter of the lesion had enlarged to 12 cm, and was draining. Multiple lymph nodes up to 2.5 cm in diameter were observed on USG. Histopathology of the excised biopsy material was consistent with granulomatous lymphadenitis. Computed tomography of the thorax and abdominal USG performed for the investigation of possible systemic involvement were normal. Serum immunoglobulins and subgroups and lymphocyte subgroup analysis were within normal limits. The patient was then evaluated for possible defects of the lymphocyte macrophage activation pathway, and flow cytometry of lymphocytes stimulated in vitro by phytohemagglutinin indicated that surfac

VAERS ID:379297 (history)  Vaccinated:0000-00-00
Age:0.1  Onset:0000-00-00
Gender:Male  Submitted:2010-02-02
Location:Foreign  Entered:2010-02-03, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The mother had give birth to an immunocompetent boy after uncomplicated full term pregnancy and delivery.
Diagnostic Lab Data: Haemoglobin was 10.5 g/dl, haematocrit 31% and white cell count 12.3 G/L with a normal differential count. Erythrocyte sedimentation rate was 60 mm/hr and cerebrospinal fluid was normal. Chest X-ray was normal and a Mantoux skin test ( 1 TU of PPD RT 23) resulted in induration of 12 mm (Mantoux tests are undertaken on all admissions to the hospital). Results of humoral and cellular immunity investigations were normal. Histological examination demonstrated an abundance of tubercles with caseous necrotic centres surrounded by epithelioid cells, lymphocytes and Langhans-type giant cells. A great number of acid-fast bacilli on Ziehl-Neelsen stain were detected. Cultures for mycobacteria and other common bacteria were negative.
CDC 'Split Type': E201000511
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  IDAR
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bacterial culture negative, CSF test normal, Chest X-ray normal, Differential white blood cell count normal, Haematocrit decreased, Haemoglobin normal, Histology abnormal, Immunology test normal, Lymphadenectomy, Lymphadenitis, Lymphadenopathy, Red blood cell sedimentation rate increased, Tuberculin test positive, White blood cell count increased
SMQs:, Haematopoietic erythropenia (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Malignancy related therapeutic and diagnostic procedures (narrow)
Write-up: Case of misuse initially received on 19-Jan-2010 through literature. This case is taken from a literature. On an unreported date, a 45 day-old male received vaccination with bacille Calmette-Guerin strain (Pasteur vaccine strain batch number not reported) half a dose intradermally to the upper part of each arm, 0.05 ml in total. The mother had give birth to an immunocompetent boy after uncomplicated full term pregnancy and delivery. The patient had been admitted at 45 days of age with bilateral axillary lymphadenitis. Two months later, the patient experienced swelling of his right axillary lymph node. The boy was treated with isoniazid in a dose of 20 mg/kg/day. After 2 months and while the patient was still on isoniazid, swelling of his left axillary lymph node was noticed and erythromycin was added. He was readmitted to hospital 6 months later. Results of physical examination were unremarkable, apart from bilateral axillary adenitis. The affected lymph nodes were not tender, well demarcated, adhered to the skin and were ready to drain. The largest lymph node was 3 cm in diameter. Haemoglobin was 10.5 g/dl, haematocrit 31% and white cell count 12.3 G/L with a normal differential count. Erythrocyte sedimentation rate was 60 mm/hr and cerebrospinal fluid was normal. Chest X-ray was normal and a Mantoux skin test ( 1 TU of PPD RT 23) resulted in induration of 12 mm (Mantoux tests are undertaken on all admissions to the hospital). Results of humoral and cellular immunity investigations were normal. The affected nodes in both axillae were excised and the wounds were sutured. Histological examination demonstrated an abundance of tubercles with caseous necrotic centres surrounded by epithelioid cells, lymphocytes and Langhans-type giant cells. A great number of acid-fast bacilli on Ziehl-Neelsen stain were detected. Cultures for mycobacteria and other common bacteria were negative. The surgical incisions healed completely over the next few days and isoniazid was stopped. No recurrence was detected during 18 months follow-up. The authors thought that bilateral lymphadenitis can occur even when BCG vaccine is administered as half a dose (0.025 ml) to each arm. Therefore, this practice should be considered neither safe not an alternative mode of prevention. Where there is advanced fluctuating lymphadenitis, surgical excision is the treatment of choice.

VAERS ID:383596 (history)  Vaccinated:0000-00-00
Age:0.3  Onset:0000-00-00
Gender:Male  Submitted:2010-03-23
Location:Foreign  Entered:2010-03-26, Days after submission: 3
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had personal immunodeficiency disorders: SCID (severe combined immunodeficiency). The patient had a family history of immunodeficiency and of consanguinity.
Diagnostic Lab Data: Immune defect tests showed SCID Rag2 deficiency T-B-NK+
CDC 'Split Type': 201001575
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bovine tuberculosis, Death, Laboratory test abnormal, Liver disorder, Lymphadenopathy
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow)
Write-up: Literature article from a foreign country received on 12 March 2010 involving 11 case reports. This case is linked with cases 2010-10574, 2010-01562, 2010-01576, 2010-01577, 2010-01578, 2010-01579, 2010-01580, 2010-01581, 2010-0582, 2010-01583. This case will described adverse event on case number 3. The aim of this prospective study was to determine the role of immunodeficiency disorders in exciting disseminated BCG infection in patients with disseminated BCG infection following immunization at birth with BCG sub strain Pasteur vaccine. Through 2 years all infants with BCG adenitis or other complications of this vaccine that had suspicious BCG infection were referred to hospital and health centers. Evaluation of immune system and in some cases genetic survey was performed in infants with evidence of histopathologic demonstration of acid-fast bacilli. Then frequency of infants who had disseminated BCG infection with immunodeficiency was defined. Clinical manifestations and hematological and immunologic changes were compared between two different groups of cases: Patients (who are children with disseminated BCG infection) and control group (who are children with complications of BCG vaccination but without disseminated BCG infection). Then frequency of patients with disseminated BCG infection who had immunodeficiency was reported. From 122093 BCG vaccinated children through 24 month period, 48 infants with BCG lymphadenitis, within range of 2-62 months (mean +- SD: 9.9 +- 9.85) were selected. 28 infants were male (58.3%) and 20 infants were female (41.7%). Onset age was between 1-21 months (mean +- SD: 6.36 +- 4.62). Twenty four cases had multiple lymphadenitis near to BCG incubation such as cervical, axiliary, and supraclaviculs, 11 cases had suppurative lymphadenitis with fistula and abscesses and 5 cases had ulcer of BCG incubation. Osteomyelitis due to BCG vaccination was detected in 2 cases and disseminated BCG infection in 11 cases (22.9%) with multi organ involvement and systemic symptoms were detected. Family history of BCG infection or immunodeficiency was positive in 22.9% of control group and the rate of consanguineous marriages in the parent of them was 37.5% (18 cases). Disseminated BCG infection was diagnosed in 11 cases with multi organ involvement and systemic symptoms, almost all of whom had immunodeficiency. Definitive immunodeficiency was detected in approximately all of children with disseminated BCG infection including: SCID in 7 cases with homozygous mutation and homozygous polymorphism in Rag2 in one patient with heterozygous for the Rag 2 mutation and polymorphism in the both parents of him and exclusion of Rag1, Rag2 and Artemis defect in another patient. Other cases were CGD, IL12RB1 deficiency and MSMD. In one cases of MSMD we could exclude an IL12RB1 deficiency. So he had a normal expression of IL12RB1 on cell surface with two different antibodies. HIV was not identified in any of the cases. Overall, the mortality rate was 72.8% (8 cases). Consanguineous was found in more than half (7 cases) of patients and family history of disseminated BCG infection or immunodeficiency was found in nearly one third (3 cases) of patients. A chi-square test comparing the clinical manifestations in children with disseminated BCG infection with control group showed statistically significant differences for the two groups of children. Comparison of immunologic markers showed that significant differences were seen between two groups of children. The mean value of CD3 in patients was (P = 0.005) in comparison with control group and the mean value of CD4 in patients was (P < 0.001) in comparison with control group (Table 3). Although antimycobacterial regimens used for the treatment of patients with 4 drugs, but 8 of the patients died despite aggressive management. Case report #3: A 04-month-old male patient had a disseminated BCG infection after immunization at birth with BCG sub strain Pasteur vaccine (Manufacturer and b

VAERS ID:383599 (history)  Vaccinated:0000-00-00
Age:0.5  Onset:0000-00-00
Gender:Female  Submitted:2010-03-23
Location:Foreign  Entered:2010-03-26, Days after submission: 3
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had personal immunodeficiency disorders: severe combined immunodeficiency (SCID) T-B-NK+. The patient had no family history of immunodeficiency, no consanguinity
Diagnostic Lab Data: Immune defect tests showed SCID T-B-NK+
CDC 'Split Type': 201001577
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bovine tuberculosis, Death, Gastric disorder, Immunology test abnormal, Lymphadenopathy
SMQs:, Hypersensitivity (broad)
Write-up: Foreign literature article received on 12 March 2010 involving 11 case reports. This case is linked with cases 2010-01562, 2010-01574, 2010-01575, 2010-01576, 2010-01578, 2010-01579, 2010-01580, 2010-01581, 2010-0582, 2010-01583. This case will describe adverse event on case number 5. The aim of this prospective study was to determine the role of immunodeficiency disorder in exciting disseminated BCG infection in patients with disseminated BCG infection following immunization at birth with BCG sub strain Pasteur vaccine. Through 2 years all infants with BCG adenitis or other complications of this vaccine that had suspicious BCG infection were referred to a hospital and health centers. Evaluation of immune system and in some cases genetic survey was performed in infants with evidence of histopathologic demonstration of acid-fast bacilli. Then frequency of infants who had disseminated BCG infection with immunodeficiency was defined. Clinical manifestations and hematological and immunologic changes were compared between two different groups of cases: Patients (who are children with disseminated BCG infection) and control group (who are children with complications of BCG vaccination but without disseminated BCG infection). Then frequency of patients with disseminated BCG infection who had immunodeficiency was reported. From 122093 BCG vaccinated children through 24 month period. 48 infants with BCG lymphadenitis, within range of 2-62 months (mean +- SD: 9.9 +- 9.85) were selected. 28 infants were male (58.3%) and 20 infants were female (41.7%). Onset age was between 1-21 months (mean +- SD: 6.36 +- 4.62). Twenty four caseshad multiple lymphadenitis near to BCG incubation such as cervical, axiliary, and supraclaviculs, 11 case had suppurative lymphadenitis with fistula and abscesses and 5 cases had ulcer of BCG incubation. Osteomyelitis due to BCG vaccination was detected in 2 cases and disseminated BCG infection in 11 cases (22.9%) with multi organ involvement and systemic symptoms was detected. Family history of BCG infection or immunodeficiency was positive in 22.9% of control group and the rate of consanguineous marriages in the parents of them was 37.5% (18 cases). Disseminated BCG infection was diagnosed in 11 cases with multi organ involvement and systemic symptoms, almost all of whom had immunodeficiency. Definitive immunodeficiency was detected in approximately all of children with disseminated BCG infection including: SCID in 7 cases with homozygous mutation and homozygous polymorphism in Rag2 in one patient with heterozygous for the Rag2 mutation and polymorphism in the both parents of him and exclusion of Rag1, Rag2 and Artemis defect in another patient. Other cases were CGD, IL12RB1 deficiency and MSMD. In one cases of MSMD we could exclude in IL12RB1 deficiency. So he had a normal expression of IL12RB1 on cell surface with two different antibodies. HIV was not identified in any of the cases. Overall, the mortality rate was 72.8% (8 cases). Consanguineous was found in more than half (7 cases) of patients and family history of disseminated BCG infection or immunodeficiency was found in nearly on third (3 cases) of patients. A chi-square test comparing the clinical manifestations in children with disseminated BCG infection with control group showed statistically significant differences for the two groups of children. Comparison of immunologic markers showed that significant differences were seen between two groups of children. The mean value of CD3 in patients was (P = 0.005) in comparison with control group and the mean of CD4 in patients was (P < 0.001) in comparison with control group (Table 3). Although antimycobacterial regimens used for the treatment of patients with 4 drugs, but 8 of the patients died despite aggressive management. Case report # 5: A 06-month-old female patient had a disseminated BCG infection after immunization at birth with BCG sub strain pasteur vaccine (Manufacturer andbatch number unknown) Th

VAERS ID:383601 (history)  Vaccinated:0000-00-00
Age:0.4  Onset:0000-00-00
Gender:Female  Submitted:2010-03-23
Location:Foreign  Entered:2010-03-26, Days after submission: 3
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had personal immunodeficiency disorders of severe combined immunodeficiency (SCID). The patient had a family history of immunodeficiency and consanguinity.
Diagnostic Lab Data: Immune defect tests showed T-B-NK+ SCID
CDC 'Split Type': 201001578
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Death, Immunology test abnormal, Liver disorder, Lymphadenopathy
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Hypersensitivity (broad)
Write-up: Literature article received on 12 March 2010 involving 11 case reports. This case is linked with cases 2010-01562, 2010-01574, 2010-01575, 2010-01576, 2010-01577, 2010-01579, 2010-01580, 2010-01581, 2010-01582, 2010-01583. This case will describe adverse event on case number 6. Through 2 years all infants with BCG adenitis or other complications of this vaccine that had suspicious BCG infection were referred to hospital and health centers. Evaluation of immune system and in some cases genetic survey was performed in infants with evidence of histopathologic demonstration of acid-fast bacilli. Then frequency of infants who had dissmeninated BCG infection with immunodeficiency was defined. Clinical manifestations and hematological and immunologic changes were compared between two different groups of cases: Patients (who are children with disseminated BCG infection) and control group (who are children with complication of BCG vaccination but without disseminated BCG infection). Then frequency of patients with disseminated BCG infection who had immunodeficiency was reported. From 122093 BCG vaccinated children through 24 month period, 48 infants with BCG lymphadenitis, within range of 2-62 months (mean + SD: 9.9 + 9.85) were selected. 28 infants were male (58.3%) and 20 infants were female (41.7%). Onset age was between 1-21 months (mean + SD: 6.36 + 4.62). Twenty four cases had multiple lymphadenitis near to BCG incubation such as cervical, axiliary, and supraclaviculs, 11 cases had suppurative lymphadenitis with fistula and abscesses and 5 cases had ulcer of BCG incubation. Osteomyelitis due to BCG vaccination was detected in 2 cases and disseminated BCG infection in 11 cases (22.9%) with multi organ involvement and systemic symptoms was detected. Family history of BCG infection or immunodeficiency was positive in 22.9% of control group and the rate of consanguineous marriages in the parents of them was 37.5% (18 cases). Disseminated BCG infection was diagnosed in 11 cases with multi organ involvement and systemic symptoms, almost all of whom had immunodeficiency. Definitive immunodeficiency was detected in approximately all of children with disseminated BCG infection including: SCID in 7 cases with homozygous mutation and homozygous polymorphism in Rag2 in one patient with heterozygous for the Rag2 mutation and polymorphism in the both parents of him and exclusion of Rag1, Rag2 and Artemis defect in another patient. Other cases were CGD, IL12RB1 deficiency and MSMD. In one cases of MSMD we could exclude an IL12RB1 deficiency. So he had a normal expression of IL12RB1on cell surface with two different antibodies. HIV was not identified in any of the cases. Overall, the mortality rate was 72.8% (8 cases). Consanguineous was found in more than half (7 cases) of patients and family history of dissmeninated BCG infection or immunodeficiency was found in nearly one third (3 cases) of patients. A chi-square test comparing the clinical manifestations in children with disseminated BCG infection with control group showed statistically significant differences for the two groups of children. Comparison of immunologic markers showed that significant differences were seen between two groups of children. The mean value of CD3 in patients was (P = 0.005) in comparison with control group and the mean value of CD4 in patients was (P < 0.001) in comparison with control group (Table 3). Although antimycobacterial regimens used for the treatment of patients with 4 drugs, but 8 of the patients died despite aggressive management. Case report # 6: A 05-month-old female patient had a disseminated BCG infection after immunization at birth with BCG sub strain Pasteur vaccine (Manufacturer and batch number unknown). The patient had personal immunodeficiency disorders of severe combined immunodeficiency (SCID), T-B-NK+. The patient had a family history of immunodeficiency and consanguinity. The patient was referred to hospital. The sites of dissemination wer

VAERS ID:383602 (history)  Vaccinated:0000-00-00
Age:0.4  Onset:0000-00-00
Gender:Female  Submitted:2010-03-23
Location:Foreign  Entered:2010-03-26, Days after submission: 3
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had personal immunodeficiency disorders: severe combined immunodeficiency (SCID), The patient had a family history of immunodeficiency. History of consanguinity
Diagnostic Lab Data: Immune defect tests showed SCID - T-B+NK+
CDC 'Split Type': 201001580
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Ascites, Bovine tuberculosis, Death, Immunology test abnormal, Liver disorder, Lymphadenopathy
SMQs:, Liver related investigations, signs and symptoms (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Acute pancreatitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Hypersensitivity (broad)
Write-up: Literature article received on 12 March 2010 involving 11 case reports. This case is linked with cases 2010-01562, 2010-01574, 2010-01575, 2010-01576, 2010-01577, 2010-01578, 2010-01579, 2010-01580, 2010-01581, 2010-01582, 2010-01583. This case will describe adverse event on case number 8. The aim of this prospective study was to determine the role of immunodeficiency disorders in exciting disseminated BCG infection in patients with disseminated BCG infection following immunization at birth with BCG sub strain Pasteur vaccine. Through 2 years all infants with BCG adenitis or other complications of this vaccine that had suspicious BCG infection were referred to hospital and health centers. Evaluation of immune system and in some cases genetic survey was performed in infants with evidence of histopathologic demonstration of acid-fast bacilli. Then frequency of infants who had disseminated BCG infection with immunodeficiency was defined. Clinical manifestations and hematological and immunologic changes were compared between two different groups of cases: Patients (who are children with disseminated BCG infection) and control group (who are children with complications of BCG vaccination but without disseminated BCG infection). Then frequency of patients with disseminated BCG infection who had immunodeficiency was reported. From 122093 BCG vaccinated children through 24 month period, 48 infants with BCG lymphadenitis, within range of 2-62 months (mean +_ SD: 9.9 +_ 9.85) were selected. 28 infants were male (58.3%) and 20 infants were female (41.7%). Onset age was between 1-21 months (mean +_ SD: 6.36 +_ 4.62). Twenty four cases had multiple lymphadenitis near to BCG incubation such as cervical, axiliary, and supraclaviculs, 11 cases had suppurative lymphadenitis with fistula and abscesses and 5 cases had ulcer of BCG incubation. Osteomyelitis due to BCG vaccination was detected in 2 cases and disseminated BCG infection in 11 cases (22.9%) with multi organ involvement and systemic symptoms was detected. Family history of BCG infection or immunodeficiency was positive in 22.9% of control group and the rate of consanguineous marriages in the parents of them was 37.5% (18 cases). Disseminated BCG infection was diagnosed on 11 cases with multi organ involvement and systemic symptoms, almost all of whom had immunodeficiency. Definitive immunodeficiency was detected in approximately all of children with disseminated BCG infection including: SCID in 7 cases with homozygous mutation and homozygous polymorphism in Rag2 in one patient with heterozygous for the Rag2 mutation and polymorphism in the both parents of him and exclusion of Rag1, Rag2 and Artemis defect in another patient. Other cases were CGD, IL12RB1 deficiency and MSMD. In one cases of MSMD we could exclude an IL12RB1 deficiency. So he had a normal expression of IL12RB1 on cell surface with two different antibodies. HIV was not identified in any of the cases. Overall, the mortality rate was 72.8% (8 cases). Consanguineous was found in nearly one third (3 cases) of patients. A chi-square test comparing the clinical manifestations in children with disseminated BCG infection with control group showed statistically significant differences for the two groups of children. Comparison of immunologic markers showed that significant differences were seen between two groups of children. The mean value of CD3 in patients was (P=0.005) in comparison with control group and the mean value of CD4 in patients was (P<0.001) in comparison with control group (Table 3). Although antimycobacterial regimens used for the treatment of patients with 4 drugs, but 8 of the patients died despite aggressive management. A 06-month-old female patient had a disseminated BCG infection after immunization at birth with BCG sub strain Pasteur vaccine (manufacturer and batch number unknown). The patient had personal immunodeficiency disorders of severe combined immunodeficiency, T-B+NK+. The patient had a family hist

VAERS ID:383604 (history)  Vaccinated:0000-00-00
Age:0.3  Onset:0000-00-00
Gender:Male  Submitted:2010-03-23
Location:Foreign  Entered:2010-03-26, Days after submission: 3
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had personal immunodeficiency disorders of severe combined immunodeficiency (SCID). The patient had no family history of immunodeficiency and history of consanguinity.
Diagnostic Lab Data: Immune defect tests showed T-B-NK+ (exclusion of Rag1, Rag2 and Artemis defect)
CDC 'Split Type': 201001579
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bovine tuberculosis, Death, Disseminated tuberculosis, Eye disorder, Immunology test abnormal, Lymphadenopathy
SMQs:, Corneal disorders (broad), Retinal disorders (broad), Hypersensitivity (broad)
Write-up: Literature article received on 12 March 2010 involving 11 case reports. This case is linked with cases 2010-01562, 2010-01574, 2010-01575, 2010-01576, 2010-01577, 2010-01578, 2010-0582, 2010-01583. This case will describe adverse event on case number 7. The aim of this prospective study was to determine the role of immunodeficiency disorders in exciting disseminated BCG infection in patients with disseminated BCG infection following immunization at birth with BCG sub strain Pasteur vaccine. Through 2 years all infants with BCG adenitis or other complications of this vaccine that had suspicious BCG infection were referred to hospital and health centers. Evaluation of immune system and in some cases genetic survey was performed in infants with evidence of histopathologic demonstration of acid-fast bacilli. Then frequency of infants who had disseminated BCG infection with immunodeficiency was defined. Clinical manifestations and hematological and immunologic changes were compared between two different groups of cases: Patients (who are children with disseminated BCG infection) and control group (who are children with complications of BCG vaccination but without disseminated BCG infection). The frequency of patients with disseminated BCG infection who had immunodeficiency was reported. From 122093 BCG vaccinated children through 24 month period, 48 infants with BCG lymphadentitis, within range of 2-62 months (mean + SD: 9.9 + 9.85) were selected. 28 infants were male (58.3%) and 20 infants were female (41.7%). Onset age was between 1-21 months (mean SD: 6.36 + 4.62). Twenty four cases had multiple lymphadentitis near to BCG incubation such as cervical, axilliary, and supraclaviculs, 11 cases had suppurative lymphadentitis with fistula and abscesses and 5 cases had ulcer of BCG incubation. Osteomyelitis due to BCG vaccination was detected in 2 cases and disseminated BCG infection in 11 cases (22.9%) with multi organ involvement and systemic symptoms was detected. Family history of BCG infection or immunodeficiency was positive in 22.9% of control group and the rate of consanguineous marriages in the parents of them was 37.5% (18 cases). Disseminated BCG infection was diagnosed in 11 cases with multi-organ involvement and systemic symptoms, almost all of whom had immunodeficiency. Definitive immunodeficiency was detected in approximately all of children with disseminated BCG infection including: SCID in 7 cases with homozygous mutation and homozygous polymorphism in Rag2 in on patient with heterozygous for the Rag2 mutation and polymorphism in the both parents of him and exclusion of Rag1, Rag2 and Artemis defect in another patient. Other cases were CGD, IL12RB1 deficiency and MSMD. In on cases of MSMD we could exclude an IL12RB1 deficiency. So he had a normal expression of IL12RB1 on cell surface with two different antibodies. HIV was not identified in any of the cases. Overall, the mortality rate was 72.8% (8 cases). Consanguineous was found in more than half (7 cases) of patients and family history of disseminated BCG infection or immunodeficiency was found in nearly one third (3 cases) of patients. A chi-square test comparing the clinical manifestations in children with disseminated BCG infection with control group showed statistically significant differences for the two groups of children. Comparison of immunologic markers showed that significant differences were seen between two groups of children. The mean value of CD3 in patients was (P =0.005) in comparison with control group and the mean value of CD4 in patients was (P < 0.001) in comparison with control group (Table 3). Although antimycobacterial regimens used for the treatment of patients with 4 drugs, but 8 out of the patients died despite aggressive management. Case report #7: A 4/5 month-male patient had a disseminated BCG infection after immunization at birth with BCG sub strain Pasteur vaccine (Manufacturer and batch number unknown). The patient had persona immunode

VAERS ID:383633 (history)  Vaccinated:0000-00-00
Age:0.3  Onset:0000-00-00
Gender:Female  Submitted:2010-03-23
Location:Foreign  Entered:2010-03-26, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient had personal immunodeficiency disorder of severe combined immunodeficiency (SCID). The patient has no family history of immunodeficiency. History of consanguinity.
Diagnostic Lab Data: Immune defect tests showed IL12R deficiency
CDC 'Split Type': 201001582
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Abscess, Aspiration, Bovine tuberculosis, Combined immunodeficiency, Fistula, Immunodeficiency, Immunology test abnormal
SMQs:, Congenital, familial and genetic disorders (narrow), Hypersensitivity (broad)
Write-up: Literature article received on 12 March 2010 involving 11 case reports. This case is linked with cases 2010-01562, 2010-01574, 2010-01575, 2010-01576, 2010-01577, 2010-01578, 2010-01579, 2010-01580, 2010-01581, 2010-01583. This case will describe adverse event on case number 10. The aim of this prospective study was to determine the role of immunodeficiency disorders in exciting disseminated BCG infection in patients with disseminated BCG infection following immunization at birth with BCG sub strain Pasteur vaccine. Through 2 years all infants with BCG adenitis or other complications of this vaccine that had suspicious BCG infection were referred to hospital and health centers. Evaluation of immune system and in some cases genetic survey was performed in infants with evidence of histopathologic demonstration of acid-fast bacilli. Then frequency of infants who had disseminated BCG infection with immunodeficiency was defined. Clinical manifestations and hematological and immunologic changes were compared between two different groups of cases: Patients (who are children with disseminated BCG infection) and control group (who are children with complications of BCG vaccination but without disseminated BCG infection). Then frequency of patients with disseminated BCG infection who had immunodeficiency was reported. From122093 BCG vaccinated children through 24 month period, 48 infants with BCG lymphadenitis, within range of 2-62 months (mean +- SD: 9.9 +- 9.85) were selected. 28 infants were male (58.3%) and 20 infants were female (41.7%). Onset age was between 1-21 months (mean +- SD: 6.36 +- 4.62). Twenty four caseshad multiple lymphadenitis near to BCG incubation such as cervical, axiliary, and supraclaviculs, 11 cases had suppurative lymphadenitis with fistula and abscesses and 5 cases had ulcer of BCG incubation. Osteomyelitis due to BCG vaccination was detected in 2 cases and disseminated BCG infection in 11 cases (22.9%) with multi organ involvement and systemic symptoms was detected. Family history of BCG infection or immunodeficiency was positive in 22.9% of control group and the rate of consanguineous marriages in parents of them was 37.5% (18 cases). Disseminated BCG was diagnosed in 11 cases with multi organ involvement and systemic symptoms, almost all of whom had immunodeficiency. Definitive immunodeficiency was detected in approximately all of children with disseminated BCG infection including: SCID in 7 cases with homozygous mutation and homozygous polymorphism in Rag2 in one patient with heterozygous for the Rag2 mutation and polymorphism in the both parents of him and exclusion of Rag1, Rag2 and Artemis defect in another patient. Other cases were CGD, IL12RB1 deficiency and MSMD. In one cases of MSMD we could exclude an IL12RB1 deficiency. So he had a normal expression of IL12RB1on cell surface with two different antibodies. HIV was not identified in any of the cases. Overall, the mortality rate was 72.8% (8 cases). Consanguineous was found in more than half (7 cases) of patients and family history of disseminated BCG infection or immunodeficiency was found in nearly one third (3 cases) of patients. A chi-square test comparing the clinical manifestations in children with disseminated BCG infection with control group show statistically significant differences for the two groups of children. Comparison of immunologic markers showed that significant differences were seen between two groups of children. The mean value of CD3 in patients was (P = 0.005) in comparison with control group and the mean value of CD4 in patients was (P < 0.001) in comparison with control group (Table 3). Although antimycobacterial regimens used for the treatment of patients with 4 drugs, but 8 of the patients died despite aggressive management. A 04-month-old female patient had a disseminated BCG infection after immunization at birth with BCG sub strain Pasteur vaccine (Manufacturer and batch number unknown) The patient had personal immunodefi

VAERS ID:383747 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2010-03-26
Location:Foreign  Entered:2010-03-29, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: diagnostic procedure, Examination of the humoral immunity: Normal immunoglobulin levels and normal IgG subclasses; diagnostic laboratory test, titration of pneumococcal antibody: Significant antibody response; diagnostic laboratory test, Granulocyte chemotaxis: Normal; diagnostic laboratory test, lymphocyte transformation test: Normal; blood CD19 count, normal; lymphocyte count, normal; serum C-reactive protein, increased (between 3 -8 mg/dl); erythrocyte sedimentation rate, increased sedimentation (50 mm after 1 h); complement assays, complement system: normal
CDC 'Split Type': WAES1003USA03118
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.  UNUN
PNC: PNEUMO (PREVNAR)PFIZER/WYETH  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Antibody test positive, Aphthous stomatitis, Blood immunoglobulin G normal, C-reactive protein increased, Chills, Complement factor normal, Decreased appetite, Fatigue, Granulocyte count, Immunoglobulins normal, Irritability, Laboratory test normal, Lymphadenopathy, Lymphocyte count normal, Lymphocyte transformation test negative, Pharyngitis, Pyelonephritis, Pyrexia, Red blood cell sedimentation rate increased, Tonsillectomy, Tonsillitis
SMQs:, Agranulocytosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Vasculitis (broad), Hypersensitivity (broad)
Write-up: Information has been received from a physician via a literature article title as stated above, on 15-MAR-2010. The patient (birth date and gender unknown) experienced very high fever approximately on week after he received a dose of MMR (trade name, batch number and date of vaccination not reported). Secondary suspect vaccination included PREVNAR, on an unspecified date. Regular episodes of fever followed each other since then. Medical history: at the age of 1 year, the patient experienced high fever during 3-4 days for which he received an antipyretic treatment; fever lasted for 4 days. Since then, he showed likewise episodes almost every month, introduced by general fatigue, irritability, decreased appetite, and finally leading to 3-5 days of high fever frequently associated with fever shivering. Mostly, at the same time, a bilateral cervical adenophaty appeared and a non-purulent tonsillitis was diagnosed. No other systemic complaints or symptoms were observed. About 4 months later, the symptom-free intervals decreased to 2-3 weeks. Antibiotic treatment did not influence the clinical development of such episodes. Pyelonephritis was diagnosed at the age of 1.5 years. Since then, the frequency of fever episodes increased to 2 weeks. Generally, blood analysis showed an increase of C reactive proteins (CRP) (Between 3 to 8 mg/dl), without important leukocytosis but with increased sedimentation (50 mm after 1 hour). Examination of the humoral immunity showed normal immunoglobulin levels and normal IgG subclasses. Titration of pneumococcal antibodies after PREVNAR showed a significant antibody response. Titration of B-lymphocytes and T lymphocytes: normal. Lymphocytes transformation test, granulocyte chemotaxis and the complement system were normal. The recurrence of the fever episodes with bilateral cervical adenophaty, with or without tonsillitis/ pharyngitis, normal cellular and humoral immunity frames the experienced periodic fever into the category "periodic fever, aphtous stomatitis, pharyngitis and adenopathy (PFAFA) syndrome". The patient has a tonsillectomy and the recurrent episodes of fever disappeared. Very high fever, periodic fever, aphthous stomatitis, pharyngitis, bilateral cervical adenopathy, pyelonephritis, non-purulent tonsillitis, general fatigue, irritability, decreased appetite, shivering, blood sedimentation increased and increase of C reactive proteins were considered to be an other important medical events by the reporter. Other business partner number include E2010-01693. No further information is available.

VAERS ID:387339 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:2010-05-12
Location:Foreign  Entered:2010-05-13, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Patient and sibling brother with complete interleukin-12 receptor b1 deficiency. The parents and a sister were healthy and had been vaccinated with BCG, with no adverse effect.
Diagnostic Lab Data: Negative for human immunodeficiency virus using serologic methods. M. bovis BCG was cultured from bronchoaveolar lavage fluid and a lymph node biopsy sample. Classic immunodeficiencies and IFN gamma R1 and IFN gamma R2 deficiencies were at first excluded. Mutations were found in the IL12RB1 gene. The patient was tested negative for human immunodeficiency virus using serologic methods. The patient had high titers of serum IgG antibodies specific for cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus.
CDC 'Split Type': E201003041
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Biopsy lymph gland abnormal, Bovine tuberculosis, Culture positive, Cytomegalovirus test positive, Epstein-Barr virus antibody positive, Gene mutation identification test positive, HIV test negative, Ileitis, Immunodeficiency, Interferon gamma receptor deficiency, Lymphadenitis, Peritonitis, Salmonella sepsis, Tuberculosis, Typhoid fever, Varicella virus test positive
SMQs:, Agranulocytosis (broad), Congenital, familial and genetic disorders (narrow), Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation (narrow), Gastrointestinal nonspecific inflammation (narrow), Malignant lymphomas (broad), Noninfectious diarrhoea (broad)
Write-up: Case retrieved from the literature in foreign country on 27-Apr-2010. This case is linked with the case E2010-03071 (same article, same vaccination in the patient''s sibling sister). A male patient (child) with complete interleukin-12 receptor b1 deficiency was vaccinated at birth with BCG (MFR UNK, batch number not reported). The patient was one of two siblings born to consanguineous (first-cousins) parents from foreign country who were investigated. The family lived in foreign country, where tuberculosis was endemic and BCG vaccination was compulsory. Shortly after vaccination the patient developed disseminated BCG infection. M bovis BCG was cultured from bronchoaveolar lavage fluid and a lymph node biopsy sample. The patient responds well to a 12-month course of antimycobacterial therapy. It was specified that at age 4 years, he developed Salmonella typhimurium adenitis and, at age 7 years, he developed S. typhimurium septicemia. Both infections responded well to antibiotics. He is now well at 14 years, with no prophylactic treatment. Classic immunodeficiencies and IFN gamma R1 and IFN gamma R2 deficiencies were at first excluded. Mutations were found in the IL12RB1 gene. The patient was tested negative for human immunodeficiency virus using serologic methods. The patient had high titers of serum IgG antibodies specific for cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus. To be noted that it was specified in the article that the patient''s sister, with interleukin-12 receptor betal deficiency, had received the injection of BCG substrain Pasteur at birth and at ages 6 and 15 years. She showed no adverse reaction, despite 3 inoculations with live BCG, but developed ileitis, peritonitis, and mesenteric adenitis due to Mycobacterium tuberculosis (Case E2010-03071). It was also specified that the parents and a sister were healthy and have been vaccinated with BCG vaccine with no adverse effects.

VAERS ID:462557 (history)  Vaccinated:2011-07-12
Age:0.0  Onset:0000-00-00
Gender:Male  Submitted:2012-08-20
Location:Foreign  Entered:2012-08-21, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical history and concomitant medications were not reported.
Diagnostic Lab Data: Not reported
CDC 'Split Type': 201207575
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURERG3787AA0UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Granuloma, Lymphadenopathy, Mass excision
SMQs:
Write-up: Initial case received from Health Authorities in a foreign country on 10 August 2012 under the reference AU2012-119 (HA''s number 302017). A 12-month-old male patient, with no reported medical history and concomitant medications, had received a first dose of BCG vaccine, batch number G3787AA, route and site of administration not reported, on 12 July 2011. In March 2012, the patient developed granuloma and enlarged auxiliary left node leading to hospitalization (dates not reported). The patient underwent excision in May 2012. The patient recovered (date not reported). The causality was reported as probable. The Health Authorities coded: "granuloma" and "lymphadenitis". Documents held by sender: none.

VAERS ID:466303 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:2012-09-25
Location:Foreign  Entered:2012-09-25
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data: Biopsy, see text; Bone marrow aspiration, see text; Cytomegalovirus serology, negative; Diagnostic ultrasound, conglomerate of; Epstein-Barr virus serology, negative; Erythrocyte sedimentation rate, mild elevated; Fluorescent in situ hybridizat, see text; Immunohistochemistry, see text; Nuclear magnetic resonance ima, see text; Polymerase chain reaction, see text
CDC 'Split Type': B0830999A
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER 0UNUN
HEP: HEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS 0UNUN
Administered by: Other     Purchased by: Other
Symptoms: Aspiration bone marrow abnormal, Biopsy lymph gland abnormal, Culture negative, Culture positive, Cytomegalovirus test, Cytomegalovirus test negative, Epstein-Barr virus test negative, Fluorescent in situ hybridisation negative, Granuloma, Immunohistochemistry, Inguinal mass, Lymphadenitis, Lymphadenopathy, Lymphoma, Necrosis, Neoplasm malignant, Nuclear magnetic resonance imaging normal, Polymerase chain reaction, Pseudolymphoma, Red blood cell sedimentation rate increased, Tumour marker test, Ultrasound scan abnormal, Vaccination complication
SMQs:, Haematopoietic cytopenias affecting more than one type of blood cell (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Malignant tumours (narrow), Malignant lymphomas (narrow)
Write-up: This case was reported in a literature article and described the occurrence of lymphoma-like reaction in a 2-week-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline), Bacillus calmette-guerin vaccine (non-gsk). The subject was immunocompetent and without history of HIV infection. On an unspecified date, the subject received 1st dose of ENGERIX B (unknown route and injection site, batch number not provided), 1st dose of Bacillus Calmette-Guerin vaccine (unknown route and injection site, batch number not provided). The subject was vaccinated at birth as part of the immunisation protocol. Less than one month after vaccination with Bacillus Calmette-Guerin vaccine and ENGERIX B, the subject presented with a rapidly enlarging inguinal mass growing to a diameter of 3 cm over a period of 1 week. This case was assessed as medically serious by GSK. At presentation, the only detected abnormality was a mildly elevated erythrocyte sedimentation rate, but otherwise the subject was well. An ultrasound scan revealed a conglomerate of lymph nodes in the right inguinal region. As lymphadenopathy was not in the lymphatic drainage area of the vaccination sites, there was high clinical suspicion of malignancy. The clinical picture raised suspicion of a neoplasm. A fine needle aspiration showed atypical lymphoid cells suspicious of lymphoma. The bone marrow aspirate showed no abnormality on flow cytometrical examination. An excision biopsy was performed. A 2-cm lymph node was excised which macroscopically appeared homogeneous and showed small foci of necrosis. . Coalescent palisading granulomas with copious necrosis were also noted, but no acid-fast bacilli could be identified. The immunostains highlighted effacement of the lymph node architecture. The diffuse proliferation of blasts was of T-cell phenotype with virtually no residual B-cell areas (the lack of CD20-positive cells). There was a considerable restriction to the expression of CD8 over CD4. The majority of the cells had an activated cytotoxic TIA1/granzyme B/perforin-positive phenotype in a background of abundant evenly distributed histiocytes (CD68 positive). No aberrant loss of Tcell markers including CD2, CD3, CD5, CD7, and CD43 was seen. There were scattered CD30-positive blasts. However, most cells showed strong expression of CD99 (a high proliferation index of 90% as assessed by Ki-67 immunostaining). These atypical features prompted the local pathologist to make a diagnosis of T-cell lymphoma, probably of lymphoblastic type. Upon expert review, additional immunohistochemistry showed no expression of TdT, CD34, CD10, or CD117. Epstein-Barr virus-encoded RNA was not detected by in situ hybridization. The polymerase chain reaction using the Biomed-2 T-cell receptor beta and gamma primers showed reproducible polyclonal smears. The lymph node culture was negative for BCG but grew Gemella Morbillorum, a streptococcus-like anaerobic bacterium rarely associated with disease in humans. Epstein Bar virus and Cytomegalovirus serology were negative. Upon expert review and additional molecular diagnostics, the initial pathological diagnosis of lymphoblastic T-cell lymphoma was changed to ectopic BCG lymphadenitis and hyperimmune post-vaccinal reaction. The atypical T-cell proliferation was most likely a result of the adjuvant effects of the co-administered vaccines. The subject was treated with antibiotics. The ultrasound and whole-body magnetic resonance imaging scans performed after 2 months showed no evidence of lymphadenopathy or organomegaly. Eight months after the event, the subject remained well, with no signs of disease. The author considered the events were almost certainly related to vaccination with ENGERIX B and Bacillus Calmette-Guerin vaccine.

VAERS ID:481840 (history)  Vaccinated:2012-09-28
Age:  Onset:2012-10-07, Days after vaccination: 9
Gender:Unknown  Submitted:2013-01-18, Days after onset: 103
Location:Foreign  Entered:2013-01-18
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1301GBR008140
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (NO BRAND NAME)UNKNOWN MANUFACTURER  SYRUN
Administered by: Other     Purchased by: Other
Symptoms: Aphonia, Ear pain, Lethargy, Lymphadenopathy
SMQs:, Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad)
Write-up: This case was received from the health authority on 10-Jan-2013. GB-MHRA-ADR 21881247. This case is not medically confirmed as it was reported by consumer. This case is linked to E2013-00300 and E2013-00301. A patient (age and gender unknown), with no reported medical history or concomitant medication, received an injection of measles, mumps and rubella vaccine (manufacturer unknown, batch number, dose, site and route of administration not reported) on 28-Sep-2012. Six days after the vaccination, on 04-Oct-2012, the patient experienced swollen glands and was lethargic. Eight days after the vaccination, on 06-Oct-2012, the patient had ear ache and 9 days after the vaccination, on 07-Oct-2012, the patient experienced voicelessness. The patient''s outcome was not reported. The original report from the agency concerned the adverse events experienced by the patient''s brother (case E2012-00300). According to the parents, their three children experienced very similar reactions at exactly the same time. All three children received the vaccine at the same time. A seriousness assessment for this case not provided but, as the adverse events were exactly the same, the company entered the same seriousness criteria as the original report. The other cases are described in linked cases # E2013-00300 and E2013-00301.

VAERS ID:484332 (history)  Vaccinated:2002-10-08
Age:  Onset:0000-00-00
Gender:Male  Submitted:2013-02-12
Location:Foreign  Entered:2013-02-13, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: No information reported.
Diagnostic Lab Data:
CDC 'Split Type': E201301060
Vaccination
Manufacturer
Lot
Dose
Route
Site
TYP: TYPHOID VI POLYSACCHARIDE (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Asthenia, Blastocystis infection, Blood elastase increased, Blood immunoglobulin A, Blood immunoglobulin M, Chest discomfort, Chronic fatigue syndrome, Delayed sleep phase, Disturbance in attention, Dizziness, Eosinophil percentage increased, Eosinophilia, Epstein-Barr virus antibody positive, Eructation, Fatigue, Flatulence, Gastrointestinal disorder, Immune system disorder, Influenza like illness, Malaise, Natural killer cell count decreased, Neurological examination normal, Paraesthesia, Pollakiuria, Somatoform disorder, Thinking abnormal, Weight decreased, Wheezing
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Asthma/bronchospasm (broad), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Anticholinergic syndrome (broad), Dementia (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (narrow), Depression (excl suicide and self injury) (broad), Vestibular disorders (broad), Hypersensitivity (broad)
Write-up: Case received from a medical advisor from a specialised medical advising office for representatives of injury victims on 31-Jan-2013 under the reference numbers MIE2833, MIE2834, MIE2835. Medically confirmed. Upon internal review the company considered the case as serious. An adult male patient (39 years old at the time of reporting), who joined in 1996 and was vaccinated according to the following schedule (manufacturers of the vaccines could not be traced. Batch numbers were not reported): 09-Sep-1997 Hepatitis A dose 1, unit dose 1ml; 10-Mar-1998 Hepatitis A booster, unit dose 1ml. 23-Jun-1998, Diphtheria, tetanus, polio vaccine dose 1 unit dose 1ml. 12-Jan-1999 Diphtheria, tetanus, polio vaccine revaccination, unit dose 1ml. 12-Jan-1999 Hepatitis B dose 1, unit dose 1ml. 19-Feb-1999 Measles, mumps, rubella vaccine. 19-FEB-1999 Hepatitis B dose 2, unit dose 1ml. 18-Aug-1999 Hepatitis B dose 3, unit dose 1ml. 08-Oct-2002 Typhoid vaccine, unit dose 0,5ml. 29-Sep-2003 Meningococcal vaccine ACWY (other MFR), unit dose 0,5ml. Afterwards (on an unspecified date), the patient developed flu-like symptoms with dizziness, fatigue and impaired concentration. The complaints increased in 2003. In 2005, the Epstein Barr virus appeared to be IgG positive, and it was assumed that he had gone through infectious mononucleosis in 2003. At that time he had been sick for three days. Patient continued despite the complaints, which is in accordance with his personality and the culture. In 2005, the complaints were: unable to think clearly, difficulty with concentration, fatigue, sometimes wheezing, sometimes chest pressure, belching and farting, frequent urination, sometimes tingling in the hands, some loss of strength in the legs and waking up exhausted in the morning. From 2005 he lost 15 kilogrammes of weight, after which his weight was 60 kilogrammes, with a length of 1m79. In that year, a Blastocystis hominis with mild eosinophilia was diagnosed. Various clinicians made the following diagnoses: PUS (physically unexplained symptoms), undifferentiated somatoform disorder, chronic fatigue syndrome (CFS), an immunological problem (internist), leaky gut (physician-professor), seriously delayed melatonin production with delayed sleep phase syndrome. According to a physician (internist infectious disease specialist at the clinic), on request of the court: "extensive literature review and our experience" have not brought forward that a relationship may exist between the concomitant vaccines and chronic insomnia and exhaustion. This was not further substantiated. At the time of reporting, an eosinophilia of 14% still existed, the patient was advised to be examined. All other neurological and internal examinations do not show any abnormalities, except the following, according to a physician-professor: high leucocyte elastase activity, IgA and IgM for intestinal bacteria in the peripheral blood and a low percentage of NK (Natural Killer) cells.

VAERS ID:486809 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2013-03-12
Location:Foreign  Entered:2013-03-13, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: The patient''s medical history included recurrent rhinopharyngitis, bronchitis and strongly positive tuberculin test. The patient''s sister was schizophrenic and the patient''s sister and aunt were asthmatic.
Diagnostic Lab Data:
CDC 'Split Type': E201301522
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Bronchial disorder, Bronchospasm, Cold sweat, Condition aggravated, Cough, Dyspnoea, Fatigue, Hyperhidrosis, Lung disorder, Lymphadenopathy, Nasopharyngitis, Rales, Respiratory disorder, Rhinitis, Sinus operation, Sinusitis, Temperature intolerance, Wheezing
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Asthma/bronchospasm (narrow), Neuroleptic malignant syndrome (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (narrow)
Write-up: Case retrieved from the literature on 20-Feb-2013. Case medically confirmed. An 8-year-old female patient had received a dose of BCG (manufacturer unknown, batch number not reported) on an unspecified date before June 1990 and in June 1990 she developed dry wheezing cough that was worse upon waking, she had difficulty breathing and foul-smelling, greenish purulent rhinitis. She was permanently fatigued and experienced profuse sweating. Multiple lymph nodes were enlarged and lung auscultation confirmed crackles with bronchospasm. Her medical history included recurrent rhinopharyngitis, bronchitis and strongly positive tuberculin test. The patient''s recurrent lung diseases were attributed to BCG vaccination (dosage, route, indication and time to onset not stated). She had previously received corrective treatment with antibacterial medication but her condition had not improved. She was then given homeopathic remedies and at a follow-up visit 1 month later her cough had disappeared. Ten years later, in 2000, the patient was doing well. Author comment: Homeopathy permanently cured recurrent BCG-induced lung disease in a child. At the time of reporting, only an abstract from the article was available. Full article received on 28-Feb-2013: It was reported that the patient developed recurrent pulmonary dysfunctions after she received a dose of BCG (manufacturer unknown) on an unspecified date. In 1988, she experienced cough and recurrent pneumopathy in the right middle lobe with probable bronchodilation which was treated with antibiotics, inhaled LOMUDAL, ZADITEN and physiotherapy. In 1989, she developed sinusitis which led to the fitting of a drain. In 1990, she experienced pneumopathy in the left lower lobe and she was given antibiotics, aerosol and physiotherapy. In Jun-1990, the patient consulted a homeopathic physician further to the previously reported events. Her condition had not improved despite treatment with antibiotics. She was not feverish but she was experiencing profuse sweating of head and feet and high sensitivity to cold and dampness. She was prescribed BRYONIA 4 CH and IPECA 4 CH to be taken alternatively on Sundays, THUYA 9 CH, SILICEA 9 CH, SULPHUR IODATUM 9 CH and AVIAIRE 9 CH as corrective treatment. In Jul-2010, 1 month later, cough which had persisted for 2 years resolved, sweating decreased, only mild rhinitis persisted and the physician prescribed the same treatment again. In Sep-1990, the patient was in good condition and she was given SILICEA 9 CH, 1 monthly dose for 3 months. In 2000, the patient was still in good condition, she had experienced a few episodes of rhinopharyngitis which were quickly resolved by taking a dose of SILICEA 9 CH. To be noted that the patient''s sister was schizophrenic and the patient''s sister and aunt were asthmatic. The patient was 8 years old in Jun-1990 and not at the time of onset.

VAERS ID:499716 (history)  Vaccinated:2013-03-20
Age:0.4  Onset:2013-06-13, Days after vaccination: 85
Gender:Male  Submitted:2013-08-16, Days after onset: 64
Location:Foreign  Entered:2013-08-16
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1308GBR002941
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER  SCUN
Administered by: Other     Purchased by: Other
Symptoms: Infection, Lymphadenopathy, Surgery
SMQs:
Write-up: This spontaneous report was received from a regulatory authority (No: GB-MHRA-EYC 00102351) refers to a 5 month old male patient. A 5 month old male patient developed infection and lymph node disorder on 13-JUN-2013, approximately 3 months after administration of BCG vaccine (manufacturer unknown) SSI (invalid batch no.: 110020A). He received an unknown dose of the BCG vaccine (manufacturer unknown) by subcutaneous route (wrong route of administration) on 20-MAR-2013. The father reported the child developed an infection of the lymph nodes of the left arm, which require a surgical procedure and a lengthy hospital stay. It was reported that the doctors have attributed the infection/reaction to the Bacillus Calmette-Guerin (BCG) vaccine (manufacturer unknown). At the time of reporting, he had recovered (reported as 10-JUL-2013). Additional information is not expected.

VAERS ID:514730 (history)  Vaccinated:2010-10-01
Age:0.3  Onset:0000-00-00
Gender:Female  Submitted:2013-11-26
Location:Foreign  Entered:2013-11-26
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Premature baby
Diagnostic Lab Data:
CDC 'Split Type': WAES1311GBR008875
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER109047C SYRUN
Administered by: Other     Purchased by: Other
Symptoms: Appetite disorder, Lymphadenopathy, Pain, Pyrexia, Weight increased
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Information has been received from unspecified consumer or other non-health professional refer to a 3 months old female premature baby via regulatory authority (ADR 22315089) who on 25-AUG-2010 was vaccinated with a dose of Hepatitis B Vaccine (manufacturer unknown), batch# NK34710, lot # 1646U, expiry date 12-OCT-2010 (expiry date reported as September 2010) via parenteral. On 01-OCT-2010 was vaccinated with a dose of BCG live (manufacturer unknown), batch# 109047C via parenteral. Concomitant therapy included amoxicillin. On an unspecified date, the patient presented with severe high fever, painful to touch or lift, enlarged lymph nodes of 1 cm and above, general well being affected included appetite and weight gain. It was reported that possibly the hepatitis B vaccine was no longer good as it was close to its expiry date. It was administered with an expiry date of a month later and or the BCG live (manufacturer unknown) was administered a little too early as the child was born premature. The patient could not build immune system as a full term child. The patient was monitored at the outpatient clinic''s children unit and accident and emergency by the doctors. The outcome of enlarged lymph nodes of 1 cm and above was recovering. The outcome of other adverse events was unknown. The reporter considered the events to be other medically significant. Additional information is not expected.

VAERS ID:514899 (history)  Vaccinated:2013-10-01
Age:0.3  Onset:0000-00-00
Gender:Female  Submitted:2013-11-27
Location:Foreign  Entered:2013-11-27
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Immunisation
Preexisting Conditions: Premature baby
Diagnostic Lab Data:
CDC 'Split Type': WAES1311GBR010809
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURER109047C SYRUN
Administered by: Other     Purchased by: Other
Symptoms: Decreased appetite, Lymphadenopathy, Pyrexia, Tenderness, Weight gain poor
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Information has been received from Sanofi Pasteur MSD (E2013-09618) on 19-NOV-2013 via health authority in the foreign country. GB-MHRA ADR 22315089. The case is not medically confirmed as it was reported by a consumer. A 3 month old female patient (weight 5 kg), who was a premature baby, received an injection of HBVAXPRO (batch number NK34710, lot# 1646U expiry date Sep-2010) thimerosal-free, dose in series, route and site of administration not reported, on 25-Aug-2010 and an injection of Bacillus Calmette Guerin vaccine (other manufacturer as the batch number 109047C did not correspond to SPMSD format of vaccine) dose in series, route and site of administration not reported, on 01-Oct-2010 and on an unspecified date, she experienced severe high fever, painful to touch or lift, enlarged nodes of 1 cm and, general well being affected including reduced appetite and weight gain. According to the reporter, possibly HBVAXPRO was no longer good as it was close to its expiry date and the Bacillus Calmette Guerin vaccine could have been administered a little too early as the child was born prematurely and she could not build immune system as a full term child. The patient was monitored at the outpatient clinic''s children unit and at the accident and emergency department by the doctors. She received concomitant treatment with amoxicillin (manufacturer unknown). At the time of reporting, the patient was recovering for lymph nodes and the outcome for all other adverse events was unknown. The regulatory authority considered that case serious due to be medically significant.

VAERS ID:522736 (history)  Vaccinated:2013-05-23
Age:0.4  Onset:2013-12-16, Days after vaccination: 207
Gender:Male  Submitted:2014-02-11, Days after onset: 57
Location:Foreign  Entered:2014-02-14, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown; Family history: Paternal grandmother, uncle and cousin had STAT1 deficiency and the cousin was under treatment for multifocal tuberculous osteomyelitis (not known at the time of vaccination)
Diagnostic Lab Data: On 24-Dec-2013, image examination was performed and revealed signs of multifocal osteomyelitis. A genetic test was requested and performed and diagnosis of STAT1 deficiency was made. T-SPOT was negative; Body temperature, 23MAY2013, 37.4 Degree C; Tuberculin test, UNK, Positive; bone biopsy, 26DEC2013, Negative PCR; culture, 16Jan2014, Mycobacterium tuberculosis
CDC 'Split Type': 2014SA016108
Vaccination
Manufacturer
Lot
Dose
Route
Site
BCG: BCG (NO BRAND NAME)UNKNOWN MANUFACTURERK11178 UNUN
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURERV092A2UNUN
IPV: POLIO VIRUS, INACT. (POLIOVAX)SANOFI PASTEURJ00842SCUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Abasia, Biopsy bone normal, Bone tuberculosis, Culture positive, Cytogenetic analysis abnormal, Imaging procedure, Lymphadenitis bacterial, Lymphadenopathy, Polymerase chain reaction, Primary immunodeficiency syndrome, Pyrexia, Tuberculin test positive
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Congenital, familial and genetic disorders (narrow), Dystonia (broad), Guillain-Barre syndrome (broad)
Write-up: Initial report received from the authority (Ref: #V13001158) via healthcare professional in a foreign country on 06 February 2014. A 05-month-old male patient had received a subcutaneous primary third dose of IMOVAX POLIO (Lot number: J0084, anatomical site of administration was not reported), received a dose of BCG vaccine (lot number: K11178, route and anatomical site of administration were not reported) and primary third dose of DPT vaccine (lot number: V092A, route and anatomical site of administration were not reported) all vaccines on 23 May 2013. Family history included paternal grandmother, uncle and cousin with STAT1 deficiency and the cousin was under treatment for multifocal tuberculous osteomyelitis (not known at the time of vaccination). On 15 April2013, the patient was vaccinated with primary third dose of ACTHIB (Lot number: H1620), primary third dose of PREVENAR (Lot number: 12F02A), primary second dose of DPT vaccine (Lot number: V091C) and subcutaneous primary second dose of IMOVAX POLIO. His body temperature before the vaccination was 37.4 degrees C. In early Jul-2013, he presented with swollen left axillary lymph nodes. In Oct-2013, the event resolved spontaneously. On 16 December2013, the patient presented with pyrexia. On 18-December 2013, the patient developed abasia and was hospitalized for further evaluation. At first, the patient was diagnosed with pyrexia of unknown origin and started to receive Antibiotics, however, the pyrexia did not resolve. It was reported that the patient''s cousin had been diagnosed with mycobacterium tuberculosis infection osteomyelitis with a similar clinical course and was under treatment. Therefore, on 24 December 2013, image examination was performed and revealed signs of multifocal osteomyelitis. Tuberculin test was strongly positive. T-SPOT was negative. On 26 December 2013, bone biopsy showed negative PCR; however, tuberculosis treatment was initiated. On 29 December 2013, the patient''s general condition was improving. On 07 January 2014, the patient became afebrile and remained afebrile since then. On 16 January 2014, culture of specimen collected in bone biopsy revealed Mycobacterium tuberculosis. It was determined that the Mycobacterium tuberculosis was of BCG strain. At the time of reporting, he was still under tuberculosis treatment in the hospital. As of 04 February 2014, the patient had not recovered from events. Multifocal tuberculous osteomyelitis. Reporting pediatrician''s seriousness assessment: Serious (inpatient/prolonged hospitalization). Reporting pediatrician''s causality assessment: Related. Lymphadenitis suppurative. Reporting pediatrician''s seriousness assessment: Serious (inpatient/prolonged hospitalization). Reporting pediatrician''s causality assessment: Related. Reporting pediatrician''s comment: There was no alternative explanation for the event of multifocal tuberculous osteomyelitis. A genetic test was requested and performed at a hospital, and diagnosis of STAT1 deficiency was made. The patient''s paternal grandmother, uncle and cousin had STAT1 deficiency as well. The cousin was currently under treatment for multifocal tuberculous osteomyelitis.

VAERS ID:524022 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2014-02-25
Location:Foreign  Entered:2014-02-26, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Drug hypersensitivity
Diagnostic Lab Data:
CDC 'Split Type': 2014049053
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALS  UNUN
PNC: PNEUMO (PREVNAR)PFIZER/WYETH  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Dyspepsia, General physical health deterioration, Immediate post-injection reaction, Immune system disorder, Nervous system disorder
SMQs:, Gastrointestinal nonspecific dysfunction (narrow), Hypersensitivity (narrow)
Write-up: This is a spontaneous report from a non-contactable consumer, the mother of the patient. The report was received via a web page customer engagement program. A child patient of an unspecified gender received PREVENAR and PRIORIX, both via unspecified routes of administration on an unspecified date at single doses. Medical history included drug hypersensitivity reported as the patient was sensitive to any drugs and always experienced adverse events. The mother reported that the health state of the patient started to rapidly deteriorate right after the vaccinations. On unknown dates, the patient developed neurologic problems, immunity was destroyed, had serious digestive problems, etc. It was reported that the patient was permanently disabled and needed continuous care. The clinical outcome of the event, neurologic problems, immunity was destroyed, had serious digestive problems, was unknown.

VAERS ID:25994 (history)  Vaccinated:1989-12-05
Age:1.3  Onset:1989-12-29, Days after vaccination: 24
Gender:Male  Submitted:0000-00-00
Location:Wyoming  Entered:1990-09-20
Life Threatening? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Pedizole, Tassi Organdin
Current Illness: Otitis, Bronchitis
Preexisting Conditions:
Diagnostic Lab Data: Autopsy was contradictory /w no conclusions & many signs of Pertussis reactions.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2569573 L
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.2068P0 L
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES298B12PO 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Asphyxia, Brain oedema, Immune system disorder, Infection, Necrosis, Pulmonary haemorrhage, Pulmonary oedema, Splenomegaly
SMQs:, Cardiac failure (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Acute central respiratory depression (broad), Hyponatraemia/SIADH (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: Casey was given DPT/MMR/OPV while still on anitbiotic Pedizole and tassii organdin for otitis & bronchitis. He appeared happy & well until he died in his sleep. Shots were given on 5DEC89.

VAERS ID:26811 (history)  Vaccinated:1990-11-14
Age:1.1  Onset:1990-11-15, Days after vaccination: 1
Gender:Female  Submitted:1990-11-19, Days after onset: 4
Location:New York  Entered:1990-11-27, Days after submission: 8
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Triaminicol; Amoxicillin
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1880S   
Administered by: Private     Purchased by: Private
Symptoms: Agitation, Gait disturbance, Lymphadenopathy, Rash maculo-papular
SMQs:, Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Hypersensitivity (narrow)
Write-up: Pt vaccinated with MMR/HIB developed warmness & crying, unsteady gait, falling lasted 24 hrs; morbiliform rash with post occip nodes.

VAERS ID:27105 (history)  Vaccinated:1990-11-27
Age:1.3  Onset:1990-11-28, Days after vaccination: 1
Gender:Male  Submitted:1990-11-29, Days after onset: 1
Location:Wisconsin  Entered:1990-12-18, Days after submission: 19
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Increased Temp; 6mos; DTP, 3 doses.
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: CXR-OK; 10.3-WBC, 56 Lymph, 13.0 Hgb, 37 Hct, 44 PMndiff, platelet adequate-done 29NOV90 8AM.
CDC 'Split Type': WI90052
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (PROHIBIT)CONNAUGHT LABORATORIES0J110700IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1341S0SCLA
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Convulsion, Lymphadenopathy, Pyrexia, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Generalised convulsive seizures following immunisation (narrow)
Write-up: Pt vaccinated w/HIB/MMR developed temp 103.2 24 hrs after inject, irritable, refused liquids - saw MD 3PM; 4PM started on Ceclor no local reddness or edema at injection site, lymph nodes enlarged in neck area. Also had seizure and vomit.

VAERS ID:27313 (history)  Vaccinated:1989-07-17
Age:1.6  Onset:1990-12-03, Days after vaccination: 504
Gender:Male  Submitted:1990-12-27, Days after onset: 24
Location:West Virginia  Entered:1991-01-07, Days after submission: 11
Life Threatening? No
Died? Yes
   Date died: 1990-12-05
   Days after onset: 2
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Blood Culture positive for H. Influenza type B
CDC 'Split Type': CO3731
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)CONNAUGHT LABORATORIES    
HIBV: HIB (PROHIBIT)CONNAUGHT LABORATORIES8J011710  
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES    
Administered by: Private     Purchased by: Private
Symptoms: Drug ineffective, Immune system disorder, Meningitis, Sepsis
SMQs:, Agranulocytosis (broad), Lack of efficacy/effect (narrow), Noninfectious meningitis (narrow)
Write-up: Died after developing Hib meningitis. MD sending samples to CDC for analysis. Reported that the child had some form of immune deficiency. Father told MD he also had a form of immune deficiency.

VAERS ID:27651 (history)  Vaccinated:1991-01-04
Age:1.4  Onset:1991-01-16, Days after vaccination: 12
Gender:Male  Submitted:1991-01-22, Days after onset: 6
Location:New Hampshire  Entered:1991-01-30, Days after submission: 8
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: 3 wks on Ceclor/Suprex started 14DEC90. Tine test 4JAN91 ID forearm Lederle
Current Illness:
Preexisting Conditions: eye problems
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (PROHIBIT)CONNAUGHT LABORATORIES0A211330IML
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1494S0SCA
Administered by: Private     Purchased by: Public
Symptoms: Agitation, Anorexia, Face oedema, Lymphadenopathy, Pyrexia, Somnolence
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (narrow), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Hypersensitivity (narrow)
Write-up: Drowsy for 3 days (sleeping -$g 15 hrs/day a/onset of acute sx 16JAN91. Evening hrs face became swollen, temp 103.4, began moaning, stopped eating. Seen by MD 19JAN91 dx w/cervical adonitis treated w/Augmentin sx dissipating 21JAN91.

VAERS ID:27687 (history)  Vaccinated:1991-01-08
Age:1.3  Onset:0000-00-00
Gender:Male  Submitted:1991-01-25
Location:Tennessee  Entered:1991-01-31, Days after submission: 6
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: otitis media
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM200FE0IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.188480SCLA
Administered by: Private     Purchased by: Private
Symptoms: Lymphadenopathy
SMQs:
Write-up: do not know if related to vax, swollen inguinal lymph nodes on same side of body (lt) that shot was given (lt leg)

VAERS ID:27716 (history)  Vaccinated:1991-01-10
Age:1.5  Onset:1991-01-16, Days after vaccination: 6
Gender:Male  Submitted:1991-01-18, Days after onset: 2
Location:Missouri  Entered:1991-02-04, Days after submission: 17
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: In sister, /w MMR, had lymph node swelling in neck /p vax
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': MO915
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2859203IMGM
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1417S0SCRA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES2919782PO 
Administered by: Public     Purchased by: Public
Symptoms: Cyst, Epididymitis, Infection, Lymphadenopathy, Orchitis, Otitis media, Pyrexia, Scrotal oedema
SMQs:, Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: Child woke up AM of 16JAN91 w/fever, swelling of scrotum & bilateral inguinal lymph nodes. Fever to 103. Seen by MD dx w/orchitis & ear infect given Augmentin for ear infect. Dx w/uremia from MMR resulting in a epididmitis & hydrocele.

VAERS ID:28344 (history)  Vaccinated:1991-01-14
Age:1.7  Onset:1991-01-23, Days after vaccination: 9
Gender:Male  Submitted:1991-01-31, Days after onset: 8
Location:Michigan  Entered:1991-02-18, Days after submission: 18
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: pt is adopted Korean
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Diagnostic Lab Data: none
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0433S0SCLA
Administered by: Private     Purchased by: Private
Symptoms: Agitation, Lymphadenopathy, Pyrexia, Rash, Rhinitis
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Hypersensitivity (narrow)
Write-up: 25Jan91 mother called MD''s ofc to rept possible rxn to MMR vax on 23Jan91, pm child irritable, T 101, 24Jan91 pm red raised rash starting on face, slight runny nose, 29Jan91 had rash for 4 days, swollen glands along jaw line, 31Jan91 well

VAERS ID:28351 (history)  Vaccinated:1990-12-03
Age:1.4  Onset:1990-12-03, Days after vaccination: 0
Gender:Male  Submitted:1991-02-08, Days after onset: 67
Location:Washington  Entered:1991-02-18, Days after submission: 10
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: none
Preexisting Conditions:
Diagnostic Lab Data: blood culture-nl, WA-nl, CBC-nl except WBC 16.9 (nl is 5-13), differential-nl, Throat cx-nl
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2899013IMLL
HIBV: HIB (PROHIBIT)CONNAUGHT LABORATORIES0C211320IMRL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1492S0SCLA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0622K2PO 
Administered by: Public     Purchased by: Public
Symptoms: Cough, Lymphadenopathy, Pharyngitis, Pyrexia, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Agranulocytosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)
Write-up: cough & T onset 1 hr /p vax. T up to 104, vomiting X several hrs, T lasted days, saw MD 5Dec. Throat red, enlarged anterior nodes, cough, T noted in chart. MD states UNK whether T & other illness symptoms related to vax. Recommends DT.

VAERS ID:28424 (history)  Vaccinated:1991-01-14
Age:1.3  Onset:1991-02-09, Days after vaccination: 26
Gender:Female  Submitted:0000-00-00
Location:Maryland  Entered:1991-02-25
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Delayed physical & motor development/anemia
Diagnostic Lab Data: CBC-mono test, throat culture, H&H- 10.9/32.2, WBC-18,600, SEGS-10, Lymph-81, Mono-6, Bands-3, platlets-179,000
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.    
Administered by: Unknown     Purchased by: Unknown
Symptoms: Conjunctivitis, Cough, Hepatocellular damage, Lymphadenopathy, Otitis media, Petechiae, Pharyngitis, Pyrexia, Rash, Rash maculo-papular, Spleen disorder
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Severe cutaneous adverse reactions (broad), Anaphylactic reaction (narrow), Agranulocytosis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Conjunctival disorders (narrow), Ocular infections (broad), Hypersensitivity (narrow)
Write-up: Fever, rash, pharyngitis, otitis media, exanthem on soft palate, maculo papular rash on face, trunk & extremities. Few petechia sub mandibular lymphadenopathy, liver 2 cm down, spleen tip 1 cm down, injected conjunctivitis, cough

VAERS ID:28508 (history)  Vaccinated:1991-01-29
Age:1.4  Onset:1991-02-08, Days after vaccination: 10
Gender:Female  Submitted:1991-02-13, Days after onset: 5
Location:Pennsylvania  Entered:1991-02-28, Days after submission: 15
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: teething & slight cold
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': PA9149
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2859153IMRA
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM210EP0IMRL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0213S0SCLA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0620F0PO 
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Insomnia, Lymphadenopathy, Otitis media, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Hypersensitivity (narrow)
Write-up: Irritability on 5FEB91- poor sleeping-screamed 8FEB91 & to ER; Fever 102.5(r) x 3 days better 9FEB91 AM-rash on stomach 8FEB91 spread to neck & down to knees. Gone 13FEB91. Glands swollen 8FEB91 x 1-2days. Also ear infection.

VAERS ID:28774 (history)  Vaccinated:1991-02-11
Age:1.3  Onset:1991-02-16, Days after vaccination: 5
Gender:Female  Submitted:1991-02-20, Days after onset: 4
Location:Oregon  Entered:1991-03-04, Days after submission: 12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: none
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Diagnostic Lab Data: none as of 21Feb91
CDC 'Split Type': OR914
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM670FC0IMRL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.2119R0SCLA
Administered by: Public     Purchased by: Public
Symptoms: Lymphadenopathy, Malaise, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Sat-16Feb91 @ 2000 low grade T, Sun-17Feb T 102, Mon-18Feb T 105.5, Tues-19Feb to MD T 101 & swollen glands, acts like she hurts all over, Wed-20Feb T 101, Thurs-21Feb afebrile, 0 rash yet.

VAERS ID:28853 (history)  Vaccinated:1991-01-28
Age:1.3  Onset:1991-02-15, Days after vaccination: 18
Gender:Male  Submitted:1991-02-19, Days after onset: 4
Location:Pennsylvania  Entered:1991-03-06, Days after submission: 15
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE KNOWN
Diagnostic Lab Data:
CDC 'Split Type': PA9154
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2939403IMRA
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM205EP0IMLA
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0213S0SCLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0624H2PO 
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Conjunctivitis, Lymphadenopathy, Oedema, Otitis media, Pyrexia, Rash, Rhinitis, Somnolence, Vasodilatation
SMQs:, Cardiac failure (broad), Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (narrow), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Conjunctival disorders (narrow), Ocular infections (broad), Hypersensitivity (narrow)
Write-up: Rash started behind ears on 15FEB91 moved to eyebrows, face, chest, back, abd, legs, & buttocks. Temp to 100 (forehead strep) was beet red & puffy; Enlarged glands behind ears. Cranky & slept a lot. Also ear infect & Conjunctivitis, coryza.

VAERS ID:29859 (history)  Vaccinated:1990-08-23
Age:1.4  Onset:1990-08-23, Days after vaccination: 0
Gender:Male  Submitted:1991-03-29, Days after onset: 218
Location:Tennessee  Entered:1991-04-11, Days after submission: 12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: none
Other Medications: ?
Current Illness: ?
Preexisting Conditions: ?
Diagnostic Lab Data: Strep test & blood test-neg
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2839102IM 
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0615C0SC 
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES016552PO 
Administered by: Private     Purchased by: Private
Symptoms: Arthritis, Asthma, Injection site reaction, Lymphadenopathy, Osteoarthritis, Rash, Urinary retention, Urticaria
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Asthma/bronchospasm (narrow), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Arthritis (narrow)
Write-up: T-104(R).Local rxn,pain,swelling,inc warmth @ site of inject,rash.Generalized adenopathy wheezing.Pain in joints.Inflammation of joints.Generalized rash began 30Aug90,then whelps.Saw MD when joints began swelling.Also difficult voiding

VAERS ID:29921 (history)  Vaccinated:1991-01-28
Age:1.3  Onset:1991-02-04, Days after vaccination: 7
Gender:Male  Submitted:1991-04-02, Days after onset: 57
Location:Colorado  Entered:1991-04-15, Days after submission: 12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: 4wks ex-premature infant, mild GER
Diagnostic Lab Data: NONE
CDC 'Split Type': CO9121
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM630FC0IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0896S0SCRL
Administered by: Public     Purchased by: Public
Symptoms: Arthralgia, Diarrhoea, Lymphadenopathy, Pyrexia, Rash, Screaming, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Hypersensitivity (narrow), Arthritis (broad), Noninfectious diarrhoea (narrow)
Write-up: Vomiting, & diarrhea x 2 days, self resolved; Then fever to 102F off & on x 7 days; Rash appeared on trunk, back arms & legs lasted x 5 days; Cried all day x 2 days; Mom states pt joints were sore, sl swelling in neck;

VAERS ID:30046 (history)  Vaccinated:1991-03-28
Age:1.2  Onset:1991-03-28, Days after vaccination: 0
Gender:Female  Submitted:1991-04-02, Days after onset: 5
Location:Louisiana  Entered:1991-04-22, Days after submission: 19
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: In sister;104.6F;4mos;DTP;2nd dose
Other Medications: none
Current Illness: cutting teeth
Preexisting Conditions: allergic Penicillin(Amoxil) & Ceclor
Diagnostic Lab Data: none
CDC 'Split Type': LA910401
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2759703IMLL
HIBV: HIB (PROHIBIT)CONNAUGHT LABORATORIES0J110700IMLA
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1569S0SCRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES0624L2PO 
Administered by: Public     Purchased by: Public
Symptoms: Conjunctivitis, Infection, Lymphadenopathy, Otitis media, Photosensitivity reaction, Pyrexia, Rash, Rhinitis
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Conjunctival disorders (narrow), Ocular infections (broad), Hypersensitivity (narrow)
Write-up: Recvd PC from mom 31Mar91 reporting,pt had DTP/OPV/HIB/MMR 28Mar91 that /p noon T 103F& Fri 103.3F& Sat T 101-102F.Rash Sun on abdo,back,chest,shoulders,face.Rash raised bumps.Swollen nodes behind ear-eye pinkish-sensitive to light-nose run

VAERS ID:30113 (history)  Vaccinated:1991-03-25
Age:1.3  Onset:1991-04-03, Days after vaccination: 9
Gender:Female  Submitted:1991-04-03, Days after onset: 0
Location:Michigan  Entered:1991-04-25, Days after submission: 21
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type': MI9121
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM460FN1IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1711S0SCLA
Administered by: Public     Purchased by: Public
Symptoms: Infection, Lymphadenopathy, Pharyngitis, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Agranulocytosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Oropharyngeal infections (narrow), Hypersensitivity (narrow)
Write-up: 3MAR91 pt had sl swollen glands in neck arm & both sides, w/inc temp of 104 & rash around ears; 4APR91 Seen by MD temp to 106 last night; dx massive ear, throat & gland infection; Has rash on body today; Tx ceclor for infect;

VAERS ID:30219 (history)  Vaccinated:1991-04-02
Age:1.9  Onset:1991-04-09, Days after vaccination: 7
Gender:Female  Submitted:1991-04-24, Days after onset: 15
Location:Alaska  Entered:1991-04-29, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: In brother; fever; <1yr; DTP; #1
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: allergies to dust, feathers-Amoxicillin
Diagnostic Lab Data: "Throat Culture negative, CBC, UA
CDC 'Split Type': AK91009
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2919291 RL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0216S0SCLL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES2899461PO 
Administered by: Public     Purchased by: Public
Symptoms: Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: Mom describes onset of fever 9APR91 highest temp 104; 13APR91 child covered w/rash fr head to toe; Described as blotchy, smooth to touch, involving face torso & all 4 extremities; fever dec @ this time lymph nodes swollen 24APR91;

VAERS ID:30709 (history)  Vaccinated:1991-04-09
Age:1.5  Onset:1991-04-11, Days after vaccination: 2
Gender:Male  Submitted:1991-04-12, Days after onset: 1
Location:Texas  Entered:1991-05-20, Days after submission: 38
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type': TX9139
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1716S0SCRA
Administered by: Public     Purchased by: Public
Symptoms: Lymphadenopathy
SMQs:
Write-up: Mom noticed swollen lymph node, seen by MD stated mild rxn to MMR given 9APR91; no temp, no other sx did not prescribe or tx;

VAERS ID:30914 (history)  Vaccinated:1990-10-19
Age:1.3  Onset:1990-10-19, Days after vaccination: 0
Gender:Female  Submitted:1990-10-19, Days after onset: 0
Location:Maryland  Entered:1991-05-31, Days after submission: 224
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type': MD90105
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0696S0SCLA
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES2819392PO 
Administered by: Public     Purchased by: Public
Symptoms: Injection site reaction, Lymphadenopathy, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow)
Write-up: Local rxn lt upper arm; hives; local adenopathy;

VAERS ID:33178 (history)  Vaccinated:1990-05-21
Age:1.2  Onset:1990-05-30, Days after vaccination: 9
Gender:Female  Submitted:0000-00-00
Location:Maryland  Entered:1991-05-31
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: No relevant hx
Diagnostic Lab Data: No relevant data
CDC 'Split Type': WAES90060001
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.2020R0IM 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Cough, Lymphadenopathy, Pyrexia
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: 21May90 pt vax; 30May90 mom reported that pt had fever, cough, & lump in the groin. Exam revealed inguinal adenopathy above the inject site, & distant adenopathy affecting neck; chest was clear. 101-102F fever lasted 48 hrs & resolved.

VAERS ID:31605 (history)  Vaccinated:1991-03-14
Age:1.6  Onset:1991-03-23, Days after vaccination: 9
Gender:Female  Submitted:0000-00-00
Location:Pennsylvania  Entered:1991-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Haemophilus B vaccine
Current Illness:
Preexisting Conditions: no relevant hx.
Diagnostic Lab Data: none
CDC 'Split Type': WAES91040018
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC. 0  
Administered by: Unknown     Purchased by: Unknown
Symptoms: Anorexia, Cough, Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: pt. recvd. vax & developed T-103.Later pt. developed rash& palpable postauricular & cervical adenopathy.

VAERS ID:33159 (history)  Vaccinated:1990-06-04
Age:1.3  Onset:1990-06-08, Days after vaccination: 4
Gender:Female  Submitted:0000-00-00
Location:Florida  Entered:1991-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Septra
Current Illness:
Preexisting Conditions: Infection in ear.
Diagnostic Lab Data: No relevant data
CDC 'Split Type': WAES90060550
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.   LL
Administered by: Unknown     Purchased by: Unknown
Symptoms: Lymphadenopathy
SMQs:
Write-up: 04Jun90 pt vax; 08Jun90 devel left inguinal lymphadenopathy, 1 1/2" x 1 1/2" in diameter, firm & non tender. Normal CBC. 30Jun90 gland was decreasing in size & pt exp was still being treated.

VAERS ID:33336 (history)  Vaccinated:1990-06-18
Age:1.3  Onset:1990-06-28, Days after vaccination: 10
Gender:Female  Submitted:0000-00-00
Location:New Jersey  Entered:1991-06-03
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: No relevant hx
Diagnostic Lab Data: Sepsis workup-neg; platelet count-normal;
CDC 'Split Type': WAES90070608
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (NO BRAND NAME)UNKNOWN MANUFACTURER    
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1166R   
Administered by: Unknown     Purchased by: Unknown
Symptoms: Lymphadenopathy, Petechiae, Pyrexia
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad)
Write-up: Pt recvd MMR on 18JUN90; 10 days post vax pt devel fever, petechial rash & swollen lymph nodes neccessitating admission to Hosp; Sepsis workup was neg & platelet count was normal; Pt d/c & recovered p/3 days;

VAERS ID:31759 (history)  Vaccinated:1991-05-28
Age:1.4  Onset:1991-06-04, Days after vaccination: 7
Gender:Male  Submitted:1991-06-07, Days after onset: 3
Location:Maine  Entered:1991-06-26, Days after submission: 19
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NA
Other Medications: NA
Current Illness: NA
Preexisting Conditions: Some food allergies
Diagnostic Lab Data: NA
CDC 'Split Type': ME91009
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1497S0 LA
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Lymphadenopathy, Pyrexia, Rash, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Hypersensitivity (narrow)
Write-up: T103.4F (R) 4JUN91, fussy 5JUN91, t103.6, 6JUN91, t104.0 fine rash-neck, chest, under arms, vomiting, some glandular swelling;

VAERS ID:32045 (history)  Vaccinated:1990-01-15
Age:1.7  Onset:1990-01-27, Days after vaccination: 12
Gender:Female  Submitted:0000-00-00
Location:Missouri  Entered:1991-06-28
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: No relevant history
Diagnostic Lab Data: No relevant data
CDC 'Split Type': WAES90020636
Vaccination
Manufacturer
Lot
Dose
Route
Site
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1683R0IM 
Administered by: Unknown     Purchased by: Unknown
Symptoms: Cough, Lymphadenopathy, Malaise, Otitis media, Pyrexia, Rash, Rhinitis
SMQs:, Anaphylactic reaction (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: On 27JAN90 pt devel rash started on face & by 30JAN90 progressed to entire body but dec on face; Also adenitis, fever, malaise, nasal congest, coughing, typical coryza & OM; tympanic membranes red & bulging; MD felt rash immun assoc measles

VAERS ID:32291 (history)  Vaccinated:1991-06-17
Age:1.3  Onset:1991-06-20, Days after vaccination: 3
Gender:Male  Submitted:1991-06-27, Days after onset: 7
Location:Minnesota  Entered:1991-07-08, Days after submission: 11
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: Frequent otitis
Diagnostic Lab Data:
CDC 'Split Type': MN91029
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (PROHIBIT)CONNAUGHT LABORATORIES0A211332 LA
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.0214S0 RA
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Insomnia, Lymphadenopathy, Oedema, Pyrexia
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad)
Write-up: Fever 101.8 ax on 20JUN91; Pt irritable & not sleeping; Swelling noted by mom on lt neck 20JUN91; Dx cervical adenitis; Rx Ceclor;

VAERS ID:32515 (history)  Vaccinated:1991-05-15
Age:1.3  Onset:1991-05-25, Days after vaccination: 10
Gender:Male  Submitted:1991-05-29, Days after onset: 4
Location:Pennsylvania  Entered:1991-07-12, Days after submission: 44
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Pt exp sl fever w/DTP # 1, 2, & 3;
Other Medications:
Current Illness: NONE
Preexisting Conditions:
Diagnostic Lab Data: Throat culture - positive Strep
CDC 'Split Type': PA91198
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM560FP0IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.2243S0SCRL
OPV: POLIO VIRUS, ORAL (ORIMUNE)LEDERLE LABORATORIES2919782PO 
Administered by: Public     Purchased by: Public
Symptoms: Agitation, Face oedema, Lymphadenopathy, Oedema peripheral, Pharyngitis, Pyrexia, Rash
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Agranulocytosis (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Oropharyngeal infections (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow)
Write-up: 25MAY91 became fussy, crying hysterically, did sleep off & on; 26MAY rash appeared; 27MAY rash worse covering entire body, feet swollen; 28MAY91 eyes swollen 29MAY seen by MD;Glands swollen, throat culture;T 101-102

VAERS ID:32528 (history)  Vaccinated:1991-04-24
Age:1.4  Onset:1991-05-01, Days after vaccination: 7
Gender:Female  Submitted:1991-05-23, Days after onset: 22
Location:Pennsylvania  Entered:1991-07-12, Days after submission: 50
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: NONE
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': PA91187
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTP: DTP (TRI-IMMUNOL)LEDERLE LABORATORIES2939483IMLA
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM560FP0IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1704S0SCRA
Administered by: Public     Purchased by: Public
Symptoms: Anorexia, Infection, Lymphadenopathy, Pyrexia, Rash
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow)
Write-up: 24APR91 immun given; 27APR91 pt broke out in chickenpox; 1MAY91 pt spiked t106, seen by MD in ER; given APAP & cool baths; glands became swollen & pt refused to eat x 2 days; Had rash for 2-3 days; Was not hospitalized;

VAERS ID:33039 (history)  Vaccinated:1991-04-02
Age:1.3  Onset:1991-04-09, Days after vaccination: 7
Gender:Male  Submitted:1991-06-10, Days after onset: 62
Location:Iowa  Entered:1991-07-29, Days after submission: 49
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: E. Sukazakii probably from Domestic animals @ home (hogs)
Diagnostic Lab Data: WBC 18,000-11,000
CDC 'Split Type': IA910023
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (HIBTITER)LEDERLE PRAXSISM160FH0IMRL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1502S0SCLL
Administered by: Public     Purchased by: Public
Symptoms: Conjunctivitis, Dehydration, Gastroenteritis, Infection, Lymphadenopathy,